TW202108678A - Composition, cured product, cured product production method, and additive - Google Patents

Composition, cured product, cured product production method, and additive Download PDF

Info

Publication number
TW202108678A
TW202108678A TW109115829A TW109115829A TW202108678A TW 202108678 A TW202108678 A TW 202108678A TW 109115829 A TW109115829 A TW 109115829A TW 109115829 A TW109115829 A TW 109115829A TW 202108678 A TW202108678 A TW 202108678A
Authority
TW
Taiwan
Prior art keywords
group
substituted
carbon atoms
unsubstituted
composition
Prior art date
Application number
TW109115829A
Other languages
Chinese (zh)
Inventor
金原有希子
中屋敷哲千
清水蓮
Original Assignee
日商艾迪科股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商艾迪科股份有限公司 filed Critical 日商艾迪科股份有限公司
Publication of TW202108678A publication Critical patent/TW202108678A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/04Oxygen-containing compounds
    • C08K5/10Esters; Ether-esters
    • C08K5/109Esters; Ether-esters of carbonic acid, e.g. R-O-C(=O)-O-R
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2/00Processes of polymerisation
    • C08F2/44Polymerisation in the presence of compounding ingredients, e.g. plasticisers, dyestuffs, fillers
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/36Sulfur-, selenium-, or tellurium-containing compounds
    • C08K5/37Thiols
    • C08K5/372Sulfides, e.g. R-(S)x-R'
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L101/00Compositions of unspecified macromolecular compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

A main problem addressed by the present invention is to provide a composition that provides excellent balance between curability and heat resistance of a cured product. The present invention solves said problem by providing a composition containing: a compound represented by general formula (A1); a sulfur-based antioxidant; and a curable component (refer to the description for R101, R102, R103, R104, n, a1, and X in the formula). The sulfur-based antioxidant is preferably a thioether-based antioxidant.

Description

組合物、硬化物、硬化物之製造方法及添加劑Composition, hardened product, hardened product manufacturing method and additives

本發明係關於一種硬化性及硬化物之耐熱性之平衡優異之組合物。The present invention relates to a composition having an excellent balance between curability and heat resistance of the cured product.

為提高熱塑性樹脂之耐熱性,存在添加抗氧化劑之情形。例如,專利文獻1中,記載有對熱塑性樹脂添加硫系抗氧化劑。 又,專利文獻2中,記載有對自由基硬化性樹脂添加硫系抗氧化劑及酚系抗氧化劑之兩者。 先前技術文獻 專利文獻In order to improve the heat resistance of thermoplastic resins, there are situations where antioxidants are added. For example, Patent Document 1 describes adding a sulfur-based antioxidant to a thermoplastic resin. In addition, Patent Document 2 describes adding both a sulfur-based antioxidant and a phenol-based antioxidant to a radical curable resin. Prior art literature Patent literature

專利文獻1:日本專利特開2017-128697公報 專利文獻2:日本專利特開2018-100403公報Patent Document 1: Japanese Patent Application Publication No. 2017-128697 Patent Document 2: Japanese Patent Application Publication No. 2018-100403

[發明所欲解決之問題][The problem to be solved by the invention]

然而,專利文獻1中存在如下等不良情況:有難以圖案化之情形;有加熱熔融之樹脂對其他構件引起熱劣化之情形。專利文獻2中記載之組合物存在有未充分硬化之情形等不良情況。又,存在如下等不良情況:有無法獲得充分之耐熱性之情形;有於高溫環境下產生硬化物之變色或裂痕之情形。However, Patent Document 1 has the following disadvantages: there are cases where it is difficult to pattern; there are cases where the resin melted by heating causes thermal deterioration of other components. The composition described in Patent Document 2 has disadvantages such as insufficient curing. In addition, there are the following disadvantages: there are cases where sufficient heat resistance cannot be obtained; there are cases where discoloration or cracks of the hardened material occur in a high-temperature environment.

本發明係鑒於上述問題點而成者,其主要課題在於提供一種硬化性及硬化物之耐熱性之平衡優異之組合物。 [解決問題之技術手段]The present invention was made in view of the above-mentioned problems, and its main subject is to provide a composition having an excellent balance of curability and heat resistance of the cured product. [Technical means to solve the problem]

本發明者等為解決上述課題而進行努力研究,結果發現藉由併用硫系抗氧化劑與酚性羥基已被保護基保護之特定結構之化合物作為抗氧化劑,而發揮優異之硬化性且獲得耐熱性優異之硬化物,例如獲得於80℃以上250℃以下之溫度區域之長期耐熱性優異之硬化物。 本發明者等基於該等見解而完成本發明。The inventors of the present invention made diligent research to solve the above-mentioned problems, and found that by using a sulfur-based antioxidant and a compound of a specific structure in which a phenolic hydroxyl group has been protected by a protective group as an antioxidant, excellent curability and heat resistance are obtained. Excellent cured products, such as cured products with excellent long-term heat resistance in a temperature range of 80°C to 250°C. The inventors of the present invention completed the present invention based on these findings.

即,本發明提供一種組合物,其含有下述通式(A1)所示之化合物(以下,有稱為化合物A1之情形)、硫系抗氧化劑及硬化性成分。That is, the present invention provides a composition containing a compound represented by the following general formula (A1) (hereinafter, sometimes referred to as compound A1), a sulfur-based antioxidant, and a curable component.

[化1]

Figure 02_image005
[化1]
Figure 02_image005

(式中,R101 表示碳原子數1~40之未經取代或具有取代基之脂肪族烴基、碳原子數6~40之未經取代或具有取代基之含芳香族烴之基、碳原子數2~40之未經取代或具有取代基之含雜環之基、碳原子數0~40之未經取代或具有取代基之矽烷基、或者該脂肪族烴基、該含芳香族烴之基、該含雜環之基或該矽烷基中之亞甲基之1個或2個以上被取代為選自下述群I中之二價基而成之基, R102 及R103 分別獨立地表示氫原子或碳原子數1~40之未經取代或具有取代基之脂肪族烴基, R104 表示鹵素原子、氰基、羥基、硝基、羧基、碳原子數1~40之未經取代或具有取代基之脂肪族烴基、碳原子數6~40之未經取代或具有取代基之含芳香族烴之基、碳原子數2~40之未經取代或具有取代基之含雜環之基、或者該脂肪族烴基、該含芳香族烴之基或該含雜環之基中之亞甲基之1個或2個以上被取代為選自下述群I中之二價基而成之基, 於R104 存在複數個之情形時,有複數個R104 彼此鍵結而形成苯環或萘環之情形, 於R104 存在複數個之情形時,有複數個R104 分別相同之情形,亦有分別不同之情形, n表示1~10之整數, a1表示0~2之整數, 於n為2~10之情形時,存在複數個之R101 、R102 、R103 、R104 及a1分別可相同亦可不同, X表示n價之基) 群I:-O-、-COO-、-OCO-、-CO-、-CS-、-S-、-SO-、-SO2 -、-NR230 -、-NR230 -CO-、-CO-NR230 -、-NR230 -COO-、-OCO-NR230 -或-SiR230 R231 -。R230 及R231 分別獨立地表示氫原子或未經取代之碳原子數1~40之脂肪族烴基。(In the formula, R 101 represents an unsubstituted or substituted aliphatic hydrocarbon group with 1 to 40 carbon atoms, an unsubstituted or substituted aromatic hydrocarbon-containing group with 6 to 40 carbon atoms, and a carbon atom An unsubstituted or substituted heterocyclic group containing 2-40, an unsubstituted or substituted silyl group with 0-40 carbon atoms, or the aliphatic hydrocarbon group or the aromatic hydrocarbon-containing group One or more of the heterocyclic group or the methylene group in the silyl group is substituted with a divalent group selected from the following group I, R 102 and R 103 are each independently Represents a hydrogen atom or an unsubstituted or substituted aliphatic hydrocarbon group with 1-40 carbon atoms, R 104 represents a halogen atom, a cyano group, a hydroxyl group, a nitro group, a carboxyl group, an unsubstituted or a C 1-40 aliphatic hydrocarbon group Substituent aliphatic hydrocarbon group, unsubstituted or substituted aromatic hydrocarbon-containing group with 6 to 40 carbon atoms, unsubstituted or substituted heterocyclic ring-containing group with 2 to 40 carbon atoms , Or one or more of the methylene groups in the aliphatic hydrocarbon group, the aromatic hydrocarbon-containing group or the heterocyclic group-containing group are substituted with a divalent group selected from the following group I when group R 104 in the presence of a plurality of situation, there are plural R 104 bonded to each other to form a benzene or naphthalene ring of the case, in case of presence of a plurality of R 104, there are a plurality of R 104 are the same case, There are also different situations, n represents an integer from 1 to 10, a1 represents an integer from 0 to 2, when n is 2 to 10, there are plural R 101 , R 102 , R 103 , R 104 and a1 They can be the same or different, and X represents the n-valent base) Group I: -O-, -COO-, -OCO-, -CO-, -CS-, -S-, -SO-, -SO 2 -, -NR 230 -, -NR 230 -CO-, -CO-NR 230 -, -NR 230 -COO-, -OCO-NR 230 -or -SiR 230 R 231 -. R 230 and R 231 each independently represent a hydrogen atom or an unsubstituted aliphatic hydrocarbon group having 1 to 40 carbon atoms.

根據本發明,上述組合物之硬化性及硬化物之耐熱性之平衡優異。According to the present invention, the curability of the above composition and the heat resistance of the cured product have an excellent balance.

本發明中,R101 較佳為碳原子數1~40之未經取代或具有取代基之脂肪族烴基、碳原子數6~40之未經取代或具有取代基之含芳香族烴之基、或者碳原子數2~40之未經取代或具有取代基之含雜環之基中之氧原子側末端的亞甲基被取代為選自上述群I中之二價基而成之基、或碳原子數0~40之未經取代或具有取代基之矽烷基。其原因在於,藉由使R101 為上述基,而成為硬化性及硬化物之耐熱性之平衡優異者。In the present invention, R 101 is preferably an unsubstituted or substituted aliphatic hydrocarbon group having 1 to 40 carbon atoms, an unsubstituted or substituted aromatic hydrocarbon-containing group having 6 to 40 carbon atoms, Or an unsubstituted or substituted heterocyclic-containing group having 2 to 40 carbon atoms has a methylene group at the end of the oxygen atom side substituted with a divalent group selected from the above group I, or Unsubstituted or substituted silyl group with 0-40 carbon atoms. The reason is that by making R 101 the above-mentioned group, it becomes one having an excellent balance between curability and heat resistance of the cured product.

本發明中,上述硫系抗氧化劑較佳為硫醚系抗氧化劑。其原因在於,上述組合物會成為硬化性及硬化物之耐熱性之平衡性進一步優異者。In the present invention, the sulfur-based antioxidant is preferably a thioether-based antioxidant. The reason for this is that the above-mentioned composition becomes more excellent in the balance of curability and heat resistance of the cured product.

本發明中,上述硫醚系抗氧化劑較佳為選自由下述通式(B1)、(B2)、(B3)及(B4)所組成之群中之至少一種。其原因在於,藉由使硫醚系抗氧化劑為上述各通式所示之化合物,而成為硬化性及硬化物之耐熱性之平衡性進一步優異者。In the present invention, the above-mentioned thioether antioxidant is preferably at least one selected from the group consisting of the following general formulas (B1), (B2), (B3) and (B4). The reason is that the thioether-based antioxidant is a compound represented by each of the above general formulas, so that the balance between the curability and the heat resistance of the cured product is more excellent.

[化2]

Figure 02_image007
[化2]
Figure 02_image007

(式中,R1 及R2 分別獨立地表示碳原子數6~20之芳基、碳原子數3~30之烷基、或者該烷基中之亞甲基之1個或2個以上被取代為-O-或-S-而成之基, R3 、R4 、R5 、R6 、R7 、R8 、R9 及R10 分別獨立地表示氫原子、碳原子數1~8之烷基、或者該烷基中之亞甲基之1個或2個以上被取代為-O-或-S-而成之基, 上述烷基之氫原子之1個或2個以上可被取代為烷氧基、烯基、烯氧基、羥基或氰基, 上述芳基之氫原子之1個或2個以上可被取代為羥基或碳原子數1~8之烷基)(In the formula, R 1 and R 2 each independently represent an aryl group with 6 to 20 carbon atoms, an alkyl group with 3 to 30 carbon atoms, or one or more of the methylene groups in the alkyl group. Substituted with -O- or -S-, R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 and R 10 each independently represent a hydrogen atom and the number of carbon atoms is 1-8 The alkyl group, or one or more of the methylene groups in the alkyl group is substituted with -O- or -S-. One or more of the hydrogen atoms of the above-mentioned alkyl group may be Substitution is alkoxy, alkenyl, alkenyloxy, hydroxy or cyano, and one or more of the hydrogen atoms of the aryl group may be substituted with hydroxy or alkyl with 1 to 8 carbon atoms)

[化3]

Figure 02_image009
[化3]
Figure 02_image009

(式中,R11 表示碳原子數6~20之芳基、碳原子數3~30之烷基、或者該烷基中之亞甲基之1個或2個以上被取代為-O-或-S-而成之基, R12 、R13 、R14 、R15 、R16 、R17 、R18 及R19 分別獨立地表示氫原子或碳原子數1~8之烷基, 上述烷基之氫原子之1個或2個以上可被取代為烷氧基、烯基、烯氧基、羥基或氰基, 上述芳基之氫原子之1個或2個以上可被取代為羥基或碳原子數1~8之烷基)(In the formula, R 11 represents an aryl group with 6 to 20 carbon atoms, an alkyl group with 3 to 30 carbon atoms, or one or more of the methylene groups in the alkyl group are substituted with -O- or -S-, R 12 , R 13 , R 14 , R 15 , R 16 , R 17 , R 18 and R 19 each independently represent a hydrogen atom or an alkyl group having 1 to 8 carbon atoms. One or more of the hydrogen atoms of the group may be substituted with alkoxy, alkenyl, alkenyloxy, hydroxy, or cyano, and one or more of the hydrogen atoms of the above aryl group may be substituted with hydroxy or Alkyl group with 1 to 8 carbon atoms)

[化4]

Figure 02_image011
[化4]
Figure 02_image011

(式中,R21 、R22 、R23 及R24 分別獨立地表示碳原子數3~30之烷基、或者該烷基中之亞甲基之1個或2個以上被取代為-O-或-S-而成之基, 上述烷基之氫原子之1個或2個以上可被取代為烷氧基、烯基、烯氧基、羥基或氰基)(In the formula, R 21 , R 22 , R 23 and R 24 each independently represent an alkyl group having 3 to 30 carbon atoms, or one or more of the methylene groups in the alkyl group are substituted with -O -Or -S-, one or more of the hydrogen atoms of the alkyl group may be substituted with alkoxy, alkenyl, alkenyloxy, hydroxyl or cyano

[化5]

Figure 02_image013
[化5]
Figure 02_image013

(式中,R31 及R32 分別獨立地表示氫原子、碳原子數6~20之芳基、碳原子數3~30之烷基、或者該烷基中之亞甲基之1個或2個以上被取代為-O-或-S-而成之基, L1 及L2 分別獨立地表示碳原子數1~8之伸烷基, 上述烷基及上述伸烷基之氫原子之1個或2個以上可被取代為烷氧基、烯基、烯氧基、羥基或氰基, 上述芳基之氫原子之1個或2個以上可被取代為羥基或碳原子數1~8之烷基)(In the formula, R 31 and R 32 each independently represent a hydrogen atom, an aryl group with 6 to 20 carbon atoms, an alkyl group with 3 to 30 carbon atoms, or one or two of the methylene groups in the alkyl group. More than one group substituted with -O- or -S-, L 1 and L 2 each independently represent an alkylene group having 1 to 8 carbon atoms, 1 of the above-mentioned alkyl group and the hydrogen atom of the above-mentioned alkylene group One or two or more may be substituted with alkoxy, alkenyl, alkenyl, hydroxy, or cyano, and one or two of the hydrogen atoms of the aryl group may be substituted with hydroxy or with 1-8 carbon atoms Of alkyl)

本發明中,式(B1)中之R1 及R2 分別獨立為碳原子數8~20之烷基, 式(B2)中之R11 為碳原子數8~20之烷基, 式(B3)中之R21 、R22 、R23 及R24 分別獨立為碳原子數8~20之烷基, 式(B4)中之R31 及R32 分別獨立較佳為碳原子數8~20之烷基。其原因在於,藉由使硫醚系抗氧化劑為具有上述結構之化合物,而成為硬化性及硬化物之耐熱性之平衡性進一步優異者。 In the present invention, R 1 and R 2 in the formula (B1) are each independently an alkyl group having 8 to 20 carbon atoms, and R 11 in the formula (B2) is an alkyl group having 8 to 20 carbon atoms, and the formula (B3) ) In R 21 , R 22 , R 23 and R 24 are each independently an alkyl group having 8 to 20 carbon atoms, and R 31 and R 32 in formula (B4) are each independently preferably having 8 to 20 carbon atoms alkyl. This is because the thioether-based antioxidant is a compound having the above-mentioned structure, and the balance between the curability and the heat resistance of the cured product is more excellent.

本發明中,上述硫醚系抗氧化劑較佳為上述通式(B3)或(B4)所示之化合物。其原因在於,藉由使硫醚系抗氧化劑為上述各通式所示之化合物,而成為硬化性及硬化物之耐熱性之平衡性進一步優異者。In the present invention, the above-mentioned thioether antioxidant is preferably a compound represented by the above-mentioned general formula (B3) or (B4). The reason is that the thioether-based antioxidant is a compound represented by each of the above general formulas, so that the balance between the curability and the heat resistance of the cured product is more excellent.

本發明中,上述通式(A1)所示之化合物之含量於上述通式(A1)所示之化合物及上述硫系抗氧化劑之合計100質量份中,較佳為10質量份以上70質量份以下。其原因在於,藉由使上述通式(A1)所示之化合物及上述硫系抗氧化劑之含量為上述範圍,而成為硬化性及硬化物之耐熱性之平衡性進一步優異者。In the present invention, the content of the compound represented by the general formula (A1) in 100 parts by mass of the compound represented by the general formula (A1) and the sulfur-based antioxidant is preferably 10 parts by mass or more and 70 parts by mass the following. The reason is that by setting the content of the compound represented by the general formula (A1) and the sulfur-based antioxidant in the above range, the balance between the curability and the heat resistance of the cured product is more excellent.

本發明中,上述硬化性成分較佳為含有自由基聚合性化合物。其原因在於,可有效獲得如下效果,即獲得耐熱性優異之硬化物。In the present invention, the curable component preferably contains a radically polymerizable compound. The reason is that the effect of obtaining a cured product excellent in heat resistance can be effectively obtained.

本發明提供一種硬化物,其係使上述組合物硬化而成。 根據本發明,由於使用有上述組合物,故而成為耐熱性優異者。The present invention provides a cured product obtained by curing the above-mentioned composition. According to the present invention, since the above-mentioned composition is used, it is excellent in heat resistance.

本發明提供一種硬化物之製造方法,其具有使上述組合物硬化之硬化步驟。 根據本發明,由於使用有上述組合物,故而可容易地獲得耐熱性優異之硬化物。The present invention provides a method for manufacturing a hardened product, which has a hardening step for hardening the above-mentioned composition. According to the present invention, since the above-mentioned composition is used, a cured product excellent in heat resistance can be easily obtained.

本發明提供一種添加劑,其含有下述通式(A1)所示之化合物與硫系抗氧化劑。The present invention provides an additive containing a compound represented by the following general formula (A1) and a sulfur-based antioxidant.

[化6]

Figure 02_image015
[化6]
Figure 02_image015

(式中,R101 表示碳原子數1~40之未經取代或具有取代基之脂肪族烴基、碳原子數6~40之未經取代或具有取代基之含芳香族烴之基、碳原子數2~40之未經取代或具有取代基之含雜環之基、碳原子數0~40之未經取代或具有取代基之矽烷基、或者該脂肪族烴基、該含芳香族烴之基、該含雜環之基或該矽烷基中之亞甲基之1個或2個以上被取代為選自下述群I中之二價基而成之基, R102 及R103 分別獨立地表示氫原子或碳原子數1~40之未經取代或具有取代基之脂肪族烴基, R104 分別獨立地表示鹵素原子、氰基、羥基、硝基、羧基、碳原子數1~40之未經取代或具有取代基之脂肪族烴基、碳原子數6~40之未經取代或具有取代基之含芳香族烴之基、碳原子數2~40之未經取代或具有取代基之含雜環之基、或者該脂肪族烴基、該含芳香族烴之基或該含雜環之基中之亞甲基之1個或2個以上被取代為選自下述群I中之二價基而成之基, 於R104 存在複數個之情形時,有複數個R104 彼此鍵結而形成苯環或萘環之情形, 於R104 存在複數個之情形時,有複數個R104 分別相同之情形,亦有不同之情形, n表示1~10之整數, a1表示0~2之整數, 於n為2~10之情形時,存在複數個之R101 、R102 、R103 、R104 及a1分別可相同亦可不同, X表示n價之基) 群I:-O-、-COO-、-OCO-、-CO-、-CS-、-S-、-SO-、-SO2 -、-NR230 -、-NR230 -CO-、-CO-NR230 -、-NR230 -COO-、-OCO-NR230 -或-SiR230 R231 -。R230 及R231 分別獨立地表示氫原子或未經取代之碳原子數1~40之脂肪族烴基。(In the formula, R 101 represents an unsubstituted or substituted aliphatic hydrocarbon group with 1 to 40 carbon atoms, an unsubstituted or substituted aromatic hydrocarbon-containing group with 6 to 40 carbon atoms, and a carbon atom An unsubstituted or substituted heterocyclic group containing 2-40, an unsubstituted or substituted silyl group with 0-40 carbon atoms, or the aliphatic hydrocarbon group or the aromatic hydrocarbon-containing group , One or more of the heterocyclic group or the methylene group in the silyl group is substituted with a divalent group selected from the following group I, R 102 and R 103 are each independently Represents a hydrogen atom or an unsubstituted or substituted aliphatic hydrocarbon group with 1-40 carbon atoms, R 104 each independently represents a halogen atom, a cyano group, a hydroxyl group, a nitro group, a carboxyl group, and a C 1-40 Substituted or substituted aliphatic hydrocarbon groups, unsubstituted or substituted aromatic hydrocarbon-containing groups with 6 to 40 carbon atoms, unsubstituted or substituted heterogeneous groups with 2 to 40 carbon atoms One or more of the methylene groups in the cyclic group, or the aliphatic hydrocarbon group, the aromatic hydrocarbon-containing group, or the heterocyclic group-containing group is substituted with a divalent group selected from the following group I from the group, there is to the case where a plurality of R 104, R 104 has a plurality bonded to each other to form a benzene or naphthalene ring of the case, there is to the case where a plurality of R 104, R 104 each have a plurality of identical There are also different situations. n represents an integer from 1 to 10, and a1 represents an integer from 0 to 2. When n is 2 to 10, there are multiple R 101 , R 102 , R 103 , R 104 And a1 can be the same or different, respectively, X represents the n-valent base) Group I: -O-, -COO-, -OCO-, -CO-, -CS-, -S-, -SO-, -SO 2 -, -NR 230 -, -NR 230 -CO-, -CO-NR 230 -, -NR 230 -COO-, -OCO-NR 230 -or -SiR 230 R 231 -. R 230 and R 231 each independently represent a hydrogen atom or an unsubstituted aliphatic hydrocarbon group having 1 to 40 carbon atoms.

根據本發明,由於含有上述通式(A1)所示之化合物與硫系抗氧化劑,故而藉由添加至含有硬化性成分之組合物中,可容易地形成硬化性及硬化物之耐熱性之平衡優異之組合物。 [發明之效果]According to the present invention, since it contains the compound represented by the above general formula (A1) and the sulfur-based antioxidant, by adding it to a composition containing a curable component, a balance of curability and heat resistance of the cured product can be easily formed Excellent composition. [Effects of Invention]

本發明發揮可提供硬化性及硬化物之耐熱性之平衡優異之組合物之效果。The present invention exerts the effect of providing a composition having an excellent balance of curability and heat resistance of the cured product.

本發明係關於一種組合物及其硬化物、該硬化物之製造方法、以及添加至該組合物中之添加劑。 以下,對本發明之組合物、硬化物、硬化物之製造方法及添加劑進行詳細說明。The present invention relates to a composition and its hardened product, a method of manufacturing the hardened product, and additives added to the composition. Hereinafter, the composition, hardened product, hardened product manufacturing method and additives of the present invention will be described in detail.

A.組合物 首先,對本發明之組合物進行說明。 本發明之組合物之特徵之一在於含有下述通式(A1)所示之化合物、硫系抗氧化劑、及硬化性成分。A. Composition First, the composition of the present invention will be explained. One of the characteristics of the composition of the present invention is that it contains a compound represented by the following general formula (A1), a sulfur-based antioxidant, and a curable component.

[化7]

Figure 02_image017
[化7]
Figure 02_image017

(式中,R101 表示碳原子數1~40之未經取代或具有取代基之脂肪族烴基、碳原子數6~40之未經取代或具有取代基之含芳香族烴之基、碳原子數2~40之未經取代或具有取代基之含雜環之基、碳原子數0~40之未經取代或具有取代基之矽烷基、或者該脂肪族烴基、該含芳香族烴之基、該含雜環之基或該矽烷基中之亞甲基之1個或2個以上被取代為選自下述群I中之二價基而成之基, R102 及R103 分別獨立地表示氫原子或碳原子數1~40之未經取代或具有取代基之脂肪族烴基, R104 表示鹵素原子、氰基、羥基、硝基、羧基、碳原子數1~40之未經取代或具有取代基之脂肪族烴基、碳原子數6~40之未經取代或具有取代基之含芳香族烴之基、碳原子數2~40之未經取代或具有取代基之含雜環之基、或者該脂肪族烴基、該含芳香族烴之基或該含雜環之基中之亞甲基之1個或2個以上被取代為選自下述群I中之二價基而成之基, 於R104 存在複數個之情形時,有複數個R104 彼此鍵結而形成苯環或萘環之情形, 於R104 存在複數個之情形時,有複數個R104 分別相同之情形,亦有不同之情形, n表示1~10之整數, a1表示0~2之整數, 於n為2~10之情形時,存在複數個之R101 、R102 、R103 、R104 及a1分別可相同亦可不同, X表示n價之基) 群I:-O-、-COO-、-OCO-、-CO-、-CS-、-S-、-SO-、-SO2 -、-NR230 -、-NR230 -CO-、-CO-NR230 -、-NR230 -COO-、-OCO-NR230 -或-SiR230 R231 -。R230 及R231 分別獨立地表示氫原子或未經取代之碳原子數1~40之脂肪族烴基。(In the formula, R 101 represents an unsubstituted or substituted aliphatic hydrocarbon group with 1 to 40 carbon atoms, an unsubstituted or substituted aromatic hydrocarbon-containing group with 6 to 40 carbon atoms, and a carbon atom An unsubstituted or substituted heterocyclic group containing 2-40, an unsubstituted or substituted silyl group with 0-40 carbon atoms, or the aliphatic hydrocarbon group or the aromatic hydrocarbon-containing group One or more of the heterocyclic group or the methylene group in the silyl group is substituted with a divalent group selected from the following group I, R 102 and R 103 are each independently Represents a hydrogen atom or an unsubstituted or substituted aliphatic hydrocarbon group with 1-40 carbon atoms, R 104 represents a halogen atom, a cyano group, a hydroxyl group, a nitro group, a carboxyl group, an unsubstituted or a C 1-40 aliphatic hydrocarbon group Substituent aliphatic hydrocarbon group, unsubstituted or substituted aromatic hydrocarbon-containing group with 6 to 40 carbon atoms, unsubstituted or substituted heterocyclic ring-containing group with 2 to 40 carbon atoms , Or one or more of the methylene groups in the aliphatic hydrocarbon group, the aromatic hydrocarbon-containing group or the heterocyclic group-containing group are substituted with a divalent group selected from the following group I when group R 104 in the presence of a plurality of situation, there are plural R 104 bonded to each other to form a benzene or naphthalene ring of the case, in case of presence of a plurality of R 104, there are a plurality of R 104 are the same case, There are also different situations. n represents an integer from 1 to 10, and a1 represents an integer from 0 to 2. When n is 2 to 10, there are plural R 101 , R 102 , R 103 , R 104 and a1 respectively Can be the same or different, X represents the base of n valence) Group I: -O-, -COO-, -OCO-, -CO-, -CS-, -S-, -SO-, -SO 2 -,- NR 230 -, -NR 230 -CO-, -CO-NR 230 -, -NR 230 -COO-, -OCO-NR 230 -or -SiR 230 R 231 -. R 230 and R 231 each independently represent a hydrogen atom or an unsubstituted aliphatic hydrocarbon group having 1 to 40 carbon atoms.

根據本發明,藉由併用作為上述通式(A1)所示之化合物之化合物A1及硫系抗氧化劑,上述組合物會成為硬化性及硬化物之耐熱性之平衡優異者。 此處,關於藉由併用上述化合物A1及硫系抗氧化劑,上述組合物會成為硬化性及硬化物之耐熱性之平衡優異者之原因,雖並不明確,但推測為如下。According to the present invention, by using the compound A1 as the compound represented by the general formula (A1) in combination with a sulfur-based antioxidant, the composition will have an excellent balance of curability and heat resistance of the cured product. Here, although the reason why the composition is excellent in the balance of curability and heat resistance of the cured product by using the compound A1 and the sulfur-based antioxidant in combination is not clear, it is presumed to be as follows.

即,化合物A1具有酚性羥基已被保護之結構,可將保護基R101 脫離而生成酚性羥基。已生成酚性羥基之化合物A1(以下,有稱為化合物A1'之情形)藉由可捕捉過氧自由基之作用等而發揮抗氧化能力,可實現上述組合物及其硬化物之耐熱性提高。 又,化合物A1由於具有酚性羥基已被保護基R101 保護之結構,故而與例如含有具有酚性羥基之抗氧化劑者相比,可抑制硬化性成分之硬化阻礙。因此,上述組合物成為硬化反應之感度優異,硬化不良之發生較少者,可獲得交聯密度較高之硬化物。所得之硬化物由於交聯密度較高,故而可抑制氧向硬化物內之滲入,結果可抑制高溫環境下之硬化性成分及其聚合物等之氧化劣化。其結果,上述硬化物成為耐熱性優異者。 硫系抗氧化劑藉由讓過氧化氫分解,而抑制硬化性成分及硬化性成分硬化而成之高分子量物等之氧化劣化。又,上述化合物A1'存在如下情形:藉由抗氧化能力之發揮而產生分解等,結構發生變化,使氧化劣化抑制能力消失。然而,硫系抗氧化劑可於氧化劣化抑制之作用過程中,自氧化劣化能力消失之化合物A1'再生具有氧化劣化能力之化合物A1'。如上所述,硫系抗氧化劑可抑制化合物A1'之氧化劣化能力消失,而獲得長期之耐熱性提高效果。 如上所述,藉由併用化合物A1及硫系抗氧化劑,因發揮優異之硬化性而防止氧之滲入,因過氧自由基之捕捉及過氧化氫之分解等不同機制而發揮抗氧化效果,因硫系抗氧化劑而產生化合物A1'之再生等作用,結果上述組合物會成為硬化性及硬化物之耐熱性之平衡優異者。 又,由於硬化性及硬化物之耐熱性優異,故而例如可於80℃以上250℃以下、其中為90℃以上230℃以下、尤其是100℃以上200℃以下之溫度區域發揮優異之耐熱性。進而,因該優異之硬化性及耐熱性,上述組合物對例如汽車、飛行器等運輸機器中所使用之電子機器般要求高溫環境下之長時間穩定性之構件之形成有用。That is, the compound A1 has a structure in which a phenolic hydroxyl group is protected, and the protective group R 101 can be removed to generate a phenolic hydroxyl group. The compound A1 that has formed a phenolic hydroxyl group (hereinafter referred to as compound A1') exhibits anti-oxidation ability by capturing peroxy radicals, etc., which can improve the heat resistance of the above-mentioned composition and its cured product . In addition, since the compound A1 has a structure in which the phenolic hydroxyl group is protected by the protective group R 101 , it can suppress the hardening inhibition of the curable component compared with, for example, an antioxidant having a phenolic hydroxyl group. Therefore, the composition is excellent in the sensitivity of the hardening reaction, and the occurrence of poor hardening is less, and a hardened product with a higher crosslink density can be obtained. The resulting cured product has a high crosslinking density, so oxygen can be prevented from penetrating into the cured product, and as a result, the oxidative degradation of the curable component and its polymer in a high-temperature environment can be suppressed. As a result, the above-mentioned cured product has excellent heat resistance. Sulfur-based antioxidants decompose hydrogen peroxide to suppress the oxidative degradation of the curable components and high molecular weight substances formed by the hardening of the curable components. In addition, the above-mentioned compound A1' may be decomposed due to the exertion of the antioxidant capacity, and the structure may be changed, and the oxidative degradation inhibitory capacity may disappear. However, the sulfur-based antioxidant can regenerate the compound A1' with oxidative degradation ability from the compound A1' whose oxidative degradation ability has disappeared in the process of inhibiting oxidative degradation. As described above, sulfur-based antioxidants can inhibit the loss of the oxidation degradation ability of compound A1', and obtain long-term heat resistance improvement effects. As mentioned above, by using compound A1 and sulfur-based antioxidants together, it exhibits excellent hardening properties and prevents oxygen from penetrating. It also exhibits antioxidant effects due to different mechanisms such as the capture of peroxy radicals and the decomposition of hydrogen peroxide. Sulfur-based antioxidants produce effects such as regeneration of compound A1', and as a result, the above-mentioned composition has an excellent balance of curability and heat resistance of the cured product. In addition, since the curability and heat resistance of the cured product are excellent, it can exhibit excellent heat resistance in a temperature range of, for example, 80°C or higher and 250°C or lower, among which 90°C or higher and 230°C or lower, especially 100°C or higher and 200°C or lower. Furthermore, due to the excellent curability and heat resistance, the above composition is useful for forming components that require long-term stability in a high-temperature environment, such as electronic equipment used in transportation equipment such as automobiles and aircraft.

本發明之組合物係含有化合物A1、硫系抗氧化劑及硬化性成分者。 以下,對本發明之組合物之各成分進行詳細說明。The composition of the present invention contains compound A1, sulfur-based antioxidant, and curable component. Hereinafter, each component of the composition of the present invention will be described in detail.

1.化合物A1 化合物A1係上述通式(A1)所示之化合物。 作為通式(A1)中之R101 、R102 、R103 及R104 (以下,有稱為R101 等之情形)所示之脂肪族烴基(以下,亦統稱為「R101 等所示之脂肪族烴基」),可設為僅含氫原子及碳原子且不含芳香族烴環及雜環者。該烴基係碳原子數1~40者。該烴基可未經取代,亦可具有取代基。作為R101 等所示之脂肪族烴基,例如可例舉:碳原子數1~40之烷基、碳原子數2~40之烯基、碳原子數3~40之環烷基、碳原子數4~40之環烷基烷基及該等基之氫原子之1個或2個以上被取代為後述取代基而成之基等。1. Compound A1 Compound A1 is a compound represented by the above general formula (A1). As the aliphatic hydrocarbon groups represented by R 101 , R 102 , R 103 and R 104 (hereinafter referred to as R 101 etc.) in the general formula (A1) (hereinafter, also collectively referred to as "R 101 etc.""Aliphatic hydrocarbon group") can be one that contains only hydrogen atoms and carbon atoms and does not contain an aromatic hydrocarbon ring or a heterocyclic ring. The hydrocarbon group is one having 1 to 40 carbon atoms. The hydrocarbon group may be unsubstituted or may have a substituent. Examples of the aliphatic hydrocarbon group represented by R 101 and the like include an alkyl group having 1 to 40 carbon atoms, an alkenyl group having 2 to 40 carbon atoms, a cycloalkyl group having 3 to 40 carbon atoms, and 4-40 cycloalkylalkyl groups and groups in which one or two or more of the hydrogen atoms of these groups are substituted with the substituents described below.

作為R101 等所示之碳原子數1~40之烷基,可使用僅含氫原子及碳原子之基。碳原子數1~40之烷基可為直鏈之烷基,亦可為支鏈之烷基。作為直鏈之烷基,例如可例舉:甲基、乙基、丙基、丁基、戊基、己基及庚基等。作為支鏈之烷基,例如可例舉:異丙基、第二丁基、第三丁基、異丁基、異戊基、第三戊基、2-己基、3-己基、2-庚基、3-庚基、異庚基、第三庚基、1-辛基、異辛基及第三辛基等。As the C1-C40 alkyl group represented by R 101 etc., a group containing only a hydrogen atom and a carbon atom can be used. The alkyl group having 1 to 40 carbon atoms may be a straight-chain alkyl group or a branched-chain alkyl group. Examples of linear alkyl groups include methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, and the like. Examples of branched alkyl groups include isopropyl, second butyl, tertiary butyl, isobutyl, isopentyl, tertiary pentyl, 2-hexyl, 3-hexyl, and 2-heptyl. Base, 3-heptyl, isoheptyl, third heptyl, 1-octyl, isooctyl and third octyl, etc.

作為R101 等所示之碳原子數2~40之烯基,可使用僅含氫原子及碳原子之基。碳原子數2~40之烯基可為直鏈之烯基,或者可為支鏈之烯基。例如可例舉:乙烯基、伸乙基、2-丙烯基、3-丁烯基、2-丁烯基、4-戊烯基、3-戊烯基及4-十二碳烯基。作為支鏈之烯基,例如可例舉:4,8,12-十四碳三烯基烯丙基等。As the alkenyl group having 2 to 40 carbon atoms represented by R 101 and the like, a group containing only a hydrogen atom and a carbon atom can be used. The alkenyl group having 2 to 40 carbon atoms may be a straight-chain alkenyl group or a branched-chain alkenyl group. For example, vinyl, ethylene, 2-propenyl, 3-butenyl, 2-butenyl, 4-pentenyl, 3-pentenyl, and 4-dodecenyl can be mentioned. As a branched alkenyl group, 4,8,12-tetradecatrienyl allyl etc. are mentioned, for example.

作為R101 等所示之碳原子數3~40之環烷基,可使用僅含氫原子及碳原子之基。碳原子數3~40之環烷基可為飽和單環式烷基,亦可為飽和多環式烷基。碳原子數3~40之環烷基中之氫原子之1個或2個以上可被取代為烷基。 作為上述碳原子數3~40之飽和單環式環烷基,例如可例舉:環丙基、環丁基、環戊基、環己基、環庚基、環辛基、環壬基及環癸基等。作為飽和多環式烷基,例如可例舉:金剛烷基、十氫萘基、八氫并環戊二烯基及雙環[1.1.1]戊基等。作為對飽和單環式烷基或飽和多環式烷基之環中之氫原子進行取代之烷基,可例舉與上述作為R101 等所示之碳原子數1~40之烷基所例示者相同之基。 作為飽和多環式烷基之環中之氫原子之1個或2個以上被取代為烷基而成之基,例如可例舉𦯉基等。As the cycloalkyl group having 3 to 40 carbon atoms represented by R 101 etc., a group containing only a hydrogen atom and a carbon atom can be used. The cycloalkyl group having 3 to 40 carbon atoms may be a saturated monocyclic alkyl group or a saturated polycyclic alkyl group. One or two or more of the hydrogen atoms in the cycloalkyl group having 3 to 40 carbon atoms may be substituted with an alkyl group. Examples of the saturated monocyclic cycloalkyl group having 3 to 40 carbon atoms include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, cyclononyl, and cyclo Decyl and others. As the saturated polycyclic alkyl group, for example, adamantyl group, decahydronaphthyl group, octahydrocyclopentadienyl group, bicyclo[1.1.1]pentyl group, etc. may be mentioned. Examples of the alkyl group substituted by the hydrogen atom in the ring of the saturated monocyclic alkyl group or the saturated polycyclic alkyl group include those exemplified above as the alkyl group having 1 to 40 carbon atoms represented by R 101 etc. The same basis. As a group in which one or two or more of the hydrogen atoms in the ring of the saturated polycyclic alkyl group are substituted with an alkyl group, for example, a 𦯉 group can be mentioned.

所謂R101 等所示之碳原子數4~40之環烷基烷基係指烷基之氫原子被環烷基取代之碳原子數4~40之基。碳原子數4~40之環烷基烷基中之環烷基可為飽和單環式烷基,亦可為飽和多環式烷基。作為上述碳原子數4~40之飽和單環式烷基烷基,例如可例舉:環丙基甲基、2-環丁基乙基及3-環戊基丙基等。作為碳原子數4~40之飽和多環式烷基烷基,例如可例舉3-3-金剛烷基丙基及十氫萘基丙基等。The cycloalkylalkyl group having 4 to 40 carbon atoms represented by R 101 and the like means a group having 4 to 40 carbon atoms in which the hydrogen atom of the alkyl group is substituted by a cycloalkyl group. The cycloalkyl group in the cycloalkylalkyl group having 4 to 40 carbon atoms may be a saturated monocyclic alkyl group or a saturated polycyclic alkyl group. Examples of the saturated monocyclic alkylalkyl group having 4 to 40 carbon atoms include cyclopropylmethyl, 2-cyclobutylethyl, 3-cyclopentylpropyl, and the like. Examples of the saturated polycyclic alkylalkyl group having 4 to 40 carbon atoms include 3-3-adamantylpropyl and decahydronaphthylpropyl.

本發明中,所謂基中所含之碳原子數,於基中之氫原子被取代基取代之情形時係指該取代後之基中所含之碳原子數。例如於上述碳原子數1~40之烷基之氫原子被取代之情形時,所謂碳原子數1~40係指氫原子被取代後之碳原子數,而非氫原子被取代前之碳原子數。 又,本發明中,關於特定碳原子數之基中之亞甲基被取代為二價基而成之基的碳原子數之規定設為與該取代前之基中所含之碳原子數之規定相同者。例如,本說明書中,碳原子數1~40之烷基中之亞甲基被取代為二價基而成之基之碳原子數設為1~40。In the present invention, the number of carbon atoms contained in a group refers to the number of carbon atoms contained in the substituted group when the hydrogen atom in the group is substituted by a substituent. For example, in the case where the hydrogen atoms of an alkyl group with 1-40 carbon atoms are substituted, the so-called carbon atoms 1-40 refers to the number of carbon atoms after the hydrogen atom is replaced, not the carbon atom before the hydrogen atom is replaced number. Furthermore, in the present invention, the number of carbon atoms in a group in which a methylene group in a group with a specific number of carbon atoms is substituted with a divalent group is defined as the number of carbon atoms in the group before the substitution Those with the same requirements. For example, in this specification, the number of carbon atoms of the group in which the methylene group in the alkyl group having 1 to 40 carbon atoms is substituted with a divalent group is set to 1 to 40.

作為上述R101 及R104 (以下,有稱為R104 等之情形)所示之碳原子數6~40之含芳香族烴之基(以下,亦統稱為「R104 等所示之含芳香族烴之基」),可設為含有僅含氫原子及碳原子之芳香族烴環且不含雜環者。該含芳香族烴之基可未經取代,亦可具有取代基。作為碳原子數6~40之含芳香族烴之基,例如可例舉:碳原子數6~40之芳基、碳原子數7~40之芳基烷基、脂肪族烴基之氫原子被取代為芳基而成之基、及該等基之氫原子之1個或2個以上被取代為後述取代基而成之基等。 再者,關於要由芳基取代氫原子之脂肪族烴基,可例舉R101 等所示之脂肪族烴基中之滿足特定碳原子數者。As the above-mentioned R 101 and R 104 (hereinafter, referred to as R 104, etc.), the aromatic hydrocarbon-containing group having 6 to 40 carbon atoms (hereinafter, also collectively referred to as the aromatic-containing group represented by R 104, etc.) Group of hydrocarbons") can be those containing an aromatic hydrocarbon ring containing only hydrogen and carbon atoms and not containing a heterocyclic ring. The aromatic hydrocarbon-containing group may be unsubstituted or may have a substituent. Examples of the aromatic hydrocarbon-containing group having 6 to 40 carbon atoms include: an aryl group having 6 to 40 carbon atoms, an arylalkyl group having 7 to 40 carbon atoms, and the hydrogen atom of an aliphatic hydrocarbon group is substituted A group formed by an aryl group, and a group formed by substituting one or two or more of the hydrogen atoms of these groups with the substituent mentioned later. Furthermore, as for the aliphatic hydrocarbon group whose hydrogen atom is to be replaced by an aryl group, one that satisfies the specified number of carbon atoms among the aliphatic hydrocarbon groups represented by R 101 and the like can be mentioned.

作為上述R104 等所示之碳原子數6~40之芳基,可設為具有芳香族性之基。上述芳基可為具有單環結構者,亦可為具有稠環結構者。進而,上述芳基可為將單環結構之芳基與單環結構之芳基連結而成者,亦可為將單環結構之芳基與縮合結構之芳基連結而成者,或者可為將縮合結構之芳基與縮合結構之芳基連結而成者。作為將2個芳基連結之連結基,可例舉單鍵及羰基等。上述芳基中之氫原子可被取代為未經取代或具有取代基之脂肪族烴基。作為具有單環結構之芳基,例如可例舉:苯基、聯苯基及二苯甲酮等。作為具有稠環結構之芳基,可例舉:萘基、蒽基、菲基及芘基等。作為對上述芳基中之氫原子進行取代之未經取代或具有取代基之脂肪族烴基,可例舉與上述作為R101 等所示之未經取代或具有取代基之碳原子數1~40之脂肪族烴基所例示者相同之基。對上述芳基中之氫原子進行取代之未經取代或具有取代基之脂肪族烴基較佳為碳原子數1~4之未經取代之烷基、碳原子數1~4之烷基中之氫原子之全部被取代為鹵素原子而成之基。The aryl group having 6 to 40 carbon atoms represented by the above-mentioned R 104 and the like may be an aromatic group. The above-mentioned aryl group may have a monocyclic structure or may have a condensed ring structure. Furthermore, the above-mentioned aryl group may be formed by linking an aryl group of a monocyclic structure and an aryl group of a single ring structure, or may be formed by linking an aryl group of a monocyclic structure and an aryl group of a condensed structure, or may be It is formed by connecting the aryl group of the condensed structure and the aryl group of the condensed structure. As a linking group linking two aryl groups, a single bond and a carbonyl group may, for example, be mentioned. The hydrogen atom in the above aryl group may be substituted with an unsubstituted or substituted aliphatic hydrocarbon group. As an aryl group having a monocyclic structure, for example, a phenyl group, a biphenyl group, a benzophenone, etc. may be mentioned. Examples of the aryl group having a condensed ring structure include naphthyl, anthracenyl, phenanthryl, and pyrenyl. Examples of the unsubstituted or substituted aliphatic hydrocarbon group substituted for the hydrogen atom in the above aryl group include the unsubstituted or substituted aliphatic hydrocarbon group shown as R 101 and the like above, which has 1 to 40 carbon atoms. The aliphatic hydrocarbon groups are the same as those exemplified. The unsubstituted or substituted aliphatic hydrocarbon group substituted by the hydrogen atom in the above aryl group is preferably an unsubstituted alkyl group having 1 to 4 carbon atoms and an alkyl group having 1 to 4 carbon atoms All hydrogen atoms are substituted with halogen atoms.

作為上述R104 等所示之碳原子數7~40之芳基烷基,可例舉R101 等所示之烷基中之氫原子之1個或2個以上被取代為R104 等所示的芳基而成之基等。作為碳原子數7~40之芳基烷基,例如可例舉:苄基、茀基、茚基、9-茀基甲基、α-甲基苄基、α,α-二甲基苄基、苯基乙基及萘基丙基、或者該等基中之氫原子被取代為未經取代或具有取代基之脂肪族烴基而成之基等。作為對芳基烷基中之烷基及芳基烷基中之氫原子進行取代之未經取代或具有取代基之脂肪族烴基,可例舉與上述作為R101 等所示之碳原子數1~40之未經取代或具有取代基之脂肪族烴基所例示者相同之基。As the arylalkyl group having 7-40 carbon atoms represented by R 104 and the like, one or more of the hydrogen atoms in the alkyl group represented by R 101 and the like are substituted by R 104 and the like. The aryl group becomes the base and so on. Examples of the arylalkyl group having 7 to 40 carbon atoms include benzyl, stilbyl, indenyl, 9- stilbylmethyl, α-methylbenzyl, α,α-dimethylbenzyl , Phenylethyl and naphthylpropyl, or groups in which the hydrogen atoms in these groups are substituted with unsubstituted or substituted aliphatic hydrocarbon groups, etc. Examples of the unsubstituted or substituted aliphatic hydrocarbon group in which the alkyl group in the arylalkyl group and the hydrogen atom in the arylalkyl group are substituted include those with the number of carbon atoms shown as R 101 and the like. ~40 unsubstituted or substituted aliphatic hydrocarbon groups are the same as those exemplified.

作為上述R104 等所示之碳原子數2~40之含雜環之基(以下,亦統稱為「R104 等所示之含雜環之基」),可使用含有作為含氫原子及碳原子以外之原子之環之雜環的基。上述含雜環之基可未經取代,亦可具有取代基。 作為上述含雜環之基,例如可例舉:四氫呋喃基、二氧戊環基、四氫哌喃基、𠰌啉基呋喃基、噻吩基、甲基噻吩基、己基噻吩基、苯并噻吩基、吡咯基、吡咯啶基、咪唑基、咪唑啶基、咪唑啉基、吡唑基、吡唑啶基、哌啶基及哌𠯤基等雜環;該等雜環中之氫原子被取代為未經取代或具有取代基之脂肪族烴基而成之基;脂肪族烴基之氫原子之1個或2個以上被取代為上述雜環基而成之基;該等基之氫原子之1個或2個以上被取代為後述取代基而成之基等。作為對上述含雜環之基進行取代之脂肪族烴基,可例舉上述作為R101 等所示之碳原子數1~40之未經取代或具有取代基之脂肪族烴基所例示者。再者,本說明書中,「碳原子數2~40之含雜環之基」中之「2~40」係對「含雜環之基」之碳原子數進行規定而非「雜環」。As the heterocyclic ring-containing group having 2 to 40 carbon atoms represented by R 104 and the like (hereinafter, also collectively referred to as "heterocyclic ring-containing group represented by R 104 and the like"), a group containing a hydrogen atom and carbon can be used. A heterocyclic group of a ring of atoms other than atoms. The above-mentioned heterocyclic ring-containing group may be unsubstituted or may have a substituent. Examples of the heterocyclic ring-containing group include: tetrahydrofuranyl, dioxolane, tetrahydropiperanyl, linolinylfuryl, thienyl, methylthienyl, hexylthienyl, and benzothienyl , Pyrrolyl, pyrrolidinyl, imidazolyl, imidazolidinyl, imidazolinyl, pyrazolyl, pyrazolidinyl, piperidinyl and piperidinyl and other heterocyclic rings; the hydrogen atoms in these heterocyclic rings are replaced by A group formed from an unsubstituted or substituted aliphatic hydrocarbon group; one or more of the hydrogen atoms of the aliphatic hydrocarbon group is substituted with the above-mentioned heterocyclic group; one of the hydrogen atoms of the aliphatic hydrocarbon group Or two or more groups which are substituted with the substituent mentioned later. As the aliphatic hydrocarbon group substituted with the heterocyclic ring-containing group, those exemplified as the unsubstituted or substituted aliphatic hydrocarbon group having 1 to 40 carbon atoms represented by R 101 and the like can be mentioned. In addition, in this specification, the "2-40" in the "heterocyclic ring-containing group having 2 to 40 carbon atoms" specifies the number of carbon atoms of the "heterocyclic ring-containing group" instead of the "heterocyclic ring".

R101 所示之碳原子數0~40之矽烷基可未經取代,亦可具有取代基。作為上述矽烷基,可例舉:氫原子未被取代之矽烷基、氫原子被其他取代基取代之經取代之矽烷基及該等基之氫原子之1個或2個以上被後述取代基取代之基等。 作為上述經取代之矽烷基,可例舉:單甲基矽烷基等單烷基矽烷基、單苯基矽烷基等單芳基矽烷基、二乙基矽烷基等二烷基矽烷基、二苯基矽烷基等二芳基矽烷基、三甲基矽烷基等三烷基矽烷基、三苯基矽烷基等三芳基矽烷基、甲基二苯基矽烷基等單烷基二芳基矽烷基、二甲基苯基矽烷基等二烷基單芳基矽烷基。The silyl group with 0-40 carbon atoms represented by R 101 may be unsubstituted or may have a substituent. Examples of the above-mentioned silyl group include: a silyl group in which a hydrogen atom is not substituted, a substituted silyl group in which a hydrogen atom is substituted by another substituent, and one or more of the hydrogen atoms of these groups are substituted by the substituent described later The base and so on. Examples of the above-mentioned substituted silyl groups include: monoalkylsilyl groups such as monomethylsilyl groups, monoarylsilyl groups such as monophenylsilyl groups, dialkylsilyl groups such as diethylsilyl groups, and diphenyl groups. Diarylsilyl groups such as trimethylsilyl groups, trialkylsilyl groups such as trimethylsilyl groups, triarylsilyl groups such as triphenylsilyl groups, monoalkyldiarylsilyl groups such as methyldiphenylsilyl groups, Dialkyl monoarylsilyl groups such as dimethylphenylsilyl group.

作為R104 所示之鹵素原子,可例舉:氟原子、氯原子、溴原子、碘原子等。Examples of the halogen atom represented by R 104 include a fluorine atom, a chlorine atom, a bromine atom, and an iodine atom.

上述脂肪族烴基、含芳香族烴之基或含雜環之基之亞甲基的2個以上被取代為選自上述群I中之二價基而成之基中,複數個該二價基相互可相同亦可不同,且二價基設為不相鄰者。Two or more of the aliphatic hydrocarbon group, aromatic hydrocarbon-containing group, or heterocyclic group-containing methylene group is substituted with a divalent group selected from the above group I, and a plurality of the divalent groups They may be the same or different from each other, and the divalent groups are not adjacent to each other.

作為上述脂肪族烴基之亞甲基之1個或2個以上被取代為選自上述群I中之二價基而成之基,於脂肪族烴基為烷基之情形時,例如可例舉:烷基之苯環側之末端之亞甲基被取代為-O-之基、即烷氧基等。 又,作為鍵結於苯環上之-O-R101 所示之基,亦可使用R101 之-O-側之末端之亞甲基被取代為-CO-O-之基、即-O-CO-O-R所示之基(R表示R101 之除氧原子側末端之亞甲基以外之基)等。 又,上述二價基係以氧原子不相鄰之方式選擇者。例如,於「-O-R101 」之R101 之-O-側之末端的亞甲基被選自上述群I中之二價基取代之情形時,作為上述二價基,不能選擇-O-、-OCO-,例如選擇-COO-、-CO-、-CS-、-S-、-SO-、-SO2 -、-NR230 -、-NR230 -CO-、-CO-NR230 -、-NR230 -COO-或-SiR230 R231 -。 本發明中,通常對亞甲基進行取代之二價基係以不相鄰之方式選擇者。即,由二價基取代之亞甲基係以不相鄰之方式選擇者。 作為上述群I中之R230 及R231 中所使用之未經取代之碳原子數1~40之脂肪族烴基,可使用上述R101 等中所使用之脂肪族烴基中氫原子未被取代基取代之基。As the above-mentioned aliphatic hydrocarbon group, one or two or more of the methylene groups are substituted with divalent groups selected from the above-mentioned group I. When the aliphatic hydrocarbon group is an alkyl group, for example: The methylene group at the end of the benzene ring side of the alkyl group is substituted with an -O- group, that is, an alkoxy group or the like. In addition, as the group represented by -OR 101 bonded to the benzene ring, the methylene group at the -O-side terminal of R 101 is substituted with -CO-O-, that is, -O-CO The group represented by -OR (R represents a group other than the methylene group at the end of the oxygen atom of R 101) and the like. In addition, the above-mentioned divalent group is selected so that the oxygen atoms are not adjacent to each other. For example, when the methylene group on the -O- side of R 101 of "-OR 101 " is substituted with a divalent group selected from the above group I, as the above divalent group, -O-, -OCO-, for example, select -COO-, -CO-, -CS-, -S-, -SO-, -SO 2 -, -NR 230 -, -NR 230 -CO-, -CO-NR 230 -, -NR 230 -COO- or -SiR 230 R 231 -. In the present invention, usually the divalent group substituted with the methylene group is selected in a non-adjacent manner. That is, the methylene group substituted by the divalent group is selected in a non-adjacent manner. As the unsubstituted aliphatic hydrocarbon group with 1 to 40 carbon atoms used in R 230 and R 231 in the above group I, the aliphatic hydrocarbon group used in the above R 101 and the like can be used with an unsubstituted hydrogen atom Substituted base.

作為對通式(A1)等中說明之脂肪族烴基、含芳香族烴之基及含雜環之基、矽烷基、以及該等基中之亞甲基之1個或2個以上被取代為選自上述群I中之二價基而成之基中之氫原子進行取代的取代基,更具體而言作為對上述烷基、烯基、環烷基、環烷基烷基、芳基、芳基烷基、含雜環之基及矽烷基、以及該等基中之亞甲基之1個或2個以上被取代為選自上述群I中之二價基而成之基中之氫原子的1個或2個以上進行取代之取代基,例如可例舉:乙烯基、烯丙基、丙烯酸基、甲基丙烯酸基等乙烯性不飽和基;氟、氯、溴、碘等鹵素原子;乙醯基、2-氯乙醯基、丙醯基、辛醯基、丙烯醯基、甲基丙烯醯基、苯基羰基(苯甲醯基)、鄰苯二甲醯基、4-三氟甲基苯甲醯基、特戊醯基、鄰羥苯甲醯基、草醯基、硬脂醯基、甲氧基羰基、乙氧基羰基、第三丁氧基羰基、正十八烷氧基羰基、胺甲醯基等醯基;乙醯氧基、苯甲醯氧基等醯氧基;胺基、乙基胺基、二甲基胺基、二乙基胺基、丁基胺基、環戊基胺基、2-乙基己基胺基、十二烷基胺基、苯胺基、氯苯基胺基、甲苯胺基、甲氧苯胺基、N-甲基-苯胺基、二苯基胺基、萘基胺基、2-吡啶基胺基、甲氧基羰基胺基、苯氧基羰基胺基、乙醯基胺基、苯甲醯基胺基、甲醯基胺基、特戊醯基胺基、月桂醯基胺基、胺甲醯基胺基、N,N-二甲基胺基羰基胺基、N,N-二乙基胺基羰基胺基、𠰌啉基羰基胺基、甲氧基羰基胺基、乙氧基羰基胺基、第三丁氧基羰基胺基、正十八烷氧基羰基胺基、N-甲基-甲氧基羰基胺基、苯氧基羰基胺基、胺磺醯基胺基、N,N-二甲基胺基磺醯基胺基、甲基磺醯基胺基、丁基磺醯基胺基、苯基磺醯基胺基等經取代之胺基;磺醯胺基、磺醯基、羧基、氰基、磺基、羥基、硝基、巰基、醯亞胺基、胺甲醯基、磺醯胺基、膦酸基、磷酸基、或羧基、磺基、膦酸基、磷酸基之鹽等。 即,作為上述取代基,可例舉:乙烯性不飽和基、鹵素原子、醯基、醯氧基、經取代之胺基、磺醯胺基、磺醯基、羧基、氰基、磺基、羥基、硝基、巰基、醯亞胺基、胺甲醯基、磺醯胺基、膦酸基、磷酸基、或羧基、磺基、膦酸基、磷酸基之鹽等。One or more of the aliphatic hydrocarbon group, aromatic hydrocarbon-containing group, heterocyclic group-containing group, silyl group, and methylene groups in these groups described in the general formula (A1) are substituted with Substituents substituted with hydrogen atoms in groups formed from divalent groups selected from the above group I, more specifically, as the above-mentioned alkyl group, alkenyl group, cycloalkyl group, cycloalkylalkyl group, aryl group, One or more of arylalkyl groups, heterocyclic ring-containing groups and silyl groups, and one or more of the methylene groups in these groups are substituted with hydrogen in the group formed by the divalent group selected from the above group I Substituents with one or more atoms substituted, for example, ethylenically unsaturated groups such as vinyl, allyl, acrylic, and methacrylic; halogen atoms such as fluorine, chlorine, bromine, and iodine ; Acetyl, 2-chloroacetyl, propionyl, octyl, acryloyl, methacryloyl, phenylcarbonyl (benzyl), phthaloyl, 4-trifluoromethyl Benzyl, p-pentyl, o-hydroxybenzyl, oxalanyl, stearyl, methoxycarbonyl, ethoxycarbonyl, tertiary butoxycarbonyl, n-octadecyloxy Acetyl groups such as carbonyl and aminoformyl; acetoxy groups such as acetoxy and benzyloxy groups; amino groups, ethylamino groups, dimethylamino groups, diethylamino groups, butylamino groups, Cyclopentylamino, 2-ethylhexylamino, dodecylamino, anilino, chlorophenylamino, tolylin, methoxyanilin, N-methyl-anilino, diphenyl Amino, naphthylamino, 2-pyridylamino, methoxycarbonylamino, phenoxycarbonylamino, acetylamino, benzylamino, methylamino, p-pentyl Amino, laurylamino, carbamate, N,N-dimethylaminocarbonylamino, N,N-diethylaminocarbonylamino, linolinylcarbonylamino , Methoxycarbonylamino, ethoxycarbonylamino, tertiary butoxycarbonylamino, n-octadecyloxycarbonylamino, N-methyl-methoxycarbonylamino, phenoxycarbonyl Amine group, sulfamoylamino group, N,N-dimethylaminosulfonylamino group, methylsulfonylamino group, butylsulfonylamino group, phenylsulfonylamino group, etc. Substituted amine group; sulfonamide, sulfonyl, carboxyl, cyano, sulfo, hydroxyl, nitro, sulfhydryl, amide, carbamethan, sulfonamide, phosphonic acid, phosphoric acid group , Or carboxyl, sulfo, phosphonic acid, phosphoric acid, etc. That is, as the above-mentioned substituents, ethylenically unsaturated groups, halogen atoms, acyl groups, acyloxy groups, substituted amine groups, sulfonamide groups, sulfonyl groups, carboxyl groups, cyano groups, sulfo groups, Hydroxyl group, nitro group, sulfhydryl group, amide group, carbamethan group, sulfonamide group, phosphonic acid group, phosphoric acid group, or carboxyl, sulfo, phosphonic acid, phosphoric acid salt, etc.

關於上述通式(A1)中之R101 ,就藉由加熱處理而易於脫離之觀點而言,較佳為碳原子數1~40之未經取代或具有取代基之脂肪族烴基、碳原子數6~40之未經取代或具有取代基之含芳香族烴之基、或碳原子數2~40之未經取代或具有取代基之含雜環之基中的氧原子側末端之亞甲基被取代為選自上述群I中之二價基而成之基或者碳原子數0~40之未經取代或具有取代基之矽烷基,即較佳為由上述二價基取代氧原子側末端之碳原子數1~40之未經取代或具有取代基之脂肪族烴基、碳原子數6~40之未經取代或具有取代基之含芳香族烴之基或碳原子數2~40之未經取代或具有取代基之含雜環之基、或者碳原子數0~40之未經取代或具有取代基之矽烷基,其中較佳為由-CO-O-取代氧原子側末端之碳原子數1~40之未經取代或具有取代基之脂肪族烴基,尤佳為由-CO-O-取代氧原子側末端之碳原子數1~40之未經取代或具有取代基之烷基,其中尤佳為由-CO-O-取代氧原子側末端之碳原子數1~40之未經取代或具有取代基之烷基,即-CO-O-R''(R''係碳原子數1~39之未經取代或具有取代基之烷基)所示之基。 本發明中,上述R''較佳為碳原子數1~20之未經取代或具有取代基之烷基,其中較佳為碳原子數1~8之未經取代或具有取代基之烷基,尤佳為碳原子數1~8之未經取代之烷基,其中尤佳為碳原子數3~6之未經取代之烷基,其中尤佳為異丙基、正丁基、第二丁基、第三丁基、異丁基、正戊基、異戊基、第三戊基,其中尤佳為正丁基、第二丁基、第三丁基、異丁基、第三丁基,即R101 為-CO-O-C4 H9 所示之基,其中尤佳為R''為第三丁基,即R101 為-CO-O-第三丁基。 其原因在於,藉由使上述R101 為上述基,上述化合物A1變得容易藉由加熱處理來控制R102 之脫離。 Regarding R 101 in the above general formula (A1), from the viewpoint of being easily removed by heat treatment, it is preferably an unsubstituted or substituted aliphatic hydrocarbon group having 1 to 40 carbon atoms, and the number of carbon atoms 6-40 unsubstituted or substituted aromatic hydrocarbon-containing group, or unsubstituted or substituted heterocyclic-containing group with 2-40 carbon atoms, the methylene group at the oxygen atom side terminal A group substituted with a divalent group selected from the above group I or an unsubstituted or substituted silyl group having 0 to 40 carbon atoms, that is, the oxygen atom side terminal is preferably substituted by the above divalent group The unsubstituted or substituted aliphatic hydrocarbon group with 1-40 carbon atoms, the unsubstituted or substituted aromatic hydrocarbon-containing group with 6-40 carbon atoms, or the unsubstituted aromatic hydrocarbon group with 2-40 carbon atoms A substituted or substituted heterocyclic ring-containing group, or an unsubstituted or substituted silyl group having 0-40 carbon atoms, wherein the carbon atom at the end of the oxygen atom is preferably substituted by -CO-O- An unsubstituted or substituted aliphatic hydrocarbon group of 1-40, particularly preferably an unsubstituted or substituted alkyl group with 1-40 carbon atoms at the end of the oxygen atom substituted by -CO-O-, Among them, an unsubstituted or substituted alkyl group with 1-40 carbon atoms at the end of the oxygen atom substituted by -CO-O- is particularly preferred, that is, -CO-O-R''(R'' is a carbon atom The number 1 to 39 (unsubstituted or substituted alkyl group) represented by the group. In the present invention, the above-mentioned R" is preferably an unsubstituted or substituted alkyl group having 1 to 20 carbon atoms, and particularly preferably an unsubstituted or substituted alkyl group having 1 to 8 carbon atoms , Particularly preferred are unsubstituted alkyl groups with 1 to 8 carbon atoms, and particularly preferred are unsubstituted alkyl groups with 3 to 6 carbon atoms, and particularly preferred are isopropyl, n-butyl, and second Butyl, tertiary butyl, isobutyl, n-pentyl, isopentyl, tertiary pentyl, particularly preferably n-butyl, second butyl, tertiary butyl, isobutyl, tertiary butyl The group, that is, R 101 is a group represented by -CO-OC 4 H 9 , among which R ″ is a tertiary butyl group, that is, R 101 is a -CO-O-tertiary butyl group. The reason is that by making the above-mentioned R 101 the above-mentioned group, the above-mentioned compound A1 becomes easy to control the detachment of R 102 by heat treatment.

作為上述化合物A1中所含之保護基R101 藉由加熱處理而脫離之溫度,根據上述組合物之用途等而適當設定,例如可設為80℃以上300℃以下,其中較佳為100℃以上290℃以下,尤佳為120℃以上280℃以下,其中尤佳為150℃以上250℃以下,且較佳為180℃以上240℃以下。其原因在於硬化性及硬化物之耐熱性之平衡性會變得進一步優異。 脫離溫度可設為藉由示差熱分析法而顯示出5質量%之燒失量之溫度。 作為測定方法,例如使用STA(示差熱-熱重量同步測定裝置),於試樣約5 mg、氮氣200 mL/min氛圍下,以升溫起始溫度30℃、升溫結束溫度500℃、升溫速度10℃/min進行升溫時測定試樣之燒失量,將相對於30℃時間點之試樣重量而減少5質量%之時間點的溫度設為脫離溫度。 作為示差熱-熱重量同步測定裝置,可使用STA7000(Hitachi High-Tech Science股份有限公司製造)。 The temperature at which the protective group R 101 contained in the above compound A1 is released by heat treatment is appropriately set according to the use of the above composition and the like. For example, it can be set to 80°C or higher and 300°C or lower, and 100°C or higher is preferable. 290°C or less, more preferably 120°C or more and 280°C or less, particularly preferably 150°C or more and 250°C or less, and more preferably 180°C or more and 240°C or less. The reason for this is that the balance between the curability and the heat resistance of the cured product becomes more excellent. The desorption temperature can be set to the temperature at which a loss on ignition of 5 mass% is shown by differential thermal analysis. As a measurement method, for example, using STA (differential thermal-thermogravimetric simultaneous measurement device), in an atmosphere of about 5 mg of the sample and 200 mL/min of nitrogen, the heating start temperature is 30℃, the heating end temperature is 500℃, and the heating rate is 10 Measure the loss on ignition of the sample when the temperature is raised at °C/min, and set the temperature at the time point when the weight of the sample at 30 °C is reduced by 5% by mass as the desorption temperature. As a differential calorimeter-thermogravimetry synchronous measuring device, STA7000 (manufactured by Hitachi High-Tech Science Co., Ltd.) can be used.

關於上述通式(A1)中之R101 ,就藉由光照射處理而易於脫離之觀點而言,亦可使用如鄰硝基苄基之光脫離性保護基。 再者,於上述R101 為光脫離性保護基之情形時,保護基R101 會自化合物A1脫離之光之波長例如可設為包含365 nm之波長者,更具體而言,可設為包含250 nm以上450 nm以下之波長之光者,較佳可設為包含280 nm以上380 nm以下之波長之光者。 為使R101 自上述化合物A1脫離所照射之光之累計光量例如可設為1000 mJ/cm2 以上10000 mJ/cm2 以下,較佳為超過1000 mJ/cm2 且為5000 mJ/cm2 以下,更佳為2000 mJ/cm2 以上4000 mJ/cm2 以下。其原因在於硬化性及硬化物之耐熱性之平衡性會變得進一步優異。 Regarding R 101 in the above general formula (A1), from the viewpoint of being easily released by light irradiation treatment, a photo-detachable protecting group such as o-nitrobenzyl can also be used. Furthermore, when the above-mentioned R 101 is a photo-detachable protecting group, the wavelength of the light at which the protecting group R 101 will desorb from the compound A1 can be set to include, for example, a wavelength of 365 nm, more specifically, it can be set to include The light having a wavelength of 250 nm or more and 450 nm or less can preferably be set to include light having a wavelength of 280 nm or more and 380 nm or less. In order to separate R 101 from the above compound A1, the cumulative light quantity of the irradiated light can be, for example, 1000 mJ/cm 2 or more and 10000 mJ/cm 2 or less, preferably more than 1000 mJ/cm 2 and 5000 mJ/cm 2 or less , More preferably 2000 mJ/cm 2 or more and 4000 mJ/cm 2 or less. The reason for this is that the balance between the curability and the heat resistance of the cured product becomes more excellent.

上述通式(A1)中之R102 及R103 分別獨立地較佳為氫原子、碳原子數1~40之烷基或該烷基之氫原子之1個或2個以上被進一步取代為上述取代基而成之基,即分別獨立地較佳為氫原子或碳原子數1~40之未經取代或具有取代基之烷基,其中較佳為氫原子或碳原子數1~40之未經取代之烷基,其中較佳為碳原子數1~40之烷基,其中較佳為碳原子數1~10之烷基,尤佳為碳原子數2~6之烷基,其中尤佳為-C4 H9 所示之碳原子數4之烷基,其中尤佳為第三丁基。 上述R102 及R103 較佳為至少一者為碳原子數1~40之未經取代或具有取代基之脂肪族烴基,其中較佳為R102 及R103 之兩者為碳原子數1~40之烷基或該烷基之氫原子之1個或2個以上被進一步取代為上述取代基而成之基,即較佳為R102 及R103 之兩者為碳原子數1~40之未經取代或具有取代基之烷基,尤佳為碳原子數1~40之未經取代之烷基,其中較佳為碳原子數1~10之烷基,尤佳為碳原子數2~6之烷基,其中尤佳為-C4 H9 所示之碳原子數4之烷基,其中尤佳為第三丁基。其原因在於,藉由使上述R102 及R103 為上述基,上述化合物A1會成為於保護基R101 之脫離前後,抗氧化能力之變化較大者。又原因在於,上述化合物A1可抑制硬化阻礙之發生。因此,硬化性及硬化物之耐熱性之平衡性會變得進一步優異。進而原因在於合成會變得容易。 R 102 and R 103 in the above general formula (A1) are each independently preferably a hydrogen atom, an alkyl group having 1 to 40 carbon atoms, or one or more of the hydrogen atoms of the alkyl group is further substituted as the above Substituent groups are each independently preferably a hydrogen atom or an unsubstituted or substituted alkyl group having 1 to 40 carbon atoms, and among them, a hydrogen atom or an unsubstituted or substituted alkyl group having 1 to 40 carbon atoms is preferable. The substituted alkyl group is preferably an alkyl group having 1 to 40 carbon atoms, of which an alkyl group having 1 to 10 carbon atoms is preferred, an alkyl group having 2 to 6 carbon atoms is particularly preferred, and an alkyl group having 2 to 6 carbon atoms is particularly preferred. It is an alkyl group with 4 carbon atoms represented by -C 4 H 9 , and a tertiary butyl group is particularly preferred. Preferably, at least one of R 102 and R 103 is an unsubstituted or substituted aliphatic hydrocarbon group having 1 to 40 carbon atoms, and it is preferable that both of R 102 and R 103 have 1 to carbon atoms. A 40 alkyl group or a group in which one or more of the hydrogen atoms of the alkyl group are further substituted with the above-mentioned substituents, that is, it is preferable that both of R 102 and R 103 have 1 to 40 carbon atoms The unsubstituted or substituted alkyl group is particularly preferably an unsubstituted alkyl group having 1 to 40 carbon atoms, among which an alkyl group having 1 to 10 carbon atoms is preferred, and an alkyl group having 2 to carbon atoms is particularly preferred. Among them, the alkyl group having 4 carbon atoms represented by -C 4 H 9 is particularly preferred, and the tertiary butyl group is particularly preferred. The reason is that, by making the above-mentioned R 102 and R 103 as the above-mentioned groups, the above-mentioned compound A1 becomes the one with a greater change in antioxidant capacity before and after the protective group R 101 is removed. Another reason is that the above compound A1 can inhibit the occurrence of hardening inhibition. Therefore, the balance between the curability and the heat resistance of the cured product becomes more excellent. Furthermore, the reason is that synthesis will become easy.

作為上述R104 ,較佳為鹵素原子、碳原子數1~40之未經取代或具有取代基之脂肪族烴基。其原因在於,藉由使上述R104 為上述基,上述化合物A1會成為於保護基R101 之脫離前後,抗氧化能力之變化較大者。又原因在於,上述化合物A1可抑制硬化阻礙之發生。因此,硬化性及硬化物之耐熱性之平衡性會變得進一步優異。進而原因在於合成會變得容易。The above-mentioned R 104 is preferably a halogen atom, an unsubstituted or substituted aliphatic hydrocarbon group having 1 to 40 carbon atoms. The reason is that, by making the above-mentioned R 104 as the above-mentioned group, the above-mentioned compound A1 becomes the one having a greater change in antioxidant capacity before and after the protective group R 101 is removed. Another reason is that the above compound A1 can inhibit the occurrence of hardening inhibition. Therefore, the balance between the curability and the heat resistance of the cured product becomes more excellent. Furthermore, the reason is that synthesis will become easy.

上述a1為0~2之整數,較佳為0~1,且較佳為0。其原因在於,上述組合物會成為硬化性及硬化物之耐熱性之平衡性進一步優異者。The above-mentioned a1 is an integer of 0-2, preferably 0-1, and preferably 0. The reason for this is that the above-mentioned composition becomes more excellent in the balance of curability and heat resistance of the cured product.

上述n為1~10之整數,較佳為1~6之整數,其中較佳為1~4之整數,尤佳為2~4之整數。其原因在於,藉由使上述n為上述範圍,上述組合物會成為硬化性及硬化物之耐熱性之平衡性進一步優異者。The above-mentioned n is an integer of 1-10, preferably an integer of 1-6, of which an integer of 1-4 is preferred, and an integer of 2-4 is particularly preferred. The reason is that, by setting the above n in the above range, the above composition becomes more excellent in the balance between the curability and the heat resistance of the cured product.

上述X係表示n價之原子或基者。 作為此種X,只要為可獲得所期望之硬化性及硬化物之耐熱性等者即可,例如亦可使用國際公開第2014/021023號公報中記載之X所表示之基及對烷氧基進行取代之取代基、日本專利特開2018-150301號公報之作為通式(1)中之X所表示之基等所記載之基。 關於上述X,更具體而言,可例舉:直接鍵;氫原子;鹵素原子;氰基;羥基;硝基;羧基;氮原子;氧原子;硫原子;磷原子;下述(II-a)所示之基;(II-b)所示之基;>C=O;>NR53 ;-OR53 ;-SR53 ;-NR53 R54 ;具有與n為同數之價數之碳原子數1~40之未經取代或具有取代基之脂肪族烴基;具有與n為同數之價數之碳原子數6~40之未經取代或具有取代基之含芳香族烴之基;具有與n為同數之價數之碳原子數2~40之未經取代或具有取代基之含雜環之基;或者該脂肪族烴基、該含芳香族烴之基或該含雜環之基中之亞甲基之1個或2個以上被取代為選自下述群I中之二價基而成之基等。The above-mentioned X represents an atom or a group of n-valent. As such X, as long as it can obtain the desired curability and heat resistance of the cured product, for example, the group represented by X and the p-alkoxy group described in International Publication No. 2014/021023 may also be used. Substituents to be substituted, groups described as groups represented by X in general formula (1) in JP 2018-150301 A, etc. Regarding the above-mentioned X, more specifically, a direct bond; a hydrogen atom; a halogen atom; a cyano group; a hydroxyl group; a nitro group; a carboxyl group; a nitrogen atom; an oxygen atom; a sulfur atom; a phosphorus atom; The base shown in ); the base shown in (II-b); >C=O;>NR53; -OR 53 ; -SR 53 ; -NR 53 R 54 ; carbon with the same valence as n An unsubstituted or substituted aliphatic hydrocarbon group with 1-40 atoms; an unsubstituted or substituted aromatic hydrocarbon-containing group with 6-40 carbon atoms with the same valence as n; An unsubstituted or substituted heterocyclic group containing 2-40 carbon atoms with the same number of valences as n; or the aliphatic hydrocarbon group, the aromatic hydrocarbon-containing group, or the heterocyclic-containing group One or two or more of the methylene groups in the group are substituted with divalent groups selected from the following group I, etc.

R53 及R54 分別獨立地表示氫原子、碳原子數1~40之未經取代或具有取代基之脂肪族烴基、碳原子數6~40之未經取代或具有取代基之含芳香族烴之基、碳原子數2~40之未經取代或具有取代基之含雜環之基、或者該脂肪族烴基、該含芳香族烴之基或該含雜環之基中之亞甲基之1個或2個以上被取代為選自下述群I中之二價基而成之基。R 53 and R 54 each independently represent a hydrogen atom, an unsubstituted or substituted aliphatic hydrocarbon group with 1 to 40 carbon atoms, and an unsubstituted or substituted aromatic hydrocarbon group with 6 to 40 carbon atoms The group, the unsubstituted or substituted heterocyclic group containing 2-40 carbon atoms, or the aliphatic hydrocarbon group, the aromatic hydrocarbon-containing group or the methylene group in the heterocyclic group One or two or more are substituted with a divalent group selected from the following group I.

於X為氮原子、磷原子、下述(II-a)所示之基或下述(II-b)所示之基之情形時,n為3。於X為氧原子、硫原子、>C=O、-NH-CO-、-CO-NH-或>NR53 之情形時,n為2。於X基為氫原子、鹵素原子、氰基、羥基、硝基、羧基、-OR53 、-SR53 或-NR53 R54 之情形時,n為1。X亦存在與作為X之鍵結目標之苯環一起形成環之情形。When X is a nitrogen atom, a phosphorus atom, a group shown in (II-a) below or a group shown in (II-b) below, n is 3. To X is an oxygen atom, a sulfur atom,> C = O, -NH- CO -, - CO-NH- or> NR 53 of the case, is n-2. When the X group is a hydrogen atom, a halogen atom, a cyano group, a hydroxyl group, a nitro group, a carboxyl group, -OR 53 , -SR 53 or -NR 53 R 54 , n is 1. X may also form a ring together with the benzene ring that is the bonding target of X.

群I:-O-、-COO-、-OCO-、-CO-、-CS-、-S-、-SO-、-SO2 -、-NR230 -、-NR230 -CO-、-CO-NR230 -、-NR230 -COO-、-OCO-NR230 -或-SiR230 R231 -。R230 及R231 分別獨立地表示氫原子或未經取代之碳原子數1~20之脂肪族烴基。Group I: -O-, -COO-, -OCO-, -CO-, -CS-, -S-, -SO-, -SO 2 -, -NR 230 -, -NR 230 -CO-, -CO -NR 230 -, -NR 230 -COO-, -OCO-NR 230 -or -SiR 230 R 231 -. R 230 and R 231 each independently represent a hydrogen atom or an unsubstituted aliphatic hydrocarbon group having 1 to 20 carbon atoms.

[化8]

Figure 02_image019
[化8]
Figure 02_image019

(式中,*表示鍵結部位)(In the formula, * indicates the bonding position)

作為通式(A1)中之X所示之具有與n為同數之價數的脂肪族烴基、具有與n為同數之價數之含芳香族烴之基、及具有與n為同數之價數之含雜環之基,例如可例舉自R101 等所示之脂肪族烴基、含芳香族烴之基、含雜環之基去除「n-1」個氫原子後之基中之滿足特定碳原子數者。 作為R53 及R54 所示之脂肪族烴基、含芳香族烴之基及含雜環之基,例如可例舉R101 等所示之脂肪族烴基、含芳香族烴之基及含雜環之基中之滿足特定碳原子數者。 再者,關於群I中之R230 及R231 所示之未經取代之碳原子數1~20的脂肪族烴基之內容,可設為與R101 等中所使用之群I中之R230 、R231 相同之基。As an aliphatic hydrocarbon group having the same valence as n as shown by X in the general formula (A1), an aromatic hydrocarbon-containing group having the same valence as n, and having the same number as n The valence of the heterocyclic ring-containing group, for example, can be exemplified by the aliphatic hydrocarbon group shown by R 101 , the aromatic hydrocarbon-containing group, and the heterocyclic ring-containing group after removing "n-1" hydrogen atoms. It meets the specified number of carbon atoms. Examples of the aliphatic hydrocarbon group, aromatic hydrocarbon-containing group, and heterocyclic ring-containing group represented by R 53 and R 54 include aliphatic hydrocarbon groups, aromatic hydrocarbon-containing groups, and heterocyclic ring-containing groups represented by R 101 and the like. The base of which meets the specified number of carbon atoms. In addition, the content of the unsubstituted aliphatic hydrocarbon group with 1 to 20 carbon atoms represented by R 230 and R 231 in group I can be set to be the same as R 230 in group I used in R 101 etc. , R 231 is the same base.

通式(A1)中之X於n為2~10之情形時,較佳為具有與n為同數之價數之碳原子數1~40之未經取代或具有取代基之脂肪族烴基;具有與n為同數之價數之碳原子數6~40之未經取代或具有取代基之含芳香族烴之基;具有與n為同數之價數之碳原子數2~40之未經取代或具有取代基之含雜環之基;或者該脂肪族烴基、該含芳香族烴之基或該含雜環之基中之亞甲基之1個或2個以上被取代為選自由上述群I所組成的群中之二價基而成之基,其中較佳為具有與n為同數之價數之碳原子數2~30之未經取代或具有取代基之脂肪族烴基;具有與n為同數之價數之碳原子數6~30之未經取代或具有取代基之含芳香族烴之基;具有與n為同數之價數之碳原子數3~30之未經取代或具有取代基之含雜環之基;或者該脂肪族烴基、該含芳香族烴之基或該含雜環之基中之亞甲基之1個或2個以上被取代為選自由-O-、-COO-、-OCO-及-CO-所組成的群中之二價基而成之基。尤佳為具有與n為同數之價數之碳原子數10~25之未經取代或具有取代基之脂肪族烴基;具有與n為同數之價數之碳原子數4~25之未經取代或具有取代基之含雜環之基;或者該脂肪族烴基或該含雜環之基中之亞甲基之1個或2個以上被取代為選自由-O-、-COO-、-OCO-及-CO-所組成的群中之二價基而成之基。尤佳為具有與n為同數之價數之碳原子數14~22之未經取代或具有取代基之脂肪族烴基;具有與n為同數之價數之碳原子數5~22之未經取代或具有取代基之含雜環之基;或者該脂肪族烴基或該含雜環之基中之亞甲基之1個或2個以上被取代為選自由-O-、-COO-、-OCO-及-CO-所組成的群中之二價基而成之基。其原因在於,上述組合物之硬化性及所得之硬化物之耐熱性之平衡性會變得進一步優異。 本發明中,(1)於n為2時,通式(A1)中之X較佳為下述通式(101)所示之取代基或選自下述群1之基。(2)於n為3時,通式(A1)中之X較佳為選自下述群2之基。(3)於n為4時,通式(A1)中之X較佳為選自下述群3之基。(4)於n為5時,通式(A1)中之X較佳為選自下述群4之基。(5)於n為6時,通式(A1)中之X較佳為選自下述群5之基。(6)於n為1時,通式(A1)中之X較佳為氫原子、碳原子數1~40之未經取代或具有取代基之脂肪族烴基、或者該脂肪族烴基中之亞甲基之1個或2個以上被取代為選自上述群I中之二價基而成之基。其原因在於,上述組合物會成為硬化性及硬化物之耐熱性之平衡性進一步優異者。X in the general formula (A1) is preferably an unsubstituted or substituted aliphatic hydrocarbon group with 1-40 carbon atoms having the same valence as n when n is 2-10; An unsubstituted or substituted aromatic hydrocarbon-containing group with 6-40 carbon atoms having the same valence as n; a group with 2-40 carbon atoms having the same valence as n A substituted or substituted heterocyclic-containing group; or one or more of the methylene groups in the aliphatic hydrocarbon group, the aromatic hydrocarbon-containing group, or the heterocyclic-containing group are substituted to be selected from The group consisting of the above group I is a group composed of a divalent group, which is preferably an unsubstituted or substituted aliphatic hydrocarbon group having 2 to 30 carbon atoms with the same valence as n; An unsubstituted or substituted aromatic hydrocarbon-containing group with 6-30 carbon atoms having the same valence as n; a group with 3-30 carbon atoms having the same valence as n A substituted or substituted heterocyclic-containing group; or one or more of the methylene groups in the aliphatic hydrocarbon group, the aromatic hydrocarbon-containing group, or the heterocyclic-containing group are substituted to be selected from -O-, -COO-, -OCO- and -CO- group consisting of divalent groups. Particularly preferred is an unsubstituted or substituted aliphatic hydrocarbon group with 10 to 25 carbon atoms having the same valence as n; and an unsubstituted or substituted aliphatic hydrocarbon group with 4 to 25 carbon atoms having the same valence as n A substituted or substituted heterocyclic-containing group; or one or more of the methylene groups in the aliphatic hydrocarbon group or the heterocyclic-containing group are substituted to be selected from -O-, -COO-, -OCO- and -CO- are formed by the divalent group in the group. Particularly preferred is an unsubstituted or substituted aliphatic hydrocarbon group with 14-22 carbon atoms having the same valence as n; and 5-22 carbon atoms having the same valence as n A substituted or substituted heterocyclic-containing group; or one or more of the methylene groups in the aliphatic hydrocarbon group or the heterocyclic-containing group are substituted to be selected from -O-, -COO-, -OCO- and -CO- are formed by the divalent group in the group. The reason is that the balance between the curability of the composition and the heat resistance of the resulting cured product becomes more excellent. In the present invention, (1) when n is 2, X in the general formula (A1) is preferably a substituent represented by the following general formula (101) or a group selected from the following group 1. (2) When n is 3, X in the general formula (A1) is preferably a group selected from the following group 2. (3) When n is 4, X in the general formula (A1) is preferably a group selected from the following group 3. (4) When n is 5, X in the general formula (A1) is preferably a group selected from the group 4 below. (5) When n is 6, X in the general formula (A1) is preferably a group selected from the following group 5. (6) When n is 1, X in the general formula (A1) is preferably a hydrogen atom, an unsubstituted or substituted aliphatic hydrocarbon group with 1 to 40 carbon atoms, or an aliphatic hydrocarbon group in the aliphatic hydrocarbon group. One or two or more of the methyl groups are substituted with divalent groups selected from the above group I. The reason for this is that the above-mentioned composition becomes more excellent in the balance of curability and heat resistance of the cured product.

[化9]

Figure 02_image021
[化9]
Figure 02_image021

(式中,Y111 及Y115 分別獨立地表示碳原子數1~8之未經取代或具有取代基之二價脂肪族烴基、或該脂肪族烴基中之亞甲基之1個或2個以上被取代為選自上述群I中之二價基而成之基, Y112 及Y114 分別獨立地表示-O-、-CO-、-CO-O-、-O-CO-、-NR213 -、-CO-NR213 -或-NR213 -CO-所示之基, R213 表示氫原子、碳原子數1~40之未經取代或具有取代基之脂肪族烴基、或該脂肪族烴基中之亞甲基之1個或2個以上被取代為選自上述群I中之二價基而成之基, Y113 表示-CR214 R215 -、-NR216 -、下述通式(103)所示之基、碳原子數1~40之未經取代或具有取代基之二價脂肪族烴基、碳原子數6~40之未經取代或具有取代基之二價含芳香族烴之基、或者該脂肪族烴基或該含芳香族烴之基中之亞甲基之1個或2個以上被取代為選自上述群I中之二價基而成之基, R214 及R215 分別獨立地表示氫原子、碳原子數1~8之烷基、碳原子數6~20之芳基或碳原子數7~20之芳基烷基, R216 表示氫原子、碳原子數1~40之未經取代或具有取代基之脂肪族烴基、碳原子數6~40之未經取代或具有取代基之含芳香族烴之基、碳原子數2~40之未經取代或具有取代基之含雜環之基、或者該脂肪族烴基、該含芳香族烴之基或該含雜環之基中之亞甲基之1個或2個以上被取代為選自上述群I中之二價基而成之基, *表示鍵結部位)(In the formula, Y 111 and Y 115 each independently represent an unsubstituted or substituted divalent aliphatic hydrocarbon group with 1 to 8 carbon atoms, or one or two methylene groups in the aliphatic hydrocarbon group The above is substituted with a divalent group selected from the above group I, Y 112 and Y 114 each independently represent -O-, -CO-, -CO-O-, -O-CO-, -NR 213 -, -CO-NR 213 -or -NR 213 -CO-, R 213 represents a hydrogen atom, an unsubstituted or substituted aliphatic hydrocarbon group with 1-40 carbon atoms, or the aliphatic One or two or more of the methylene groups in the hydrocarbon group are substituted with divalent groups selected from the above group I, Y 113 represents -CR 214 R 215 -, -NR 216 -, the following general formula The group shown in (103), unsubstituted or substituted divalent aliphatic hydrocarbon group with 1-40 carbon atoms, unsubstituted or substituted divalent aromatic hydrocarbon with 6-40 carbon atoms One or more of the methylene groups in the aliphatic hydrocarbon group or the aromatic hydrocarbon-containing group are substituted with divalent groups selected from the above group I, R 214 and R 215 each independently represents a hydrogen atom, an alkyl group having 1 to 8 carbon atoms, an aryl group having 6 to 20 carbon atoms, or an arylalkyl group having 7 to 20 carbon atoms, and R 216 represents a hydrogen atom and 1 carbon atom. ~40 unsubstituted or substituted aliphatic hydrocarbon groups, unsubstituted or substituted aromatic hydrocarbon-containing groups with 6 to 40 carbon atoms, unsubstituted or substituted carbon atoms with 2 to 40 One or more of the methylene groups in the heterocyclic ring-containing group or the aliphatic hydrocarbon group, the aromatic hydrocarbon-containing group, or the heterocyclic group-containing group are substituted with those selected from the above group I The base formed by the bivalent base, * indicates the bonding site)

[化10]

Figure 02_image023
[化10]
Figure 02_image023

(式中,Y119 及Y120 分別獨立地表示碳原子數1~8之未經取代或具有取代基之二價脂肪族烴基或該脂肪族烴基中之亞甲基之1個或2個以上被取代為選自上述群I中之二價基而成之基, *表示鍵結部位)(In the formula, Y 119 and Y 120 each independently represent an unsubstituted or substituted divalent aliphatic hydrocarbon group with 1 to 8 carbon atoms or one or more methylene groups in the aliphatic hydrocarbon group Substituted with a divalent group selected from the above group I, * indicates the bonding site)

[化11] <群1>

Figure 02_image025
[化11] <Group 1>
Figure 02_image025

(式中,R31 表示氫原子、碳原子數1~40之未經取代或具有取代基之脂肪族烴基、碳原子數6~40之未經取代或具有取代基之含芳香族烴之基、碳原子數2~40之未經取代或具有取代基之含雜環之基、或者該脂肪族烴基、該含芳香族烴之基或該含雜環之基中之亞甲基之1個或2個以上被取代為選自上述群I中之二價基而成之基, *表示鍵結部位)(In the formula, R 31 represents a hydrogen atom, an unsubstituted or substituted aliphatic hydrocarbon group with 1 to 40 carbon atoms, and an unsubstituted or substituted aromatic hydrocarbon-containing group with 6 to 40 carbon atoms , Unsubstituted or substituted heterocyclic-containing group with 2-40 carbon atoms, or one of the methylene groups in the aliphatic hydrocarbon group, the aromatic hydrocarbon-containing group, or the heterocyclic-containing group Or two or more groups are substituted with divalent groups selected from the above group I, * indicates the bonding site)

[化12] <群2>

Figure 02_image027
[化12] <Group 2>
Figure 02_image027

(式中,R32 表示氫原子、碳原子數1~40之未經取代或具有取代基之脂肪族烴基、碳原子數6~40之未經取代或具有取代基之含芳香族烴之基、碳原子數2~40之未經取代或具有取代基之含雜環之基、或者該脂肪族烴基、該含芳香族烴之基或該含雜環之基中之亞甲基之1個或2個以上被取代為選自上述群I中之二價基而成之基,於基中存在2個以上之R32 之情形時,2個以上之R32 可相同亦可不同, Z11 分別獨立地表示直接鍵、-O-、-S-、>CO、-CO-O-、-O-CO-、-SO2 -、-SS-、-SO-、>NR63 、-PR63 -、碳原子數1~40之未經取代或具有取代基之二價脂肪族烴基、碳原子數6~40之未經取代或具有取代基之二價含芳香族烴之基、碳原子數2~40之未經取代或具有取代基之二價含雜環之基、或者該脂肪族烴基、該含芳香族烴之基或該含雜環之基中之亞甲基之1個或2個以上被取代為選自上述群I中之二價基而成之基, R63 表示氫原子、碳原子數1~40之未經取代或具有取代基之脂肪族烴基、碳原子數6~40之未經取代或具有取代基之含芳香族烴之基、碳原子數2~40之未經取代或具有取代基之含雜環之基、或者該脂肪族烴基、該含芳香族烴之基或該含雜環之基中之亞甲基之1個或2個以上被取代為選自上述群I中之二價基而成之基, *表示鍵結部位)(In the formula, R 32 represents a hydrogen atom, an unsubstituted or substituted aliphatic hydrocarbon group with 1 to 40 carbon atoms, and an unsubstituted or substituted aromatic hydrocarbon-containing group with 6 to 40 carbon atoms , Unsubstituted or substituted heterocyclic-containing group with 2-40 carbon atoms, or one of the methylene groups in the aliphatic hydrocarbon group, the aromatic hydrocarbon-containing group, or the heterocyclic-containing group Or two or more groups are substituted with divalent groups selected from the above group I. When there are two or more R 32 groups in the group, the two or more R 32 may be the same or different, Z 11 Each independently represents a direct bond, -O-, -S-, >CO, -CO-O-, -O-CO-, -SO 2 -, -SS-, -SO-, >NR 63 , -PR 63 -Unsubstituted or substituted divalent aliphatic hydrocarbon group with 1-40 carbon atoms, unsubstituted or substituted divalent aromatic hydrocarbon-containing group with 6-40 carbon atoms, number of carbon atoms 2-40 unsubstituted or substituted divalent heterocyclic ring-containing group, or 1 or 2 of the methylene group in the aliphatic hydrocarbon group, the aromatic hydrocarbon-containing group, or the heterocyclic ring-containing group At least one group is substituted with a divalent group selected from the above group I, R 63 represents a hydrogen atom, an unsubstituted or substituted aliphatic hydrocarbon group with 1-40 carbon atoms, and a carbon 6- 40 unsubstituted or substituted aromatic hydrocarbon-containing group, unsubstituted or substituted heterocyclic-containing group with 2-40 carbon atoms, or the aliphatic hydrocarbon group, the aromatic hydrocarbon-containing group One or two or more of the methylene groups in the group or the heterocyclic ring-containing group are substituted with divalent groups selected from the above group I, * represents the bonding site)

[化13] <群3>

Figure 02_image029
[化13] <Group 3>
Figure 02_image029

(式中,R32 表示與上述群2中之R32 相同之基,於基中存在2個以上之R32 之情形時,2個以上之R32 可相同亦可不同, Z11 表示與上述群2中之Z11 所示之基為相同範圍之基, *表示鍵結部位)(In the formula, R 32 represents the same group as R 32 in the above group 2. When there are more than two R 32 in the group, the two or more R 32 may be the same or different, and Z 11 represents the same as the above The base shown by Z 11 in group 2 is the base of the same range, * indicates the bonding position)

[化14] <群4>

Figure 02_image031
[化14] <Group 4>
Figure 02_image031

(式中,Z10 、Z11 、Z12 、Z13 及Z14 所示之基分別獨立地表示與上述群2中之Z11 所示之基為相同範圍之基, *表示鍵結部位)(In the formula, the groups shown by Z 10 , Z 11 , Z 12 , Z 13 and Z 14 each independently represent the groups in the same range as the group shown by Z 11 in the above group 2, and * represents the bonding site)

[化15] <群5>

Figure 02_image033
[化15] <Group 5>
Figure 02_image033

(上述式中,Z10 、Z11 、Z12 、Z13 、Z14 及Z15 所示之基分別獨立地表示與上述群2中之Z11 所示之基為相同範圍之基, *表示鍵結部位)(In the above formula, the groups shown by Z 10 , Z 11 , Z 12 , Z 13 , Z 14 and Z 15 each independently represent groups in the same range as the groups shown by Z 11 in group 2 above, and * represents Bonding site)

再者,作為Y111 、Y113 、Y115 、Y119 及Y120 所示之未經取代或具有取代基之二價脂肪族烴基、Y113 所示之未經取代或具有取代基之二價含芳香族烴之基,分別獨立可例舉自R101 等中所使用之未經取代或具有取代基之脂肪族烴基及未經取代或具有取代基之含芳香族烴之基去除1個氫原子後之基中之滿足特定碳原子數者。 作為Y111 、Y113 、Y115 、Y119 及Y120 所示之未經取代或具有取代基之二價脂肪族烴基,可使用自未經取代或具有取代基之烷基去除1個氫原子後之未經取代或具有取代基之伸烷基等。 上述式(101)中之Y111 及Y115 可相同亦可不同。 上述式(103)中之Y119 及Y120 可相同亦可不同。 關於R213 、R216 、R217 、R31 及R32 所示之未經取代或具有取代基之脂肪族烴基、未經取代或具有取代基之含芳香族烴之基或者未經取代或具有取代基之含雜環之基,可設為與R101 等所示之具有取代基之脂肪族烴基、未經取代或具有取代基之含芳香族烴之基或未經取代或具有取代基之含雜環之基相同之內容。 作為R214 及R215 所示之碳原子數1~8之烷基、R214 及R215 所示之碳原子數6~20之芳基及碳原子數7~20之芳基烷基,可設為與R101 等中所使用之烷基、芳基及芳基烷基中之滿足特定碳原子數者相同之內容。 上述群2及群3之各式中所含之複數個Z11 彼此、上述群4之各式中所含之Z10 ~Z14 及上述群5之各式中所含之Z10 ~Z15 可相同亦可為不同者。Furthermore, as the unsubstituted or substituted divalent aliphatic hydrocarbon group represented by Y 111 , Y 113 , Y 115 , Y 119 and Y 120 , and the unsubstituted or substituted divalent hydrocarbon group represented by Y 113 The aromatic hydrocarbon-containing group can be independently exemplified from the unsubstituted or substituted aliphatic hydrocarbon group and the unsubstituted or substituted aromatic hydrocarbon-containing group used in R 101, etc. Remove one hydrogen Those who meet the specified number of carbon atoms in the base after the atom. As the unsubstituted or substituted divalent aliphatic hydrocarbon group represented by Y 111 , Y 113 , Y 115 , Y 119 and Y 120 , one hydrogen atom can be removed from the unsubstituted or substituted alkyl group The following unsubstituted or substituted alkylene groups, etc. Y 111 and Y 115 in the above formula (101) may be the same or different. Y 119 and Y 120 in the above formula (103) may be the same or different. Regarding unsubstituted or substituted aliphatic hydrocarbon groups, unsubstituted or substituted aromatic hydrocarbon-containing groups or unsubstituted or substituted aliphatic hydrocarbon groups represented by R 213 , R 216 , R 217 , R 31 and R 32 The heterocyclic ring-containing group of the substituent can be a substituted aliphatic hydrocarbon group, an unsubstituted or substituted aromatic hydrocarbon-containing group or an unsubstituted or substituted aliphatic hydrocarbon group shown in R 101, etc. The same content for the heterocyclic group. Examples of the C and R 215 R 214 shown in the alkyl group of 1 to 8, R 214 and R 215 shown in the aryl and carbon atoms of 6 to 20 carbon atoms of 7 to 20 of the arylalkyl group can be Set the same content as those satisfying the specified number of carbon atoms among the alkyl group, aryl group, and arylalkyl group used in R 101 and the like. The plural Z 11 contained in each formula of group 2 and group 3, Z 10 to Z 14 contained in each formula of group 4, and Z 10 to Z 15 contained in each formula of group 5 They may be the same or different.

本發明中,於n為2之情形時,X較佳為上述通式(101)所示之基。 上述通式(101)中,Y111 及Y115 分別獨立較佳為碳原子數1~5之未經取代或具有取代基之二價脂肪族烴基,其中較佳為碳原子數1~3之未經取代或具有取代基之二價脂肪族烴基,尤佳為未經取代之碳原子數1~3之伸烷基。 上述通式(101)中,Y112 及Y114 分別獨立較佳為-O-、-CO-、-CO-O-或-O-CO-,其中較佳為-CO-O-或-O-CO-。 上述通式(101)中,Y113 較佳為碳原子數1~40之未經取代或具有取代基之二價脂肪族烴基、該脂肪族烴基中之亞甲基之1個或2個以上被取代為選自上述群I中之二價基而成之基或上述通式(103)所示之基,其中較佳為碳原子數1~20之未經取代或具有取代基之二價脂肪族烴基、該脂肪族烴基中之亞甲基之1個或2個以上被取代為選自上述群I中之二價基而成之基或上述通式(103)所示之基,尤佳為碳原子數1~20之未經取代或具有取代基之二價脂肪族烴基中之亞甲基的1個或2個以上被取代為選自上述群I中之二價基而成之基或上述通式(103)所示之基,其中尤佳為上述通式(103)所示之基。In the present invention, when n is 2, X is preferably a group represented by the above general formula (101). In the above general formula (101), Y 111 and Y 115 are each independently preferably an unsubstituted or substituted divalent aliphatic hydrocarbon group having 1 to 5 carbon atoms, and preferably having 1 to 3 carbon atoms The unsubstituted or substituted divalent aliphatic hydrocarbon group is particularly preferably an unsubstituted alkylene group having 1 to 3 carbon atoms. In the above general formula (101), Y 112 and Y 114 are each independently preferably -O-, -CO-, -CO-O- or -O-CO-, and preferably -CO-O- or -O -CO-. In the above general formula (101), Y 113 is preferably an unsubstituted or substituted divalent aliphatic hydrocarbon group having 1 to 40 carbon atoms, and one or more of the methylene groups in the aliphatic hydrocarbon group A group substituted with a divalent group selected from the above group I or a group represented by the above general formula (103), wherein the unsubstituted or substituted divalent group having 1 to 20 carbon atoms is preferred An aliphatic hydrocarbon group, one or more of the methylene groups in the aliphatic hydrocarbon group is substituted with a divalent group selected from the group I above or a group represented by the above general formula (103), especially Preferably, one or more of the methylene groups in the unsubstituted or substituted divalent aliphatic hydrocarbon group having 1 to 20 carbon atoms are substituted with a divalent group selected from the above group I Group or the group represented by the above general formula (103), and among them, the group represented by the above general formula (103) is particularly preferred.

上述通式(103)中,Y119 及Y120 分別獨立較佳為碳原子數1~40之未經取代或具有取代基之二價脂肪族烴基、或該脂肪族烴基中之亞甲基之1個或2個以上被取代為選自上述群I中之二價基而成之基,其中較佳為碳原子數1~20之未經取代或具有取代基之二價脂肪族烴基,尤佳為碳原子數1~10之未經取代或具有取代基之二價脂肪族烴基,其中尤佳為碳原子數1~5之未經取代或具有取代基之二價脂肪族烴基,其中尤佳為碳原子數2~5之直鏈或支鏈之伸烷基。In the above general formula (103), Y 119 and Y 120 are each independently preferably an unsubstituted or substituted divalent aliphatic hydrocarbon group having 1 to 40 carbon atoms, or a methylene group in the aliphatic hydrocarbon group One or more groups are substituted with divalent groups selected from the above group I, and among them, unsubstituted or substituted divalent aliphatic hydrocarbon groups with 1 to 20 carbon atoms are preferred, especially It is preferably an unsubstituted or substituted divalent aliphatic hydrocarbon group with 1 to 10 carbon atoms, and particularly preferably an unsubstituted or substituted divalent aliphatic hydrocarbon group with 1 to 5 carbon atoms, especially It is preferably a linear or branched alkylene group having 2 to 5 carbon atoms.

本發明中,於n為3之情形時,X較佳為群2中之通式(II-2)所示之基、通式(II-3)所示之基、或通式(II-6)所示之基,其中較佳為通式(II-6)所示之基。In the present invention, when n is 3, X is preferably a group represented by general formula (II-2) in group 2, a group represented by general formula (II-3), or general formula (II- 6) The group represented by the general formula (II-6) is preferred among them.

通式(II-2)所示之基、通式(II-3)所示之基及通式(II-6)中之Z11 較佳為直接鍵或碳原子數1~40之未經取代或具有取代基之二價脂肪族烴基,其中較佳為直接鍵或碳原子數1~20之未經取代或具有取代基之二價脂肪族烴基,尤佳為直接鍵或碳原子數1~10之未經取代或具有取代基之伸烷基,其中尤佳為直接鍵或未經取代之碳原子數1~5之伸烷基。 通式(II-2)所示之基、通式(II-3)所示之基及通式(II-6)所示之基中所含之複數個Z11 可相同亦可不同。The group represented by the general formula (II-2), the group represented by the general formula (II-3), and the Z 11 in the general formula (II-6) are preferably direct bonds or carbon atoms of 1-40 A substituted or substituted divalent aliphatic hydrocarbon group, of which a direct bond or an unsubstituted or substituted divalent aliphatic hydrocarbon group with 1 to 20 carbon atoms is preferred, and a direct bond or a carbon atom number of 1 is particularly preferred. -10 unsubstituted or substituted alkylene groups, of which direct bond or unsubstituted alkylene groups having 1 to 5 carbon atoms are particularly preferred. The plural Z 11 contained in the group represented by the general formula (II-2), the group represented by the general formula (II-3), and the group represented by the general formula (II-6) may be the same or different.

其中,本發明中較佳為通式(II-2)所示之基中之3個Z11 中之至少一個為直接鍵,至少一個為碳原子數1~40之未經取代或具有取代基之二價脂肪族烴基,其中較佳為至少一個為直接鍵,至少一個為碳原子數1~20之未經取代或具有取代基之二價脂肪族烴基,尤佳為至少一個為直接鍵,至少一個為碳原子數1~10之未經取代或具有取代基之伸烷基,其中尤佳為至少一個為直接鍵,至少一個為碳原子數1~5之未經取代之伸烷基。 又,較佳為通式(II-3)所示之基及(II-6)所示之基中之Z11 之全部為碳原子數1~40之未經取代或具有取代基之二價脂肪族烴基,其中較佳為碳原子數1~20之未經取代或具有取代基之二價脂肪族烴基,尤佳為碳原子數1~10之未經取代或具有取代基之伸烷基,其中尤佳為碳原子數1~5之未經取代之烷基。 Among them, in the present invention, it is preferable that at least one of the three Z 11 in the group represented by the general formula (II-2) is a direct bond, and at least one is an unsubstituted or substituted group with 1 to 40 carbon atoms Of the divalent aliphatic hydrocarbon group, preferably at least one is a direct bond, at least one is an unsubstituted or substituted divalent aliphatic hydrocarbon group with 1 to 20 carbon atoms, particularly preferably at least one is a direct bond, At least one is an unsubstituted or substituted alkylene group having 1 to 10 carbon atoms, among which at least one is a direct bond, and at least one is an unsubstituted alkylene group having 1 to 5 carbon atoms. In addition, it is preferable that all of Z 11 in the group represented by the general formula (II-3) and the group represented by (II-6) are unsubstituted or substituted divalent groups having 1 to 40 carbon atoms Aliphatic hydrocarbon groups, among them, unsubstituted or substituted divalent aliphatic hydrocarbon groups with 1 to 20 carbon atoms are preferred, and unsubstituted or substituted alkylene groups with 1 to 10 carbon atoms are particularly preferred Among them, an unsubstituted alkyl group with 1 to 5 carbon atoms is particularly preferred.

通式(II-2)所示之基中之R32 較佳為氫原子或碳原子數1~40之未經取代或具有取代基之脂肪族烴基,其中較佳為氫原子或碳原子數1~5之未經取代或具有取代基之脂肪族烴基,尤佳為氫原子。 R 32 in the group represented by the general formula (II-2) is preferably a hydrogen atom or an unsubstituted or substituted aliphatic hydrocarbon group having 1 to 40 carbon atoms, and preferably a hydrogen atom or a carbon atom number The unsubstituted or substituted aliphatic hydrocarbon group of 1 to 5 is particularly preferably a hydrogen atom.

本發明中,於n為4之情形時,X較佳為群3中之(III-1)所示之基。通式(III-1)中,Z11 較佳為碳原子數1~40之未經取代或具有取代基之脂肪族烴基、或該脂肪族烴基中之亞甲基之1個或2個以上被取代為選自上述群I中之二價基而成之基,其中較佳為碳原子數1~20之未經取代或具有取代基之脂肪族烴基、或該脂肪族烴基中之亞甲基之1個或2個以上被取代為選自上述群I中之二價基而成之基,尤佳為碳原子數1~10之未經取代或具有取代基之伸烷基中之亞甲基的1個或2個以上被取代為選自上述群I中之二價基而成之基,其中尤佳為碳原子數1~10之未經取代之伸烷基中之亞甲基的1個或2個以上被取代為-O-、-COO-、-OCO-或-CO-而成之基,其中尤佳為碳原子數2~5之伸烷基中之亞甲基之1個被取代為-O-CO-或-CO-O-而成之基。 其原因在於,藉由在各n時使X為上述基,上述化合物A1會成為於保護基R101 之脫離前後,抗氧化能力之變化較大者。其結果,上述組合物會成為硬化性及硬化物之耐熱性之平衡優異者。In the present invention, when n is 4, X is preferably the group represented by (III-1) in group 3. In the general formula (III-1), Z 11 is preferably an unsubstituted or substituted aliphatic hydrocarbon group having 1 to 40 carbon atoms, or one or more of the methylene groups in the aliphatic hydrocarbon group A group substituted with a divalent group selected from the above group I, among which an unsubstituted or substituted aliphatic hydrocarbon group having 1 to 20 carbon atoms, or a methylene group in the aliphatic hydrocarbon group is preferred One or two or more of the groups are substituted with divalent groups selected from the above group I, and particularly preferred is an unsubstituted or substituted alkylene group having 1 to 10 carbon atoms. One or two or more of the methyl groups are substituted with divalent groups selected from the above group I, among which the methylene group in the unsubstituted alkylene group having 1 to 10 carbon atoms is particularly preferred One or more of the groups are substituted with -O-, -COO-, -OCO- or -CO-, among which the methylene group in the alkylene group with 2 to 5 carbon atoms is particularly preferred One group is substituted with -O-CO- or -CO-O-. The reason is that by setting X as the above-mentioned group at each n, the above-mentioned compound A1 becomes the one with a greater change in antioxidant capacity before and after the protective group R 101 is removed. As a result, the above-mentioned composition has an excellent balance between curability and heat resistance of the cured product.

上述X之與苯環之鍵結位置可為苯環內之可鍵結之任意位置,但例如較佳為相對於上述R101 -O-之鍵結位置而為對位。 其原因在於,藉由使上述鍵結位置為上述位置,上述化合物A1會成為於保護基R101 之脫離前後,抗氧化能力之變化較大者。其結果,上述組合物會成為硬化性及硬化物之耐熱性之平衡優異者。The bonding position of X to the benzene ring may be any position within the benzene ring that can be bonded, but for example, it is preferably a para position relative to the bonding position of R 101 -O-. The reason is that by setting the above-mentioned bonding position to the above-mentioned position, the above-mentioned compound A1 becomes the one with a greater change in antioxidant capacity before and after the protective group R 101 is removed. As a result, the above-mentioned composition has an excellent balance between curability and heat resistance of the cured product.

作為化合物A1之具體例,具體而言,可例舉國際公開第2014/021023號公報中具體記載之化合物等。As a specific example of compound A1, specifically, the compound etc. which are specifically described in International Publication No. 2014/021023 can be mentioned.

上述化合物A1之製造方法只要為可獲得所期望之結構之方法,則並無特別限定,例如可設為與國際公開第2014/021023號公報中記載之方法相同之方法。The method for producing the compound A1 is not particularly limited as long as the method can obtain the desired structure. For example, it can be the same method as the method described in International Publication No. 2014/021023.

作為上述化合物A1之種類,於組合物中可僅為1種,亦可為2種以上。As the kind of the above-mentioned compound A1, there may be only one kind in the composition, or two or more kinds.

作為上述化合物A1之含量,只要為可獲得所期望之硬化性及硬化物之耐熱性者即可,可根據上述組合物之用途等而適當設定。 作為上述化合物A1之含量,例如於上述組合物之固形物成分100質量份中,較佳為0.01質量份以上20質量份以下,其中較佳為0.05質量份以上10質量份以下,尤佳為0.1質量份以上5質量份以下。其原因在於,藉由使上述含量為上述範圍,上述組合物會成為硬化性及硬化物之耐熱性之平衡性進一步優異者。 再者,所謂固形物成分係包含溶劑以外之所有成分者。 上述化合物A1之含量根據溶劑等之含量而不同,例如於組合物100質量份中,較佳為0.001質量份以上20質量份以下,其中較佳為0.005質量份以上10質量份以下,尤佳為0.01質量份以上5質量份以下。其原因在於,藉由使上述含量為上述範圍,上述組合物會成為硬化性及硬化物之耐熱性之平衡性進一步優異者。 上述化合物A1之含量於上述化合物A1及硫系抗氧化劑之合計100質量份中,較佳為10質量份以上70質量份以下,其中較佳為15質量份以上60質量份以下,尤佳為20質量份以上55質量份以下,尤佳為25質量份以上50質量份以下。其原因在於,藉由使上述含量為上述範圍,上述組合物會成為硬化性及硬化物之耐熱性之平衡性進一步優異者。 上述化合物A1之含量於化合物A1、硫系抗氧化劑及硬化性成分之合計100質量份中,較佳為0.01質量份以上20質量份以下,其中較佳為0.05質量份以上10質量份以下,尤佳為0.1質量份以上5質量份以下。其原因在於,藉由使化合物A1之含量為上述範圍,上述組合物會成為硬化性及硬化物之耐熱性之平衡性進一步優異者。The content of the above-mentioned compound A1 may be as long as the desired curability and heat resistance of the cured product can be obtained, and it can be appropriately set according to the use of the above-mentioned composition and the like. The content of the compound A1 is, for example, in 100 parts by mass of the solid content of the composition, preferably 0.01 parts by mass or more and 20 parts by mass or less, among which 0.05 parts by mass or more and 10 parts by mass or less, and more preferably 0.1 Parts by mass or more and 5 parts by mass or less. The reason is that, by setting the above content within the above range, the above composition becomes more excellent in the balance of curability and heat resistance of the cured product. In addition, the so-called solid component includes all components other than the solvent. The content of the above-mentioned compound A1 varies according to the content of the solvent, etc., for example, in 100 parts by mass of the composition, it is preferably 0.001 parts by mass or more and 20 parts by mass or less, of which 0.005 parts by mass or more and 10 parts by mass or less, and particularly preferably 0.01 parts by mass or more and 5 parts by mass or less. The reason is that, by setting the above content within the above range, the above composition becomes more excellent in the balance of curability and heat resistance of the cured product. The content of the compound A1 in the total of 100 parts by mass of the compound A1 and the sulfur-based antioxidant is preferably 10 parts by mass or more and 70 parts by mass or less, wherein it is preferably 15 parts by mass or more and 60 parts by mass or less, and more preferably 20 parts by mass. Parts by mass or more and 55 parts by mass or less, particularly preferably 25 parts by mass or more and 50 parts by mass or less. The reason is that, by setting the above content within the above range, the above composition becomes more excellent in the balance of curability and heat resistance of the cured product. The content of the above-mentioned compound A1 in 100 parts by mass of the total of compound A1, sulfur-based antioxidants, and curable components is preferably 0.01 parts by mass or more and 20 parts by mass or less, and more preferably 0.05 parts by mass or more and 10 parts by mass or less, especially Preferably, it is not less than 0.1 part by mass and not more than 5 parts by mass. The reason is that, by setting the content of the compound A1 in the above range, the above-mentioned composition becomes more excellent in the balance between the curability and the heat resistance of the cured product.

上述化合物A1之含量相對於上述硬化性成分100質量份,較佳為0.001質量份以上20質量份以下,其中較佳為0.005質量份以上10質量份以下,尤佳為0.01質量份以上5質量份以下。其原因在於,藉由使上述含量為上述範圍,上述組合物會成為硬化性及硬化物之耐熱性之平衡性進一步優異者。 上述化合物A1及硫系抗氧化劑之合計之含量相對於上述硬化性成分100質量份,較佳為0.002質量份以上20質量份以下,其中較佳為0.01質量份以上10質量份以下,尤佳為0.1質量份以上5質量份以下。其原因在於,藉由使上述化合物A1及硫系抗氧化劑之合計之含量為上述範圍,上述組合物會成為硬化性及硬化物之耐熱性之平衡性進一步優異者。 上述化合物A1及硫系抗氧化劑之合計之含量於上述化合物A1、硫系抗氧化劑及硬化性成分之合計100質量份中,較佳為0.002質量份以上20質量份以下,其中較佳為0.01質量份以上10質量份以下,尤佳為0.1質量份以上5質量份以下。其原因在於,藉由使上述化合物A1及硫系抗氧化劑之合計之含量為上述範圍,上述組合物會成為硬化性及硬化物之耐熱性之平衡性進一步優異者。The content of the compound A1 relative to 100 parts by mass of the curable ingredient is preferably 0.001 parts by mass or more and 20 parts by mass or less, among them, 0.005 parts by mass or more and 10 parts by mass or less, and particularly preferably 0.01 parts by mass or more and 5 parts by mass. the following. The reason is that, by setting the above content within the above range, the above composition becomes more excellent in the balance of curability and heat resistance of the cured product. The total content of the compound A1 and the sulfur-based antioxidant relative to 100 parts by mass of the curable ingredient is preferably 0.002 parts by mass or more and 20 parts by mass or less, and among them, 0.01 parts by mass or more and 10 parts by mass or less, and more preferably 0.1 parts by mass or more and 5 parts by mass or less. The reason is that, by setting the total content of the compound A1 and the sulfur-based antioxidant in the above range, the composition becomes more excellent in the balance of curability and heat resistance of the cured product. The total content of the compound A1 and the sulfur-based antioxidant in 100 parts by mass of the total of the compound A1, the sulfur-based antioxidant and the curable component is preferably 0.002 parts by mass or more and 20 parts by mass or less, and more preferably 0.01 parts by mass Part or more and 10 parts by mass or less, more preferably 0.1 part by mass or more and 5 parts by mass or less. The reason is that, by setting the total content of the compound A1 and the sulfur-based antioxidant in the above range, the composition becomes more excellent in the balance of curability and heat resistance of the cured product.

上述化合物A1、硫系抗氧化劑及硬化性成分之合計之含量於固形物成分100質量份中,較佳為10質量份以上,較佳為30質量份以上,且較佳為40質量份以上。其原因在於,藉由使上述化合物A1、硫系抗氧化劑及硬化性成分之合計之含量為上述範圍,上述組合物會成為硬化性及硬化物之耐熱性之平衡性進一步優異者。關於上述化合物A1、硫系抗氧化劑及硬化性成分之合計之含量之上限,可根據本發明之組合物之用途等而適當設定,可設為99質量份以下。其原因在於,藉由使上述含量為上述範圍,上述組合物會成為硬化性及硬化物之耐熱性之平衡性進一步優異者。The total content of the compound A1, sulfur-based antioxidant, and curable component in 100 parts by mass of the solid content is preferably 10 parts by mass or more, preferably 30 parts by mass or more, and preferably 40 parts by mass or more. The reason is that, by setting the total content of the compound A1, sulfur-based antioxidant, and curable component within the above range, the composition becomes more excellent in the balance of curability and heat resistance of the cured product. The upper limit of the total content of the aforementioned compound A1, sulfur-based antioxidant, and curable component can be appropriately set according to the use of the composition of the present invention, etc., and can be set to 99 parts by mass or less. The reason is that, by setting the above content within the above range, the above composition becomes more excellent in the balance of curability and heat resistance of the cured product.

2.硫系抗氧化劑 上述硫系抗氧化劑係含有硫原子且具有抗氧化能力者。 作為此種硫系抗氧化劑,只要為可獲得所期望之硬化性及耐熱性者即可,例如可例舉:具有硫醇基(-SH)之硫醇系抗氧化劑、具有於硫原子(S)上鍵結有2個碳原子(C)之結構之硫醚系抗氧化劑。 本發明中,上述硫系抗氧化劑較佳為硫醚系抗氧化劑。其原因在於,上述組合物會成為硬化性及硬化物之耐熱性之平衡性進一步優異者。 又,上述硫系抗氧化劑只要為含有硫原子者即可。上述硫系抗氧化劑較佳為不具有酚性羥基者。其原因在於,會成為硬化性更優異者。又,其結果,會成為耐熱性亦優異者。2. Sulfur-based antioxidants The above-mentioned sulfur-based antioxidants contain sulfur atoms and have antioxidant capacity. Such sulfur-based antioxidants may be those capable of obtaining the desired curability and heat resistance. For example, thiol-based antioxidants having a thiol group (-SH), and those having a sulfur atom (S ) A thioether antioxidant with a structure of 2 carbon atoms (C) bonded to it. In the present invention, the sulfur-based antioxidant is preferably a thioether-based antioxidant. The reason for this is that the above-mentioned composition becomes more excellent in the balance of curability and heat resistance of the cured product. In addition, the above-mentioned sulfur-based antioxidant may be any one containing a sulfur atom. It is preferable that the said sulfur-type antioxidant does not have a phenolic hydroxyl group. The reason for this is that it becomes one with more excellent curability. Moreover, as a result, it becomes a thing excellent also in heat resistance.

(1)硫醚系抗氧化劑 作為上述硫醚系抗氧化劑,只要為具有硫醚結構且可獲得所期望之硬化性及耐熱性者即可。具體而言,可較佳地使用選自由下述通式(B1)、(B2)、(B3)及(B4)所示之化合物所組成之群中之至少一種。其原因在於,藉由將上述化合物與上述化合物A1併用,上述組合物會成為硬化性及硬化物之耐熱性之平衡性進一步優異者。 本發明中,就易於形成硬化性更優異之組合物之觀點而言,上述硫醚系抗氧化劑較佳為不具有酚性羥基者。例如,較佳為選自由上述通式(B1)、(B2)、(B3)及(B4)所示之化合物中之上述通式(B1)、(B3)及(B4)所示之化合物所組成的群中之至少一種。由於該等化合物不含酚性羥基作為必需結構,故而易於成為硬化性更優異之組合物。 本發明中,其中較佳為選自由上述通式(B3)及(B4)所示之化合物所組成之群中之至少一種。其原因在於,藉由將上述化合物與上述化合物A1併用,上述組合物會成為硬化性及硬化物之耐熱性之平衡性進一步優異者。 本發明中,就揮發性較低,可容易地製造耐熱性之經時變化較少之硬化物之觀點而言,上述硫醚系抗氧化劑較佳為上述通式(B3)所示之化合物。 本發明中,就與硬化性成分之相溶性良好,易於製造分散穩定性優異之組合物,且易於製造硫醚系抗氧化劑良好地分散之硬化物之觀點而言,上述硫醚系抗氧化劑較佳為上述通式(B4)所示之化合物。(1) Thioether antioxidant As the above-mentioned thioether-based antioxidant, any one that has a thioether structure and can obtain desired curability and heat resistance. Specifically, at least one selected from the group consisting of compounds represented by the following general formulas (B1), (B2), (B3), and (B4) can be preferably used. The reason is that by using the above compound and the above compound A1 in combination, the above composition becomes more excellent in the balance between the curability and the heat resistance of the cured product. In the present invention, it is preferable that the above-mentioned thioether-based antioxidant does not have a phenolic hydroxyl group from the viewpoint of easily forming a composition having more excellent curability. For example, it is preferably selected from the compounds represented by the general formulas (B1), (B2), (B3) and (B4), among the compounds represented by the general formulas (B1), (B3) and (B4). At least one of the group consisting of. Since these compounds do not contain a phenolic hydroxyl group as an essential structure, they tend to be compositions with more excellent curability. In the present invention, it is preferably at least one selected from the group consisting of compounds represented by the above general formulas (B3) and (B4). The reason is that by using the above compound and the above compound A1 in combination, the above composition becomes more excellent in the balance between the curability and the heat resistance of the cured product. In the present invention, the thioether antioxidant is preferably a compound represented by the general formula (B3) from the viewpoint of low volatility and easy production of a cured product with less change in heat resistance over time. In the present invention, the above-mentioned thioether-based antioxidant is relatively more compatible with the curable component, easy to produce a composition with excellent dispersion stability, and easy to produce a cured product in which the thioether-based antioxidant is well dispersed. It is preferably a compound represented by the above general formula (B4).

[化16]

Figure 02_image035
[化16]
Figure 02_image035

(式中,R1 及R2 分別獨立地表示碳原子數6~20之芳基、碳原子數3~30之烷基、或該烷基中之亞甲基之1個或2個以上被取代為-O-或-S-而成之基, R3 、R4 、R5 、R6 、R7 、R8 、R9 及R10 分別獨立地表示氫原子、碳原子數1~8之烷基、或該烷基中之亞甲基之1個或2個以上被取代為-O-或-S-而成之基, 上述烷基之氫原子之1個或2個以上可被取代為烷氧基、烯基、烯氧基、羥基或氰基, 上述芳基之氫原子之1個或2個以上可被取代為羥基或碳原子數1~8之烷基)(In the formula, R 1 and R 2 each independently represent an aryl group with 6 to 20 carbon atoms, an alkyl group with 3 to 30 carbon atoms, or one or more of the methylene groups in the alkyl group. Substituted with -O- or -S-, R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 and R 10 each independently represent a hydrogen atom and the number of carbon atoms is 1-8 The alkyl group, or one or more of the methylene groups in the alkyl group is substituted with -O- or -S-. One or more of the hydrogen atoms of the above-mentioned alkyl group may be (Substituted with alkoxy, alkenyl, alkenyloxy, hydroxyl or cyano, one or more of the hydrogen atoms of the above aryl group may be substituted with a hydroxyl group or an alkyl group with 1 to 8 carbon atoms)

[化17]

Figure 02_image037
[化17]
Figure 02_image037

(式中,R11 表示碳原子數6~20之芳基、碳原子數3~30之烷基、或該烷基中之亞甲基之1個或2個以上被取代為-O-或-S-而成之基, R12 、R13 、R14 、R15 、R16 、R17 、R18 及R19 分別獨立地表示氫原子或碳原子數1~8之烷基, 上述烷基之氫原子之1個或2個以上可被取代為烷氧基、烯基、烯氧基、羥基或氰基, 上述芳基之氫原子之1個或2個以上可被取代為羥基或碳原子數1~8之烷基)(In the formula, R 11 represents an aryl group with 6 to 20 carbon atoms, an alkyl group with 3 to 30 carbon atoms, or one or more of the methylene groups in the alkyl group are substituted with -O- or -S-, R 12 , R 13 , R 14 , R 15 , R 16 , R 17 , R 18 and R 19 each independently represent a hydrogen atom or an alkyl group having 1 to 8 carbon atoms. One or more of the hydrogen atoms of the group may be substituted with alkoxy, alkenyl, alkenyloxy, hydroxy, or cyano, and one or more of the hydrogen atoms of the above aryl group may be substituted with hydroxy or Alkyl group with 1 to 8 carbon atoms)

[化18]

Figure 02_image039
[化18]
Figure 02_image039

(式中,R21 、R22 、R23 及R24 分別獨立地表示碳原子數3~30之烷基、或該烷基中之亞甲基之1個或2個以上被取代為-O-或-S-而成之基, 上述烷基之氫原子之1個或2個以上可被取代為烷氧基、烯基、烯氧基、羥基或氰基)(In the formula, R 21 , R 22 , R 23 and R 24 each independently represent an alkyl group having 3 to 30 carbon atoms, or one or more of the methylene groups in the alkyl group are substituted with -O -Or -S-, one or more of the hydrogen atoms of the alkyl group may be substituted with alkoxy, alkenyl, alkenyloxy, hydroxyl or cyano)

[化19]

Figure 02_image041
[化19]
Figure 02_image041

(式中,R31 及R32 分別獨立地表示氫原子、碳原子數6~20之芳基、碳原子數3~30之烷基、或該烷基中之亞甲基之1個或2個以上被取代為-O-或-S-而成之基, L1 及L2 分別獨立地表示碳原子數1~8之伸烷基, 上述烷基及上述伸烷基之氫原子之1個或2個以上可被取代為烷氧基、烯基、烯氧基、羥基或氰基, 上述芳基之氫原子之1個或2個以上可被取代為羥基或碳原子數1~8之烷基)(In the formula, R 31 and R 32 each independently represent one or two of a hydrogen atom, an aryl group having 6 to 20 carbon atoms, an alkyl group having 3 to 30 carbon atoms, or the methylene group in the alkyl group. More than one group substituted with -O- or -S-, L 1 and L 2 each independently represent an alkylene group having 1 to 8 carbon atoms, 1 of the above-mentioned alkyl group and the hydrogen atom of the above-mentioned alkylene group One or two or more may be substituted with alkoxy, alkenyl, alkenyl, hydroxy, or cyano, and one or two of the hydrogen atoms of the aryl group may be substituted with hydroxy or with 1-8 carbon atoms Of alkyl)

作為通式(B1)中之R1 及R2 所示之碳原子數3~30之烷基,可使用上述R101 等所示之烷基中之特定碳原子數者。 作為通式(B1)中之R1 及R2 所示之碳數6~20之芳基,可使用上述R101 等所示之芳基中之特定碳原子數者。作為對該芳基之氫原子進行取代之碳原子數1~8之烷基,可使用上述R101 等所示之烷基中之特定碳原子數者。 通式(B1)中,作為R3 ~R10 所示之碳原子數1~8之烷基,可使用上述R101 等中所使用之芳基中之特定碳原子數者。As the alkyl group having 3 to 30 carbon atoms represented by R 1 and R 2 in the general formula (B1), those having a specific number of carbon atoms in the alkyl group represented by R 101 and the like can be used. As the aryl group having 6 to 20 carbon atoms represented by R 1 and R 2 in the general formula (B1), those having a specific number of carbon atoms in the aryl group represented by R 101 and the like can be used. As the alkyl group having 1 to 8 carbon atoms to which the hydrogen atom of the aryl group is substituted, the alkyl group having the specified number of carbon atoms in the alkyl group represented by R 101 and the like can be used. In the general formula (B1), as the alkyl group having 1 to 8 carbon atoms represented by R 3 to R 10 , those having the specified number of carbon atoms in the aryl group used in the above-mentioned R 101 and the like can be used.

關於對R1 ~R10 所示之烷基中之氫原子進行取代之烷氧基、烯基,可使用上述R101 等中所使用之基中之特定碳原子數者。 作為對R1 ~R10 所示之烷基中之氫原子進行取代之烯氧基,可使用上述R101 等所示之烯基之末端之亞甲基被取代為-O-之基中之特定碳原子數者。Regarding the alkoxy group and alkenyl group substituted for the hydrogen atom in the alkyl group represented by R 1 to R 10 , those having the specified number of carbon atoms in the groups used in the above-mentioned R 101 and the like can be used. As the alkenyloxy group for substituting the hydrogen atom in the alkyl group represented by R 1 to R 10 , one of the groups in which the methylene group at the end of the alkenyl group represented by R 101 and the like is substituted with -O- can be used Those with a specific number of carbon atoms.

上述通式(B2)中之R11 所示之碳原子數3~30之烷基及碳原子數6~20之芳基、R12 、R13 、R14 、R15 、R16 、R17 、R18 及R19 所示之碳原子數1~8之烷基可使用與上述通式(B1)中之R1 及R3 ~R10 中所使用之基相同之基。 又,關於對R11 所示之芳基中之氫原子進行取代之碳原子數1~8之烷基,亦可使用與對上述通式(B1)中之R1 或R2 中所使用之芳基之氫原子進行取代的碳原子數1~8之烷基相同之基。進而,關於對R11 、R12 、R13 、R14 、R15 、R16 、R17 、R18 及R19 所示之烷基之氫原子進行取代之烷氧基、烯基及烯氧基,亦可使用與對上述通式(B1)中之R1 ~R10 所示之烷基之氫原子進行取代者相同的基。The alkyl group having 3 to 30 carbon atoms and the aryl group having 6 to 20 carbon atoms represented by R 11 in the above general formula (B2) , R 12 , R 13 , R 14 , R 15 , R 16 , R 17 The alkyl group having 1 to 8 carbon atoms represented by R 18 and R 19 can be the same as those used for R 1 and R 3 to R 10 in the general formula (B1). In addition, the alkyl group having 1 to 8 carbon atoms substituted for the hydrogen atom in the aryl group represented by R 11 can also be used with the one used for R 1 or R 2 in the above general formula (B1) The hydrogen atom of the aryl group is the same as the alkyl group having 1 to 8 carbon atoms. Furthermore, regarding the alkoxy, alkenyl and alkenyloxy groups substituted with hydrogen atoms of the alkyl groups represented by R 11 , R 12 , R 13 , R 14 , R 15 , R 16 , R 17 , R 18 and R 19 As the group, the same group as the one substituted for the hydrogen atom of the alkyl group represented by R 1 to R 10 in the above general formula (B1) can also be used.

作為上述通式(B3)中之R21 、R22 、R23 及R24 所示之碳原子數3~30之烷基,可使用與上述通式(B1)中之R1 所示之基相同之基。 又,關於對R21 、R22 、R23 及R24 中所使用之烷基中之氫原子進行取代之烷氧基、烯基,可使用上述R101 等中所使用之基中之特定碳原子數者。 作為對R21 、R22 、R23 及R24 中所使用之烷基中之氫原子進行取代之烯氧基,可使用上述R101 等中所使用之烯基之末端之亞甲基被取代為-O-之基中之特定碳原子數者。As the alkyl group having 3 to 30 carbon atoms represented by R 21 , R 22 , R 23 and R 24 in the above general formula (B3), the group represented by R 1 in the above general formula (B1) can be used The same base. In addition, with regard to the alkoxy and alkenyl groups that replace the hydrogen atoms in the alkyl groups used in R 21 , R 22 , R 23 and R 24 , specific carbons in the groups used in the above-mentioned R 101 and the like can be used Atomic number. As the alkenyloxy group for substituting the hydrogen atom in the alkyl group used in R 21 , R 22 , R 23 and R 24 , the methylene group at the end of the alkenyl group used in the above-mentioned R 101 etc. can be substituted It is the specific number of carbon atoms in the base of -O-.

作為上述通式(B4)中之R31 及R32 所示之碳原子數3~30之烷基及碳原子數6~20之芳基,可使用與上述通式(B1)中之R1 及R3 ~R10 中所使用之基相同之基。 作為對R31 及R32 所示之烷基之氫原子進行取代之烷氧基、烯基、烯氧基,可使用與上述通式(B1)中所使用之基相同之基。作為對上述通式(B4)中之R31 及R32 所示之芳基之氫原子進行取代的碳原子數1~8之烷基,可使用與上述通式(B1)中所使用之基相同之基。 作為上述通式(B4)中之L1 及L2 中所使用之碳原子數1~8之伸烷基,可使用自R101 等中所使用之碳原子數1~40之烷基去除1個氫原子後之基中的特定碳原子數者。 關於對L1 及L2 所示之伸烷基之氫原子進行取代之烷氧基、烯基、烯氧基,可使用與上述通式(B1)中所使用之基相同之基。As the alkyl group having 3 to 30 carbon atoms and the aryl group having 6 to 20 carbon atoms represented by R 31 and R 32 in the above general formula (B4), the same as R 1 in the above general formula (B1) can be used. The same groups as those used in R 3 to R 10. As the alkoxy group, alkenyl group, and alkenyloxy group substituted for the hydrogen atom of the alkyl group represented by R 31 and R 32, the same groups as those used in the above general formula (B1) can be used. As the alkyl group having 1 to 8 carbon atoms substituted for the hydrogen atom of the aryl group represented by R 31 and R 32 in the above general formula (B4), the same group as used in the above general formula (B1) can be used The same base. As the alkylene group having 1 to 8 carbon atoms used in L 1 and L 2 in the above general formula (B4), the alkylene group having 1 to 40 carbon atoms used in R 101 and the like can be used to remove 1 A specific number of carbon atoms in the base after a hydrogen atom. Regarding the alkoxy group, alkenyl group, and alkenyloxy group substituted for the hydrogen atom of the alkylene group represented by L 1 and L 2, the same groups as those used in the above general formula (B1) can be used.

上述通式(B3)中之R21 、R22 、R23 及R24 分別獨立較佳為碳原子數6~25之烷基,其中較佳為碳原子數8~20之烷基,尤佳為碳原子數10~15之烷基。其原因在於,上述組合物會成為硬化性及硬化物之耐熱性之平衡性進一步優異者。 上述R21 、R22 、R23 及R24 中所使用之烷基較佳為烷基中之氫原子之1個或2個以上未被取代為烷氧基等之未經取代之烷基。 又,上述R21 、R22 、R23 及R24 中所使用之基較佳為烷基中之亞甲基之1個或2個以上未被取代為-O-或-S-之未經取代之烷基。 上述R21 、R22 、R23 及R24 可相同亦可不同。R21 、R22 、R23 及R24 較佳為相同。 其原因在於,藉由使上述R21 、R22 、R23 及R24 為上述基,上述組合物會成為硬化性及硬化物之耐熱性之平衡性進一步優異者。又,上述組合物可穩定地發揮所期望之耐熱性。 R 21 , R 22 , R 23 and R 24 in the above general formula (B3) are each independently preferably an alkyl group with 6 to 25 carbon atoms, and among them, an alkyl group with 8 to 20 carbon atoms is preferred, and most preferably It is an alkyl group having 10 to 15 carbon atoms. The reason for this is that the above-mentioned composition becomes more excellent in the balance of curability and heat resistance of the cured product. The alkyl group used in the above-mentioned R 21 , R 22 , R 23 and R 24 is preferably an unsubstituted alkyl group in which one or more of the hydrogen atoms in the alkyl group are not substituted with an alkoxy group or the like. In addition, the groups used in the above-mentioned R 21 , R 22 , R 23 and R 24 are preferably those with one or more methylene groups in the alkyl group that are not substituted with -O- or -S- Substituted alkyl. The above-mentioned R 21 , R 22 , R 23 and R 24 may be the same or different. R 21 , R 22 , R 23 and R 24 are preferably the same. The reason is that by making the above-mentioned R 21 , R 22 , R 23, and R 24 the above-mentioned group, the above-mentioned composition becomes a more excellent balance between the curability and the heat resistance of the cured product. In addition, the above-mentioned composition can stably exhibit the desired heat resistance.

上述通式(B4)中之R31 及R32 分別獨立較佳為碳原子數6~25之烷基,其中較佳為碳原子數8~20之烷基,尤佳為碳原子數10~18之烷基,其中尤佳為碳原子數10~15之烷基。其原因在於,上述組合物會成為硬化性及硬化物之耐熱性之平衡性進一步優異者。 上述R31 及R32 中所使用之烷基及芳基較佳為烷基及芳基中之氫原子之1個或2個以上未被烷氧基等取代之未經取代之烷基及芳基。 又,上述R31 及R32 中所使用之基較佳為烷基中之亞甲基之1個或2個以上未被取代為-O-或-S-之未經取代之烷基。 又,上述R31 及R32 可相同亦可不同,但較佳為相同。 其原因在於,藉由使上述R31 及R32 為上述基,上述組合物會成為硬化性及硬化物之耐熱性之平衡性進一步優異者。又,上述組合物可穩定地發揮所期望之耐熱性。 R 31 and R 32 in the above general formula (B4) are each independently preferably an alkyl group having 6 to 25 carbon atoms, of which an alkyl group having 8 to 20 carbon atoms is preferred, and an alkyl group having 10 to carbon atoms is particularly preferred. The alkyl group of 18 is particularly preferably an alkyl group having 10 to 15 carbon atoms. The reason for this is that the above-mentioned composition becomes more excellent in the balance of curability and heat resistance of the cured product. The alkyl groups and aryl groups used in R 31 and R 32 are preferably unsubstituted alkyl groups and aryl groups in which one or more of the hydrogen atoms in the alkyl group and the aryl group are not substituted by an alkoxy group, etc. base. In addition, the groups used in the above-mentioned R 31 and R 32 are preferably unsubstituted alkyl groups in which one or more of the methylene groups in the alkyl group are not substituted with -O- or -S-. In addition, the above-mentioned R 31 and R 32 may be the same or different, but are preferably the same. The reason is that by making the above-mentioned R 31 and R 32 as the above-mentioned group, the above-mentioned composition becomes one having a more excellent balance between the curability and the heat resistance of the cured product. In addition, the above-mentioned composition can stably exhibit the desired heat resistance.

上述通式(B4)中之L1 及L2 較佳為碳原子數1~5之伸烷基,其中較佳為碳原子數1~3之伸烷基,尤佳為碳原子數1~2之伸烷基、即亞甲基或伸乙基,其中尤佳為伸乙基。其原因在於,藉由使上述硫醚系抗氧化劑之結構為上述結構,上述組合物會成為硬化性及硬化物之耐熱性之平衡性進一步優異者。又,上述組合物可穩定地發揮所期望之耐熱性。 上述L1 及L2 中所使用之伸烷基較佳為伸烷基中之氫原子未被取代為烷氧基等之未經取代之伸烷基。 其原因在於,藉由使上述L1 及L2 為上述基,上述組合物會成為硬化性及硬化物之耐熱性之平衡性進一步優異者。又,上述組合物可穩定地發揮所期望之耐熱性。In the above general formula (B4), L 1 and L 2 are preferably alkylene groups having 1 to 5 carbon atoms, and among them, alkylene groups having 1 to 3 carbon atoms are preferred, and particularly preferred are alkylene groups having 1 to 3 carbon atoms. The alkylene group of 2 is methylene or ethylene group, and ethylene group is particularly preferred. The reason for this is that by making the structure of the thioether-based antioxidant the above-mentioned structure, the above-mentioned composition becomes more excellent in the balance between the curability and the heat resistance of the cured product. In addition, the above-mentioned composition can stably exhibit the desired heat resistance. The alkylene group used in the above L 1 and L 2 is preferably an unsubstituted alkylene group in which the hydrogen atom in the alkylene group is not substituted with an alkoxy group or the like. The reason is that by making the above-mentioned L 1 and L 2 as the above-mentioned group, the above-mentioned composition becomes more excellent in the balance between the curability and the heat resistance of the cured product. In addition, the above-mentioned composition can stably exhibit the desired heat resistance.

作為可用作上述硫醚系抗氧化劑之具體之化合物,例如可例舉日本專利特開2017-128697號公報中記載之化合物。 又,作為硫醚系抗氧化劑之市售品,可例舉:ADEKA股份有限公司製造之AO-412S、AO-503,三洋貿易股份有限公司製造之K-NOX1520、K-NOX1726等。As a specific compound that can be used as the above-mentioned thioether-based antioxidant, for example, the compound described in JP 2017-128697 A can be cited. In addition, as commercial products of thioether antioxidants, AO-412S and AO-503 manufactured by ADEKA Co., Ltd., K-NOX1520 and K-NOX1726 manufactured by Sanyo Trading Co., Ltd. can be mentioned.

上述硫醚系抗氧化劑於組合物中可僅存在1種,亦可存在2種以上。The above-mentioned thioether-based antioxidant may be present in the composition by only one type or two or more types.

(2)硫醇系抗氧化劑 上述硫醇系抗氧化劑只要為具有硫醇基者即可,例如可例舉2-巰基苯并咪唑等。 作為上述硫醇系抗氧化劑之市售品,例如可例舉Sumika Chemtex股份有限公司製造之Sumilizer MB等。(2) Thiol-based antioxidants The aforementioned thiol-based antioxidant may be one having a thiol group, and for example, 2-mercaptobenzimidazole may be mentioned. As a commercial item of the said thiol-type antioxidant, Sumilizer MB etc. which are manufactured by Sumika Chemtex Co., Ltd. can be mentioned, for example.

(3)其他 本發明之組合物中之上述硫系抗氧化劑之含量於上述組合物之固形物成分100質量份中,較佳為0.01質量份以上20質量份以下,其中較佳為0.05質量份以上10質量份以下,尤佳為0.1質量份以上5質量份以下。其原因在於,藉由使上述含量為上述範圍,上述組合物會成為硬化性及硬化物之耐熱性之平衡優異者。 上述硫系抗氧化劑之含量根據溶劑等之含量而不同,例如於組合物100質量份中,可設為0.001質量份以上20質量份以下,其中較佳為0.005質量份以上10質量份以下,尤佳為0.01質量份以上5質量份以下。其原因在於,藉由使上述含量為上述範圍,上述組合物會成為硬化性及硬化物之耐熱性之平衡優異者。 上述硫系抗氧化劑之含量於化合物A1、硫系抗氧化劑及硬化性成分之合計100質量份中,較佳為0.01質量份以上20質量份以下,其中較佳為0.05質量份以上10質量份以下,尤佳為0.1質量份以上5質量份以下。其原因在於,藉由使上述含量為上述範圍,上述組合物會成為硬化性及硬化物之耐熱性之平衡性進一步優異者。 上述硫系抗氧化劑之含量相對於上述硬化性成分100質量份,較佳為0.001質量份以上20質量份以下,其中較佳為0.005質量份以上10質量份以下,尤佳為0.01質量份以上5質量份以下。其原因在於,藉由使上述含量為上述範圍,上述組合物會成為硬化性及硬化物之耐熱性之平衡性進一步優異者。(3) Other The content of the sulfur-based antioxidant in the composition of the present invention is based on 100 parts by mass of the solid content of the composition, preferably 0.01 parts by mass or more and 20 parts by mass or less, and more preferably 0.05 parts by mass or more and 10 parts by mass Below, it is especially preferable that it is 0.1 mass part or more and 5 mass parts or less. The reason is that, by setting the above content within the above range, the above composition becomes one having an excellent balance of curability and heat resistance of the cured product. The content of the sulfur-based antioxidant varies according to the content of the solvent, etc., for example, in 100 parts by mass of the composition, it can be set to 0.001 parts by mass or more and 20 parts by mass or less, and preferably 0.005 parts by mass or more and 10 parts by mass or less, especially Preferably it is 0.01 part by mass or more and 5 parts by mass or less. The reason is that, by setting the above content within the above range, the above composition becomes one having an excellent balance of curability and heat resistance of the cured product. The content of the above-mentioned sulfur-based antioxidant is in 100 parts by mass of the total of compound A1, sulfur-based antioxidant and hardenable components, preferably 0.01 part by mass or more and 20 parts by mass or less, and more preferably 0.05 part by mass or more and 10 parts by mass or less , Particularly preferably not less than 0.1 parts by mass and not more than 5 parts by mass. The reason is that, by setting the above content within the above range, the above composition becomes more excellent in the balance of curability and heat resistance of the cured product. The content of the sulfur-based antioxidant relative to 100 parts by mass of the curable component is preferably 0.001 parts by mass or more and 20 parts by mass or less, among them, 0.005 parts by mass or more and 10 parts by mass or less, and particularly preferably 0.01 parts by mass or more. Parts by mass or less. The reason is that, by setting the above content within the above range, the above composition becomes more excellent in the balance of curability and heat resistance of the cured product.

3.硬化性成分 上述硬化性成分係包含硬化性化合物者。 又,上述硬化性成分係作為上述化合物A1以外之成分而含有於上述組合物中者,作為上述化合物A1之具有聚合性者不包含於上述硬化性成分中。因此,作為化合物A1之含有烯基等者不屬於本發明中之硬化性成分。 作為上述硬化性化合物,可使用2種以上之硬化性化合物鍵結而可形成高分子量物之化合物,例如可例舉硬化性化合物彼此可直接鍵結而高分子量化之聚合性化合物、可藉由加熱而高分子量化之熱硬化性化合物等。 作為上述聚合性化合物,例如可例舉:自由基聚合性化合物、陽離子聚合性化合物及陰離子聚合性化合物等。 本發明中,其中,就可獲得硬化性及硬化物之耐熱性之平衡優異之組合物之效果變得更顯著而言,上述硬化性成分較佳為包含聚合性化合物,其中較佳為包含自由基聚合性化合物。 又,本發明中,硬化性成分亦較佳為包含自由基聚合性化合物及熱硬化性化合物之兩者。其原因在於,上述組合物會成為硬化性及硬化物之耐熱性之平衡優異者。3. Hardening ingredients The above-mentioned curable component contains a curable compound. Moreover, the said curable component is what is contained in the said composition as a component other than the said compound A1, and the polymerizable thing as the said compound A1 is not included in the said curable component. Therefore, the compound A1 containing alkenyl group and the like does not belong to the curable component in the present invention. As the above-mentioned curable compound, two or more curable compounds can be used to bond to form a high molecular weight compound. For example, a polymerizable compound in which curable compounds can be directly bonded to each other to form a high molecular weight can be used. Heat-curable compounds with high molecular weight, etc. As said polymerizable compound, a radical polymerizable compound, a cation polymerizable compound, an anionic polymerizable compound, etc. are mentioned, for example. In the present invention, among others, in terms of the effect of obtaining a composition excellent in the balance of curability and heat resistance of the cured product, the curable component preferably contains a polymerizable compound, and preferably contains free Base polymerizable compound. In addition, in the present invention, the curable component also preferably contains both of a radical polymerizable compound and a thermosetting compound. The reason is that the above-mentioned composition becomes an excellent balance between the curability and the heat resistance of the cured product.

上述自由基聚合性化合物只要為可進行自由基聚合之化合物即可。作為上述自由基聚合性化合物,例如可例舉:具有丙烯酸基、甲基丙烯酸基、乙烯基等乙烯性不飽和基之化合物。本發明之組合物中,作為具有1個以上之乙烯性不飽和基之化合物,可使用具有1個乙烯性不飽和基之單官能化合物、具有2個以上之乙烯性不飽和基之多官能化合物。作為上述自由基聚合性化合物,可使用公知之化合物,例如可使用國際公開第2018/012383號公報中記載之自由基聚合性化合物、國際公開第2014/021023號公報中記載之自由基聚合性有機物質等。The above-mentioned radically polymerizable compound may be any compound that can undergo radical polymerization. As said radical polymerizable compound, the compound which has ethylenic unsaturated groups, such as an acrylic group, a methacryl group, and a vinyl group, is mentioned, for example. In the composition of the present invention, as the compound having one or more ethylenically unsaturated groups, a monofunctional compound having one ethylenically unsaturated group and a polyfunctional compound having two or more ethylenically unsaturated groups can be used . As the above-mentioned radically polymerizable compound, known compounds can be used. For example, the radically polymerizable compound described in International Publication No. 2018/012383 and the radically polymerizable compound described in International Publication No. 2014/021023 can be used. Substances and so on.

作為上述自由基聚合性化合物,就可賦予鹼性顯影性之觀點而言,較佳為使用具有羧基等酸性基與乙烯性不飽和基之化合物。 作為上述具有羧基等酸性基與乙烯性不飽和基之化合物,例如可使用:丙烯酸及甲基丙烯酸等不飽和單羧酸、日本專利特開2016-180880號公報中記載之含羧基之感光性樹脂、國際公開第2016/208187號公報中記載之含羧基之樹脂、日本專利特開2018-53215號公報中記載之含羧基之樹脂、日本專利特開2016-151744號公報中記載之包含具有羧基之結構單元之聚合物、及日本專利特開2005-234362號公報中記載之[A]共聚物等。As the above-mentioned radically polymerizable compound, it is preferable to use a compound having an acidic group such as a carboxyl group and an ethylenically unsaturated group from the viewpoint of imparting alkali developability. As the compound having an acidic group such as a carboxyl group and an ethylenically unsaturated group, for example, unsaturated monocarboxylic acids such as acrylic acid and methacrylic acid, and a carboxyl group-containing photosensitive resin described in JP 2016-180880 A can be used , The carboxyl-containing resin described in International Publication No. 2016/208187, the carboxyl-containing resin described in Japanese Patent Laid-Open No. 2018-53215, and the carboxyl-containing resin described in Japanese Patent Laid-Open No. 2016-151744 Polymers of structural units, and [A] copolymers described in Japanese Patent Laid-Open No. 2005-234362, etc.

作為上述具有羧基等酸性基與乙烯性不飽和基之化合物,較佳為使用含羧基之樹脂。 作為上述含羧基之樹脂,可例舉:使甲酚酚醛清漆型環氧樹脂與丙烯酸或甲基丙烯酸反應所得之環氧丙烯酸酯樹脂;使多官能環氧化合物與不飽和羧酸反應,進而與多元酸或其酸酐反應而成之酸改性不飽和環氧酯樹脂;及不飽和改性丙烯酸系樹脂等,其係使將選自丙烯酸及甲基丙烯酸之化合物聚合所得之結構單元所具有之丙烯酸系樹脂、與含乙烯性不飽和基之環氧化合物反應,而導入有乙烯性不飽和基。As the compound having an acidic group such as a carboxyl group and an ethylenically unsaturated group, it is preferable to use a carboxyl group-containing resin. Examples of the above-mentioned carboxyl group-containing resin include: epoxy acrylate resin obtained by reacting a cresol novolac type epoxy resin with acrylic or methacrylic acid; reacting a multifunctional epoxy compound with an unsaturated carboxylic acid, and then reacting with An acid-modified unsaturated epoxy ester resin formed by the reaction of a polybasic acid or its anhydride; and an unsaturated modified acrylic resin, etc., which are contained in a structural unit obtained by polymerizing a compound selected from acrylic acid and methacrylic acid The acrylic resin reacts with the epoxy compound containing the ethylenically unsaturated group to introduce the ethylenically unsaturated group.

作為上述多官能環氧化合物,只要為1分子中具有至少兩個環氧基者即可。作為該多官能環氧化合物,例如可例舉:雙酚A型環氧樹脂、雙酚F型環氧樹脂及雙酚AD型環氧樹脂等雙酚型環氧樹脂;聯苯型環氧樹脂;萘型環氧樹脂;二環戊二烯型環氧樹脂;矽酮改性環氧樹脂等橡膠改性環氧樹脂;ε-己內酯改性環氧樹脂;雙酚A型、雙酚F型、雙酚AD型等酚系酚醛清漆型環氧樹脂;鄰甲酚酚醛清漆型等甲酚酚醛清漆型環氧樹脂;環狀脂肪族多官能環氧樹脂;縮水甘油酯型多官能環氧樹脂;縮水甘油胺型多官能環氧樹脂;雜環式多官能環氧樹脂;雙酚改性酚醛清漆型環氧樹脂;多官能改性酚醛清漆型環氧樹脂;酚類與具有酚性羥基之芳香族醛之縮合物型環氧樹脂等。又,亦可使用於該等樹脂中導入有Br、Cl等鹵素原子者。 該等多官能環氧化合物可單獨使用,又,亦可混合2種以上而使用。As the said polyfunctional epoxy compound, what has at least two epoxy groups in 1 molecule should just be sufficient. As the polyfunctional epoxy compound, for example, bisphenol type epoxy resin such as bisphenol A type epoxy resin, bisphenol F type epoxy resin, and bisphenol AD type epoxy resin; biphenyl type epoxy resin ; Naphthalene type epoxy resin; Dicyclopentadiene type epoxy resin; Silicone modified epoxy resin and other rubber modified epoxy resin; ε-caprolactone modified epoxy resin; Bisphenol A type, bisphenol Phenolic novolac type epoxy resins such as F type and bisphenol AD type; cresol novolac type epoxy resins such as o-cresol novolac type; cycloaliphatic multifunctional epoxy resin; glycidyl ester type multifunctional ring Oxygen resin; glycidylamine type multifunctional epoxy resin; heterocyclic type multifunctional epoxy resin; bisphenol modified novolac epoxy resin; multifunctional modified novolac epoxy resin; phenolic and phenolic Hydroxyl aromatic aldehyde condensate type epoxy resin, etc. In addition, it is also possible to use those having halogen atoms such as Br and Cl introduced into these resins. These polyfunctional epoxy compounds may be used alone, or two or more of them may be mixed and used.

作為上述不飽和羧酸,例如可例舉:丙烯酸、甲基丙烯酸、丁烯酸、桂皮酸等不飽和單羧酸。該等不飽和單羧酸中,較佳為丙烯酸或甲基丙烯酸。 多官能環氧化合物與不飽和單羧酸之反應方法並無特別限定,例如可藉由將多官能環氧化合物與不飽和單羧酸於適當之溶劑中加熱而使之反應。As said unsaturated carboxylic acid, unsaturated monocarboxylic acid, such as acrylic acid, methacrylic acid, crotonic acid, and cinnamic acid, can be mentioned, for example. Among these unsaturated monocarboxylic acids, acrylic acid or methacrylic acid is preferred. The reaction method of the polyfunctional epoxy compound and the unsaturated monocarboxylic acid is not particularly limited. For example, the polyfunctional epoxy compound and the unsaturated monocarboxylic acid can be reacted by heating in a suitable solvent.

作為上述多元酸或其酸酐,可使用多飽和、不飽和之任一種。 作為上述多元酸,例如可例舉:琥珀酸、馬來酸、己二酸、檸檬酸、鄰苯二甲酸、四氫鄰苯二甲酸、3-甲基四氫鄰苯二甲酸、4-甲基四氫鄰苯二甲酸、3-乙基四氫鄰苯二甲酸、4-乙基四氫鄰苯二甲酸、六氫鄰苯二甲酸、3-甲基六氫鄰苯二甲酸、4-甲基六氫鄰苯二甲酸、3-乙基六氫鄰苯二甲酸、4-乙基六氫鄰苯二甲酸、甲基四氫鄰苯二甲酸、甲基六氫鄰苯二甲酸、內亞甲基四氫鄰苯二甲酸、甲基內亞甲基四氫鄰苯二甲酸、偏苯三甲酸、均苯四甲酸及二甘醇酸等。 作為上述多元酸酐,可例舉上述多元酸之酸酐。As the polybasic acid or its anhydride, either polysaturated or unsaturated can be used. As the above-mentioned polybasic acid, for example, succinic acid, maleic acid, adipic acid, citric acid, phthalic acid, tetrahydrophthalic acid, 3-methyltetrahydrophthalic acid, 4-methyl Tetrahydrophthalic acid, 3-ethyltetrahydrophthalic acid, 4-ethyltetrahydrophthalic acid, hexahydrophthalic acid, 3-methylhexahydrophthalic acid, 4- Methylhexahydrophthalic acid, 3-ethylhexahydrophthalic acid, 4-ethylhexahydrophthalic acid, methyltetrahydrophthalic acid, methylhexahydrophthalic acid, internal Methylenetetrahydrophthalic acid, methylendomethyltetrahydrophthalic acid, trimellitic acid, pyromellitic acid and diglycolic acid, etc. As said polybasic acid anhydride, the acid anhydride of the said polybasic acid can be mentioned.

關於上述含乙烯性不飽和基之環氧化合物,例如可例舉:甲基丙烯酸縮水甘油酯、(甲基)丙烯酸4-羥丁酯縮水甘油醚、(甲基)丙烯酸3,4-環氧環己基甲酯等。Regarding the above-mentioned ethylenically unsaturated group-containing epoxy compound, for example, glycidyl methacrylate, 4-hydroxybutyl (meth)acrylate glycidyl ether, and 3,4-epoxy (meth)acrylate may be mentioned. Cyclohexyl methyl ester and so on.

再者,(甲基)丙烯酸基包含丙烯酸基及甲基丙烯酸基之兩者。 又,(甲基)丙烯酸酯包含丙烯酸酯及甲基丙烯酸酯之兩者。Furthermore, the (meth)acrylic group includes both an acrylic group and a methacrylic group. In addition, (meth)acrylate includes both acrylate and methacrylate.

作為含羧基之樹脂,可使用市售品。作為該含羧基之樹脂之市售品,例如可例舉:ZAR-2000、ZFR-1122、FLX-2089、ZCR-1601H、CCR-1171H、CCR-1235、CCR-1291H、CCR-1307H、CCR-1309H(以上為日本化藥股份有限公司製造),Cyclomer P(ACA)Z-250(Daicel Chemical industries股份有限公司製造),RIPOXY SP-4621、SPC-1000、SPC-3000、PR-300CP(昭和高分子股份有限公司製造)等。As the carboxyl group-containing resin, commercially available products can be used. As a commercially available product of the carboxyl group-containing resin, for example, ZAR-2000, ZFR-1122, FLX-2089, ZCR-1601H, CCR-1171H, CCR-1235, CCR-1291H, CCR-1307H, CCR- 1309H (manufactured by Nippon Kayaku Co., Ltd.), Cyclomer P (ACA) Z-250 (manufactured by Daicel Chemical Industries Co., Ltd.), RIPOXY SP-4621, SPC-1000, SPC-3000, PR-300CP (Showa High (Manufactured by Molecule Co., Ltd.) and so on.

上述含羧基之樹脂之酸值只要為可形成耐久性優異之硬化物之數值即可,例如較佳為40 mgKOH/g以上150 mgKOH/g以下,其中較佳為50 mgKOH/g以上130 mgKOH/g以下。其原因在於,藉由使含羧基之樹脂之酸值為上述範圍內,上述組合物易於形成耐久性優異之硬化物。又,原因在於上述組合物易於圖案化。The acid value of the above-mentioned carboxyl group-containing resin may be a value capable of forming a cured product with excellent durability. For example, it is preferably 40 mgKOH/g or more and 150 mgKOH/g or less, and more preferably 50 mgKOH/g or more and 130 mgKOH/g. g or less. The reason is that, by setting the acid value of the carboxyl group-containing resin within the above range, the composition can easily form a cured product having excellent durability. In addition, the reason is that the above-mentioned composition is easy to pattern.

上述含羧基之樹脂之重量平均分子量只要為可獲得耐久性優異之硬化物者即可,可使用1000以上者。 關於上述含羧基之樹脂之重量平均分子量,就易於圖案化之觀點而言,例如較佳為2000以上150000以下,其中較佳為5000以上100000以下。其原因在於,藉由使上述含羧基之樹脂之平均分子量為上述範圍,上述組合物易於形成耐久性優異之硬化物。又,原因在於上述組合物易於圖案化。 上述含羧基之樹脂之重量平均分子量Mw例如可使用Tosoh股份有限公司製造之HLC-8120GPC,將洗提溶劑設為添加有0.01莫耳/公升之溴化鋰之N-甲基吡咯啶酮,將校正曲線用聚苯乙烯標準設為Mw377400、210500、96000、50400、20650、10850、5460、2930、1300、580(以上為Polymer Laboratories公司製造之Easi PS-2系列)及Mw1090000(Tosoh股份有限公司製造),將測定管柱設為TSK-GEL ALPHA-M×2根(Tosoh股份有限公司製造)來進行測定而獲得。又,測定溫度可設為40℃,流速可設為1.0 mL/min。The weight average molecular weight of the above-mentioned carboxyl group-containing resin may be one that can obtain a cured product excellent in durability, and one of 1,000 or more can be used. Regarding the weight average molecular weight of the above-mentioned carboxyl group-containing resin, from the viewpoint of easy patterning, for example, it is preferably 2,000 or more and 150,000 or less, and particularly preferably 5,000 or more and 100,000 or less. The reason is that, by setting the average molecular weight of the carboxyl group-containing resin within the above range, the composition can easily form a cured product having excellent durability. In addition, the reason is that the above-mentioned composition is easy to pattern. For the weight average molecular weight Mw of the above-mentioned carboxyl-containing resin, for example, HLC-8120GPC manufactured by Tosoh Co., Ltd. can be used, and the elution solvent is set to N-methylpyrrolidone added with 0.01 mol/liter of lithium bromide, and the calibration curve Use polystyrene standards as Mw377400, 210500, 96000, 50400, 20650, 10850, 5460, 2930, 1300, 580 (the above are Easi PS-2 series manufactured by Polymer Laboratories) and Mw1090000 (manufactured by Tosoh Co., Ltd.), It is obtained by measuring the measurement column as TSK-GEL ALPHA-M×2 (manufactured by Tosoh Co., Ltd.). In addition, the measurement temperature can be set to 40°C, and the flow rate can be set to 1.0 mL/min.

作為上述具有羧基之化合物之含量,只要為可形成耐久性優異之硬化物者即可,例如於上述組合物之固形物成分100質量份中,較佳為1質量份以上90質量份以下,更佳為20質量份以上80質量份以下,且較佳為40質量份以上70質量份以下。其原因在於,上述組合物會成為可容易地形成硬化性及耐熱性優異之硬化物者。又,原因在於上述組合物會成為可容易地形成圖案化者。The content of the compound having a carboxyl group may be one that can form a cured product with excellent durability. For example, in 100 parts by mass of the solid content of the composition, it is preferably 1 part by mass or more and 90 parts by mass or less, and more It is preferably 20 parts by mass or more and 80 parts by mass or less, and more preferably 40 parts by mass or more and 70 parts by mass or less. The reason is that the above composition can easily form a cured product having excellent curability and heat resistance. In addition, the reason is that the above-mentioned composition can be easily patterned.

亦可為上述自由基聚合性化合物中之不具有羧基者(以下,有稱為不具有羧基之化合物之情形)。作為不具有羧基之化合物,例如可較佳地使用下述通式(14)所示之化合物。其原因在於,藉由為該化合物,本發明之組合物會成為硬化性及硬化物之耐熱性之平衡性進一步優異者。It may be a compound having no carboxyl group among the above-mentioned radically polymerizable compounds (hereinafter, it may be referred to as a compound having no carboxyl group). As the compound having no carboxyl group, for example, a compound represented by the following general formula (14) can be preferably used. The reason is that by using this compound, the composition of the present invention is more excellent in the balance of curability and heat resistance of the cured product.

[化20]

Figure 02_image043
[化20]
Figure 02_image043

(式中,R1401 表示氫原子或甲基, X14 表示具有與n14為同數之價數之碳原子數1~40之未經取代或具有取代基之脂肪族烴基;具有與n14為同數之價數之碳原子數6~40之未經取代或具有取代基之含芳香族烴之基;具有與n14為同數之價數之碳原子數2~40之未經取代或具有取代基之含雜環之基;或者該脂肪族烴基、該含芳香族烴之基或該含雜環之基中之亞甲基之1個或2個以上被取代為選自上述群I中之二價基而成之基, n14表示1~10之整數)(In the formula, R 1401 represents a hydrogen atom or a methyl group, and X 14 represents an unsubstituted or substituted aliphatic hydrocarbon group with the same number of valences as n14 and a carbon number of 1-40; Unsubstituted or substituted aromatic hydrocarbon-containing group with the number of valences of 6-40 carbon atoms; unsubstituted or substituted group with 2-40 carbons with the same valence as n14 Or one or more of the methylene groups in the aliphatic hydrocarbon group, the aromatic hydrocarbon-containing group, or the heterocyclic group-containing group are substituted with those selected from the above group I A base formed by a divalent base, n14 represents an integer from 1 to 10)

關於X14 所示之具有與n14為同數之價數之未經取代或具有取代基之脂肪族烴基;具有與n14為同數之價數之未經取代或具有取代基之含芳香族烴之基;及具有與n14為同數之價數之未經取代或具有取代基之含雜環之基,可例舉與上述通式(A1)中之X相同之基。About X 14 has shown the number of non-n14 is the number of different substituted or divalent aliphatic hydrocarbon group having the substituent group; n14 having substituents having a substituted or without the same number of valence of the aromatic hydrocarbon containing The group; and the unsubstituted or substituted heterocyclic-containing group having the same valence as n14, the same group as X in the above general formula (A1) can be exemplified.

n14為1~10之整數,較佳為1~6之整數,其中較佳為1~3之整數,尤佳為1~2之整數。其原因在於,上述組合物會成為硬化性及硬化物之耐熱性之平衡性進一步優異者。又,就成為組合物之硬化性更優異者之觀點而言,n14較佳為2~8之整數,其中較佳為3~7之整數,尤佳為4~6之整數。 本發明中,通式(14)中之X14 較佳為含芳香族烴之基、含雜環之基、或該等基中之亞甲基之1個或2個以上被取代為選自上述群I中之二價基而成之基。其原因在於,可更有效地發揮所得之硬化物之耐熱性更優異之效果。又,本發明中,上述X14 亦較佳為烷基或該烷基中之亞甲基之1個或2個以上被取代為選自上述群I中之二價基而成之基。其原因在於,組合物之硬化性會更優異。n14 is an integer from 1 to 10, preferably an integer from 1 to 6, wherein an integer from 1 to 3 is preferred, and an integer from 1 to 2 is particularly preferred. The reason for this is that the above-mentioned composition becomes more excellent in the balance of curability and heat resistance of the cured product. In addition, from the viewpoint of being more excellent in the curability of the composition, n14 is preferably an integer of 2-8, particularly preferably an integer of 3-7, and particularly preferably an integer of 4-6. In the present invention, X 14 in the general formula (14) is preferably an aromatic hydrocarbon-containing group, a heterocyclic group-containing group, or one or more of the methylene groups in these groups are substituted to be selected from The base formed by the divalent base in the above group I. The reason is that the heat resistance of the cured product obtained can be more effectively exhibited. Furthermore, in the present invention, the above X 14 is also preferably a group in which one or more of the alkyl group or the methylene group in the alkyl group is substituted with a divalent group selected from the above group I. The reason is that the curability of the composition will be more excellent.

上述X14 只要為可獲得所期望之硬化性及耐熱性者即可,較佳為具有與n14為同數之價數之碳原子數6~40之未經取代或具有取代基之含芳香族烴之基;具有與n14為同數之價數之碳原子數2~40之未經取代或具有取代基之含雜環之基;或者該含芳香族烴之基或該含雜環之基中之亞甲基之1個或2個以上被取代為選自上述群I中之二價基而成之基。其中較佳為具有與n14為同數之價數之碳原子數10~30之未經取代或具有取代基之含芳香族烴之基;具有與n14為同數之價數之碳原子數2~20之未經取代或具有取代基之含雜環之基;或者該含芳香族烴之基或該含雜環之基中之亞甲基之1個或2個以上被取代為選自上述群I中之二價基而成之基,尤佳為具有與n14為同數之價數之碳原子數15~30之未經取代或具有取代基的含芳香族烴之基中之亞甲基之1個或2個以上被取代為選自上述群I中之二價基而成之基;或具有與n14為同數之價數之碳原子數2~10之未經取代或具有取代基之含雜環之基。 作為上述X14 所示之具有與n14為同數之價數之碳原子數15~30之未經取代或具有取代基的含芳香族烴之基中之亞甲基之1個或2個以上被取代為選自上述群I中之二價基而成之基,於n14為2之情形時,較佳為碳原子數15~30之直鏈或支鏈之烷基中之亞甲基的1個或2個以上被取代為自芳基去除1個氫原子後所得之基而成之基,其中尤佳為下述通式(14-1)所示之基。 其原因在於,藉由使上述X14 為上述結構,上述組合物會成為硬化性及硬化物之耐熱性之平衡性進一步優異者。The above-mentioned X 14 may be one that can obtain the desired curability and heat resistance, and is preferably an unsubstituted or substituted aromatic containing 6-40 carbon atoms having the same valence as n14 A hydrocarbon group; an unsubstituted or substituted heterocyclic group containing 2-40 carbon atoms with the same number of valences as n14; or the aromatic hydrocarbon-containing group or the heterocyclic group-containing group One or two or more of the methylene groups are substituted with divalent groups selected from the above group I. Among them, it is preferably an unsubstituted or substituted aromatic hydrocarbon-containing group having 10 to 30 carbon atoms with the same valence as n14; and 2 with the same valence as n14 ~20 unsubstituted or substituted heterocyclic ring-containing groups; or one or more of the methylene groups in the aromatic hydrocarbon-containing group or the heterocyclic ring-containing group are substituted as selected from the above A group composed of a divalent group in group I, particularly preferably methylene in an unsubstituted or substituted aromatic hydrocarbon-containing group with 15 to 30 carbon atoms with the same valence as n14 One or more of the groups are substituted with divalent groups selected from the above group I; or unsubstituted or substituted with 2-10 carbon atoms with the same valence as n14 The group contains a heterocyclic group. One or more methylene groups in the unsubstituted or substituted aromatic hydrocarbon-containing group having 15-30 carbon atoms and having the same number of valence as n14 shown in the above X 14 A group substituted with a divalent group selected from the above group I. When n14 is 2, it is preferably a methylene group in a linear or branched alkyl group with 15 to 30 carbon atoms One or two or more are substituted with a group obtained by removing one hydrogen atom from an aryl group, and among them, a group represented by the following general formula (14-1) is particularly preferred. The reason for this is that, by setting the above X 14 to the above structure, the above composition becomes more excellent in the balance between the curability and the heat resistance of the cured product.

[化21]

Figure 02_image045
[化21]
Figure 02_image045

式中,R14a-1 及R14a-2 分別獨立地表示氫原子或碳原子數1~20之直鏈或支鏈之烷基, L11 及L12 分別獨立地表示直接鍵、碳原子數1~10之直鏈或支鏈之伸烷基或該伸烷基中之亞甲基之1個或2個以上被取代為-O-之基, *表示鍵結部位。In the formula, R 14a-1 and R 14a-2 each independently represent a hydrogen atom or a linear or branched alkyl group with 1 to 20 carbon atoms, and L 11 and L 12 each independently represent a direct bond, the number of carbon atoms 1 to 10 linear or branched alkylene groups or one or more of the methylene groups in the alkylene groups are substituted with -O- groups, and * represents a bonding site.

作為通式(14-1)中之R14a-1 及R14a-2 所示之碳原子數1~20之直鏈或支鏈之烷基,可例舉R101 等所示之直鏈或支鏈之烷基中之特定碳原子數者。 作為L11 及L12 所示之碳原子數1~10之直鏈或支鏈之伸烷基,可例舉作為自R101 等所示之直鏈或支鏈之烷基去除1個氫原子後之基的伸烷基中之特定碳原子數者。As the linear or branched alkyl group having 1 to 20 carbon atoms represented by R 14a-1 and R 14a-2 in the general formula (14-1), a linear or branched alkyl group represented by R 101 and the like can be exemplified The specific number of carbon atoms in the branched alkyl group. The linear or branched alkylene group having 1 to 10 carbon atoms represented by L 11 and L 12 can be exemplified by removing one hydrogen atom from the linear or branched alkyl group represented by R 101 and the like The specific number of carbon atoms in the alkylene group of the latter group.

上述通式(14-1)中,R14a-1 及R14a-2 分別獨立較佳為氫原子、或碳原子數1~10之直鏈或支鏈之烷基,其中較佳為碳原子數1~5之直鏈之烷基,尤佳為碳原子數1~3之直鏈之烷基。 上述通式(14-1)中,L11 及L12 分別獨立較佳為碳原子數1~5之直鏈或支鏈之伸烷基或該伸烷基中之亞甲基之1個或2個以上被取代為-O-之基,其中較佳為碳原子數2~4之直鏈之伸烷基或該伸烷基中之亞甲基之1個或2個以上被取代為-O-之基,尤佳為碳原子數2~4之直鏈之伸烷基中之亞甲基的1個或2個以上被取代為-O-之基。 其原因在於,藉由使上述R14a-1 及R14a-2 與L11 及L12 為上述基,上述組合物會成為硬化性及硬化物之耐熱性之平衡性進一步優異者。In the above general formula (14-1), R 14a-1 and R 14a-2 are each independently preferably a hydrogen atom, or a linear or branched alkyl group having 1 to 10 carbon atoms, of which a carbon atom is preferred. The straight-chain alkyl group having 1 to 5 is particularly preferably a straight-chain alkyl group having 1 to 3 carbon atoms. In the above general formula (14-1), L 11 and L 12 are each independently preferably a linear or branched alkylene group having 1 to 5 carbon atoms or one of the methylene groups in the alkylene group or Two or more groups substituted with -O-, of which one or more of the linear alkylene groups having 2 to 4 carbon atoms or the methylene groups in the alkylene group are preferably substituted with- The O- group is particularly preferably one or more of the methylene groups in the linear alkylene group having 2 to 4 carbon atoms, which is substituted with -O-. The reason is that by making the above-mentioned R 14a-1 and R 14a-2 and L 11 and L 12 as the above-mentioned group, the above-mentioned composition becomes a more excellent balance between the curability and the heat resistance of the cured product.

作為X14 所示之具有與n14為同數之價數之碳原子數2~10的未經取代或具有取代基之含雜環之基,於n14為1之情形時,X14 較佳為碳原子數3~7之未經取代或具有取代基之含雜環之基,且較佳為碳原子數3~7之未經取代之含雜環之基。 作為上述含雜環之基中所含之雜環,可使用具有芳香族性之芳香族雜環,不顯示出芳香族性之脂肪族雜環之任一種,但較佳為芳香族雜環。 作為上述芳香族雜環,只要為於形成環結構之原子中包含碳原子以外之原子者即可,可為單環亦可為稠環,例如可例舉:呋喃環、苯并呋喃環、二苯并呋喃環、噻吩環等。X 14 as the number of carbon atoms and n14 is the valence of the same number of 2 to 10 shown without having a substituent or a heterocyclic group containing the substituent group, the case where the time is to n14. 1, preferably X 14 The unsubstituted or substituted heterocyclic ring-containing group having 3 to 7 carbon atoms is preferably an unsubstituted heterocyclic ring-containing group having 3 to 7 carbon atoms. As the heterocyclic ring contained in the heterocyclic ring-containing group, any of aromatic heterocyclic rings having aromaticity and aliphatic heterocyclic rings showing no aromaticity can be used, but aromatic heterocyclic rings are preferred. As the above-mentioned aromatic heterocyclic ring, as long as it contains atoms other than carbon atoms in the atoms forming the ring structure, it may be a single ring or a condensed ring. For example, a furan ring, a benzofuran ring, two Benzofuran ring, thiophene ring, etc.

本發明中,就成為硬化性及硬化物之耐熱性之平衡性進一步優異,且尤其是硬化性優異者之觀點而言,X14 較佳為碳原子數1~40之未經取代或具有取代基之脂肪族烴基、或該脂肪族烴基中之亞甲基之1個或2個以上被取代為選自上述群I中之二價基而成之基,其中較佳為碳原子數3~20之未經取代或具有取代基之脂肪族烴基、或該脂肪族烴基中之亞甲基之1個或2個以上被取代為選自上述群I中之二價基而成之基,尤佳為碳原子數4~10之未經取代或具有取代基之脂肪族烴基、或碳原子數5~15之未經取代或具有取代基之脂肪族烴基中之亞甲基的1個或2個以上被取代為選自上述群I中之二價基而成之基,尤佳為碳原子數4~10之未經取代或具有取代基之脂肪族烴基、或碳原子數5~15之未經取代或具有取代基之脂肪族烴基中之亞甲基的1個或2個以上被取代為選自上述群I中之二價基而成之基。 又,就組合物成為硬化性更優異者而言,上述X14 中所使用之脂肪族烴基較佳為烷基。 In the present invention, X 14 is preferably unsubstituted or substituted with 1 to 40 carbon atoms from the viewpoint that the balance between the curability and the heat resistance of the cured product is more excellent, and especially the curability is excellent One or two or more of the aliphatic hydrocarbon group or the methylene group in the aliphatic hydrocarbon group is substituted with a divalent group selected from the above group I, wherein the number of carbon atoms is preferably 3 to 20 unsubstituted or substituted aliphatic hydrocarbon groups, or groups in which one or more of the methylene groups in the aliphatic hydrocarbon group are substituted with divalent groups selected from the above group I, especially Preferably, 1 or 2 of the methylene group in the unsubstituted or substituted aliphatic hydrocarbon group with 4 to 10 carbon atoms, or the unsubstituted or substituted aliphatic hydrocarbon group with 5 to 15 carbon atoms More than one group substituted with a divalent group selected from the above group I, particularly preferably an unsubstituted or substituted aliphatic hydrocarbon group with 4 to 10 carbon atoms, or a group with 5 to 15 carbon atoms One or two or more of the methylene groups in the unsubstituted or substituted aliphatic hydrocarbon group are substituted with divalent groups selected from the above group I. In addition, in terms of the composition becoming more excellent in curability, the aliphatic hydrocarbon group used in the above-mentioned X 14 is preferably an alkyl group.

作為上述不具有羧基之化合物之具體例,只要為具有1個以上之乙烯性不飽和基且不具有羧基者即可,例如可例舉:丙烯酸-2-羥乙酯、丙烯酸-2-羥丙酯、丙烯酸異丁酯、丙烯酸正辛酯、丙烯酸異辛酯、丙烯酸異壬酯、丙烯酸硬脂酯、丙烯酸甲氧基乙酯、丙烯酸二甲基胺基乙酯、丙烯酸鋅、1,4-丁二醇二丙烯酸酯、新戊二醇二丙烯酸酯、1,6-己二醇二丙烯酸酯、三羥甲基丙烷三丙烯酸酯、甲基丙烯酸-2-羥乙酯、甲基丙烯酸-2-羥丙酯、甲基丙烯酸丁酯、甲基丙烯酸第三丁酯、甲基丙烯酸環己酯、1,4-丁二醇二甲基丙烯酸酯、新戊二醇二甲基丙烯酸酯、三羥甲基丙烷三甲基丙烯酸酯、聚乙二醇二(甲基)丙烯酸酯、異氰尿酸酯二(甲基)丙烯酸酯、二季戊四醇五丙烯酸酯、二季戊四醇六丙烯酸酯、季戊四醇四丙烯酸酯、季戊四醇三丙烯酸酯、己內酯改性二季戊四醇六(甲基)丙烯酸酯、雙酚A二縮水甘油醚(甲基)丙烯酸酯、雙酚F二縮水甘油醚(甲基)丙烯酸酯、雙酚Z二縮水甘油醚(甲基)丙烯酸酯、三丙二醇二(甲基)丙烯酸酯等。 作為上述不具有羧基之自由基聚合性化合物,亦可使用酸式磷酸單(2-丙烯醯氧基乙基)酯等具有磷酸酯結構之(甲基)丙烯酸酯等。 作為上述不具有羧基之自由基聚合性化合物,亦可使用胺基甲酸酯丙烯酸酯、聚酯丙烯酸酯、及環氧丙烯酸酯等。作為此種胺基甲酸酯丙烯酸酯、聚酯丙烯酸酯、及環氧丙烯酸酯之市售品,例如可使用日本專利特開2018-53215號公報中記載者。As a specific example of the above-mentioned compound having no carboxyl group, as long as it has one or more ethylenically unsaturated groups and does not have a carboxyl group, for example: 2-hydroxyethyl acrylate, 2-hydroxypropyl acrylate Ester, isobutyl acrylate, n-octyl acrylate, isooctyl acrylate, isononyl acrylate, stearyl acrylate, methoxyethyl acrylate, dimethylaminoethyl acrylate, zinc acrylate, 1,4- Butylene glycol diacrylate, neopentyl glycol diacrylate, 1,6-hexanediol diacrylate, trimethylolpropane triacrylate, 2-hydroxyethyl methacrylate, methacrylic acid-2 -Hydroxypropyl ester, butyl methacrylate, tert-butyl methacrylate, cyclohexyl methacrylate, 1,4-butanediol dimethacrylate, neopentyl glycol dimethacrylate, three Methylolpropane trimethacrylate, polyethylene glycol di(meth)acrylate, isocyanurate di(meth)acrylate, dipentaerythritol pentaacrylate, dipentaerythritol hexaacrylate, pentaerythritol tetraacrylate Ester, pentaerythritol triacrylate, caprolactone modified dipentaerythritol hexa(meth)acrylate, bisphenol A diglycidyl ether (meth)acrylate, bisphenol F diglycidyl ether (meth)acrylate, Bisphenol Z diglycidyl ether (meth)acrylate, tripropylene glycol di(meth)acrylate, etc. As the radically polymerizable compound having no carboxyl group, (meth)acrylate having a phosphate structure such as acid phosphate mono(2-propenoxyethyl) ester can also be used. As the radically polymerizable compound which does not have a carboxyl group, urethane acrylate, polyester acrylate, epoxy acrylate, etc. can also be used. As commercially available products of such urethane acrylate, polyester acrylate, and epoxy acrylate, for example, those described in JP 2018-53215 A can be used.

亦可使用上述不具有羧基之化合物中之於室溫(25℃)下為液狀者作為將上述含羧基之樹脂等溶解之稀釋劑。Among the above-mentioned compounds having no carboxyl group, those that are liquid at room temperature (25°C) can also be used as a diluent for dissolving the above-mentioned carboxyl group-containing resin and the like.

上述自由基聚合性成分於含有具有羧基等酸性基之化合物作為自由基聚合性化合物之情形時,較佳為將具有酸性基之化合物與不具有酸性基之化合物併用。其原因在於,會成為組合物之硬化性及硬化物之耐熱性與鹼性顯影性之平衡優異者。 上述自由基聚合性成分於含有具有羧基之化合物作為自由基聚合性化合物之情形時,較佳為將具有羧基之化合物與不具有羧基之化合物併用。其原因在於,會成為組合物之硬化性及硬化物之耐熱性與鹼性顯影性之平衡優異者。When the above-mentioned radically polymerizable component contains a compound having an acidic group such as a carboxyl group as the radically polymerizable compound, it is preferable to use a compound having an acidic group and a compound not having an acidic group in combination. The reason for this is that the composition is excellent in the curability of the composition and the balance between the heat resistance of the cured product and the alkali developability. When the above-mentioned radically polymerizable component contains a compound having a carboxyl group as the radically polymerizable compound, it is preferable to use a compound having a carboxyl group and a compound not having a carboxyl group in combination. The reason for this is that the composition is excellent in the curability of the composition and the balance between the heat resistance of the cured product and the alkali developability.

於上述硬化性成分含有具有羧基等酸性基之化合物及不具有羧基等酸性基之化合物之兩者作為自由基聚合性化合物之情形時,不具有酸性基之化合物之含量於具有酸性基之化合物及不具有酸性基之化合物之合計100質量份中,較佳為1質量份以上90質量份以下,更佳為20質量份以上70質量份以下,尤佳為30質量份以上50質量份以下。其原因在於,上述組合物會成為硬化性優異者,且所得之硬化物會成為耐熱性優異者。又,上述組合物可更容易地進行圖案化之形成。 於上述硬化性成分含有具有羧基之化合物及不具有羧基之化合物之兩者作為自由基聚合性化合物之情形時,不具有羧基之化合物之含量於具有羧基之化合物及不具有羧基之化合物之合計100質量份中,較佳為1質量份以上90質量份以下,更佳為20質量份以上70質量份以下,尤佳為30質量份以上50質量份以下。其原因在於,上述組合物會成為硬化性優異者,且所得之硬化物會成為耐熱性優異者。又,上述組合物可更容易地進行圖案化之形成。When the above-mentioned curable component contains both a compound having an acidic group such as a carboxyl group and a compound having no acidic group such as a carboxyl group as a radically polymerizable compound, the content of the compound having no acidic group is greater than that of the compound having an acidic group and The total 100 parts by mass of the compound having no acidic group is preferably 1 part by mass or more and 90 parts by mass or less, more preferably 20 parts by mass or more and 70 parts by mass or less, and particularly preferably 30 parts by mass or more and 50 parts by mass or less. The reason is that the above-mentioned composition has excellent curability, and the obtained cured product has excellent heat resistance. In addition, the above-mentioned composition can be more easily patterned. When the above-mentioned curable component contains both of a compound having a carboxyl group and a compound not having a carboxyl group as a radically polymerizable compound, the content of the compound having no carboxyl group is equal to the total of the compound having a carboxyl group and the compound having no carboxyl group 100 Among the parts by mass, it is preferably 1 part by mass or more and 90 parts by mass or less, more preferably 20 parts by mass or more and 70 parts by mass or less, and particularly preferably 30 parts by mass or more and 50 parts by mass or less. The reason is that the above-mentioned composition has excellent curability, and the obtained cured product has excellent heat resistance. In addition, the above-mentioned composition can be more easily patterned.

作為上述陽離子聚合性化合物,只要為可進行陽離子聚合之化合物即可,例如可例舉:環氧化合物、氧雜環丁烷化合物等環狀醚化合物、環狀硫醚化合物、乙烯醚化合物等。 作為此種陽離子聚合性化合物,更具體而言,可使用國際公開第2018/012383號公報中記載之環氧化合物、氧雜環丁烷化合物、乙烯醚化合物等陽離子聚合性化合物、日本專利特開2016-180880號公報中記載之環氧化合物、日本專利特開2018-53215號公報中記載之作為1分子中具有2個以上之環狀醚基及環狀硫醚基之熱硬化性成分等所記載之化合物。The above-mentioned cationically polymerizable compound may be a compound capable of undergoing cation polymerization, and examples thereof include cyclic ether compounds such as epoxy compounds and oxetane compounds, cyclic sulfide compounds, and vinyl ether compounds. As such a cationically polymerizable compound, more specifically, cationically polymerizable compounds such as epoxy compounds, oxetane compounds, and vinyl ether compounds described in International Publication No. 2018/012383, and Japanese Patent Laid-Open The epoxy compound described in 2016-180880, and the thermosetting component described in Japanese Patent Laid-Open No. 2018-53215 as a thermosetting component having two or more cyclic ether groups and cyclic sulfide groups in a molecule, etc. Recorded compound.

作為上述陰離子聚合性化合物,只要為可進行陰離子聚合之化合物即可,例如可例舉:環氧化合物、氧雜環丁烷化合物等環狀醚化合物、環狀硫醚化合物、丙烯酸酯化合物、甲基丙烯酸酯化合物等。 作為用作此種陰離子聚合性化合物之環狀醚化合物、環狀硫醚化合物,可使用作為上述陽離子聚合性化合物之例所例舉者。又,作為用作陰離子聚合性化合物之丙烯酸酯化合物及甲基丙烯酸酯化合物,可使用作為上述自由基聚合性化合物所例示者中之具有丙烯酸酯基或甲基丙烯酸酯基之化合物。As the above-mentioned anionic polymerizable compound, any compound capable of undergoing anionic polymerization may be used. For example, cyclic ether compounds such as epoxy compounds and oxetane compounds, cyclic sulfide compounds, acrylate compounds, and methyl ester compounds may be used. -Based acrylate compounds, etc. As the cyclic ether compound and cyclic sulfide compound used as such an anionic polymerizable compound, those exemplified as the above-mentioned cationic polymerizable compound can be used. Moreover, as an acrylate compound and a methacrylate compound used as an anionic polymerizable compound, the compound which has an acrylate group or a methacrylate group among those exemplified as the radical polymerizable compound can be used.

作為上述熱硬化性化合物,可例舉:酚樹脂,脲樹脂,胺基樹脂,多官能環氧化合物等環氧化合物、多官能氧雜環丁烷化合物等氧雜環丁烷化合物等環狀醚化合物,不飽和聚酯樹脂,苯并胍胺衍生物,異氰酸酯化合物,嵌段異氰酸酯化合物,順丁烯二醯亞胺化合物,苯并㗁 𠯤化合物,㗁唑啉化合物,碳二醯亞胺化合物,環碳酸酯化合物、多官能氧雜環丁烷化合物、環硫化物樹脂等環狀硫醚化合物等。 作為上述多官能環氧化合物,可使用與作為上述含羧基之樹脂之形成中所使用之例所記載者相同者。作為上述多官能環氧化合物之市售品,例如可使用日本專利特開2018-53215號公報中記載者。 作為上述異氰酸酯化合物、嵌段異氰酸酯化合物、多官能氧雜環丁烷化合物、環硫化物樹脂,例如可使用日本專利特開2017-111453號公報中記載之具有異氰酸酯基或嵌段化異氰酸酯基之化合物,多官能氧雜環丁烷化合物、酚醛清漆型環氧樹脂之環氧基之氧原子被取代為硫原子之樹脂。 作為上述胺基樹脂,例如可使用日本專利特開2017-111453號公報中記載之三聚氰胺衍生物、苯并胍胺衍生物等。 本發明中,熱硬化性化合物較佳為含有環狀醚化合物、環狀硫醚化合物等,其中較佳為含有環狀醚化合物,尤佳為含有環氧化合物,其中尤佳為含有多官能環氧化合物。其原因在於,上述組合物會成為硬化性及硬化物之耐熱性之平衡優異者。Examples of the above-mentioned thermosetting compound include phenol resins, urea resins, amino resins, epoxy compounds such as polyfunctional epoxy compounds, and cyclic ethers such as oxetane compounds such as polyfunctional oxetane compounds. Compounds, unsaturated polyester resins, benzoguanamine derivatives, isocyanate compounds, blocked isocyanate compounds, maleimide compounds, benzoimide compounds, oxazoline compounds, carbodiimide compounds, Cyclic sulfide compounds such as cyclic carbonate compounds, polyfunctional oxetane compounds, episulfide resins, and the like. As the above-mentioned polyfunctional epoxy compound, the same as those described in the examples used in the formation of the above-mentioned carboxyl group-containing resin can be used. As a commercially available product of the above-mentioned polyfunctional epoxy compound, for example, what is described in JP 2018-53215 A can be used. As the above-mentioned isocyanate compound, blocked isocyanate compound, polyfunctional oxetane compound, and episulfide resin, for example, a compound having an isocyanate group or a blocked isocyanate group described in JP 2017-111453 A can be used , Polyfunctional oxetane compounds, resins in which the oxygen atoms of the epoxy groups of the novolac type epoxy resins are replaced with sulfur atoms. As the above-mentioned amine-based resin, for example, melamine derivatives and benzoguanamine derivatives described in JP 2017-111453 A can be used. In the present invention, the thermosetting compound preferably contains a cyclic ether compound, a cyclic sulfide compound, etc., among them, a cyclic ether compound is preferably contained, an epoxy compound is particularly preferred, and a polyfunctional ring is particularly preferred. Oxygen compounds. The reason is that the above-mentioned composition becomes an excellent balance between the curability and the heat resistance of the cured product.

本發明之組合物中之上述硬化性成分之含量根據上述組合物之用途等而適當設定。上述硬化性成分之含量於上述組合物之固形物成分100質量份中,較佳為5質量份以上,其中較佳為20質量份以上,尤佳為30質量份以上99。其原因在於,藉由使上述含量為上述範圍,上述組合物會成為硬化性及硬化物之耐熱性之平衡優異者。 再者,所謂固形物成分係包含溶劑以外之所有成分者。 上述硬化性成分之含量根據溶劑等之含量而不同,例如於組合物100質量份中,較佳為1質量份以上,其中較佳為5質量份以上,尤佳為10質量份以上99質量份以下。其原因在於,藉由使上述含量為上述範圍,上述組合物會成為硬化性及硬化物之耐熱性之平衡優異者。 上述硬化性成分之含量於上述化合物A1、硫系抗氧化劑及硬化性成分之合計100質量份中,較佳為5質量份以上,其中較佳為20質量份以上,尤佳為30質量份以上99質量份以下。其原因在於,藉由使上述硬化性成分之含量為上述範圍,上述組合物會成為硬化性及硬化物之耐熱性之平衡優異者。The content of the curable component in the composition of the present invention is appropriately set according to the use of the composition and the like. The content of the curable component in 100 parts by mass of the solid content of the composition is preferably 5 parts by mass or more, among which 20 parts by mass or more is preferable, and 30 parts by mass or more are particularly preferable. The reason is that, by setting the above content within the above range, the above composition becomes one having an excellent balance of curability and heat resistance of the cured product. In addition, the so-called solid component includes all components other than the solvent. The content of the above-mentioned sclerosing component varies according to the content of the solvent, etc., for example, in 100 parts by mass of the composition, preferably 1 part by mass or more, wherein preferably 5 parts by mass or more, and particularly preferably 10 parts by mass or more and 99 parts by mass the following. The reason is that, by setting the above content within the above range, the above composition becomes one having an excellent balance of curability and heat resistance of the cured product. The content of the curable component is preferably 5 parts by mass or more in the total of 100 parts by mass of the compound A1, sulfur-based antioxidant, and curable component, and more preferably 20 parts by mass or more, and particularly preferably 30 parts by mass or more 99 parts by mass or less. The reason for this is that by setting the content of the curable component within the above range, the composition will have an excellent balance of curability and heat resistance of the cured product.

4.硬化觸媒 上述組合物可於硬化性成分之基礎上含有硬化觸媒。 硬化觸媒只要為可促進硬化性成分之硬化反應,容易讓2種以上之硬化性化合物鍵結而形成高分子量物者即可,可根據硬化性成分之種類、組合物之用途等而適當選擇。 硬化觸媒於硬化性成分含有自由基聚合性化合物、陽離子聚合性化合物,陰離子聚合性化合物等聚合性化合物之情形時,分別可含有自由基聚合起始劑、陽離子聚合起始劑及陰離子聚合起始劑等聚合起始劑。4. Hardening catalyst The above composition may contain a hardening catalyst in addition to the hardening component. As long as the curing catalyst promotes the curing reaction of the curing component, it is easy to bond two or more curing compounds to form a high molecular weight product. It can be appropriately selected according to the type of the curing component, the application of the composition, etc. . When the curing component contains polymerizable compounds such as radical polymerizable compounds, cationic polymerizable compounds, and anionic polymerizable compounds, the curing catalyst may contain a radical polymerization initiator, a cationic polymerization initiator, and an anionic polymerization initiator, respectively. Starter and other polymerization initiators.

作為自由基聚合起始劑,例如可使用國際公開第2018/012383號公報等中記載之苯乙酮系化合物、二苯乙二酮化合物、二苯甲酮系化合物、9-氧硫𠮿

Figure 109115829-A0304-12-01
系化合物及肟酯系化合物之光自由基聚合起始劑,偶氮系化合物、過氧化物及過硫酸鹽等熱自由基聚合起始劑等。又,作為自由基聚合起始劑,亦可使用國際公開第2017/170493號公報、國際公開第2019/013112號公報等中記載之苯乙酮系化合物、二苯乙二酮化合物、二苯甲酮系化合物、9-氧硫𠮿
Figure 109115829-A0304-12-01
系化合物、雙咪唑系化合物、吖啶系化合物、醯基膦系化合物等。As a radical polymerization initiator, for example, acetophenone compounds, benzophenone compounds, benzophenone compounds, and 9-oxysulfur described in International Publication No. 2018/012383 etc. can be used.
Figure 109115829-A0304-12-01
Initiator for photo-radical polymerization of compound and oxime ester-based compound, thermal radical polymerization initiator such as azo compound, peroxide and persulfate, etc. In addition, as a radical polymerization initiator, acetophenone compounds, benzophenone compounds, and benzophenone compounds described in International Publication No. 2017/170493 and International Publication No. 2019/013112 can also be used. Ketone compounds, 9-oxysulfur𠮿
Figure 109115829-A0304-12-01
-Based compounds, bisimidazole-based compounds, acridine-based compounds, phosphine-based compounds, etc.

作為陽離子聚合起始劑,例如可使用國際公開第2018/012383號公報等中記載之作為藉由能量線之照射而釋出路易斯酸之鎓鹽的複鹽或其衍生物等光陽離子聚合起始劑,鋶鹽、噻吩鎓鹽等熱陽離子聚合起始劑等。 作為陰離子聚合起始劑,於硬化性成分含有環狀醚化合物、環狀硫醚化合物等作為陰離子聚合性化合物之情形時,例如可使用咪唑衍生物、雙氰胺等胺化合物、肼化合物、磷化合物、S-三𠯤衍生物等熱硬化觸媒。又,作為熱硬化觸媒及其市售品,例如可使用日本專利特開2017-11143號公報中記載者。As the cationic polymerization initiator, for example, the photocationic polymerization initiator described in International Publication No. 2018/012383 etc. as the double salt of the onium salt of Lewis acid released by the irradiation of energy rays or its derivative can be used. Agents, sulfonium salts, thiophenium salts and other thermal cationic polymerization initiators. As an anionic polymerization initiator, when the curable component contains a cyclic ether compound, a cyclic sulfide compound, etc. as anionic polymerizable compounds, for example, imidazole derivatives, amine compounds such as dicyandiamide, hydrazine compounds, and phosphorus can be used. Thermal hardening catalysts such as compounds and S-tris derivatives. In addition, as the thermosetting catalyst and its commercially available products, for example, those described in JP 2017-11143 A can be used.

作為本發明之組合物中之聚合起始劑之含量,只要為可獲得所期望之硬化性者即可,例如相對於作為硬化性成分所含有之聚合性成分100質量份,較佳為0.1質量份以上30質量份以下,其中較佳為1質量份以上20質量份以下。其原因在於,藉由使上述含量為上述範圍,可獲得硬化性及硬化物之耐熱性之平衡優異之組合物。As the content of the polymerization initiator in the composition of the present invention, it is sufficient if the desired curability is obtained. For example, it is preferably 0.1 mass parts relative to 100 parts by mass of the polymerizable component contained as the curable component. Part or more and 30 parts by mass or less, and more preferably 1 part by mass or more and 20 parts by mass or less. The reason is that, by setting the above content within the above range, a composition having an excellent balance between curability and heat resistance of the cured product can be obtained.

硬化觸媒於硬化性成分含有多官能環氧化合物、多官能氧雜環丁烷化合物等環狀醚化合物、環硫化物樹脂等具有複數個環狀硫醚基之環狀硫醚化合物作為熱硬化性化合物之情形時,較佳為含有可形成上述熱硬化性化合物之高分子量物之熱硬化劑。 作為上述熱硬化劑,可例舉:咪唑衍生物、雙氰胺等胺化合物、肼化合物、磷化合物、S-三𠯤衍生物、聚硫醇、酸酐、酚樹脂、羧酸化合物等。 作為此種熱硬化觸媒及其市售品,例如可例舉日本專利特開2017-111453號公報中記載之作為熱硬化觸媒等所記載者。 本發明中,作為熱硬化劑,較佳為含有胺化合物,其中較佳為含有咪唑衍生物及雙氰胺之兩者。其原因在於,上述組合物會成為硬化性及硬化物之耐熱性之平衡優異者。 作為上述熱硬化劑之含量,只要為可獲得所期望之硬化性者即可,例如相對於上述環狀醚化合物及環狀硫醚化合物之合計100質量份,可設為0.1質量份以上50質量份以下。其原因在於,藉由使上述熱硬化劑之含量為上述範圍,可獲得硬化性及硬化物之耐熱性之平衡優異之組合物。The curing catalyst contains cyclic ether compounds such as polyfunctional epoxy compounds and polyfunctional oxetane compounds, and cyclic sulfide compounds having multiple cyclic sulfide groups, such as episulfide resins, in the curing component as the thermosetting In the case of a sexual compound, it is preferable to contain a thermosetting agent capable of forming a high molecular weight compound of the above-mentioned thermosetting compound. Examples of the thermosetting agent include imidazole derivatives, amine compounds such as dicyandiamide, hydrazine compounds, phosphorus compounds, S-triacetin derivatives, polythiols, acid anhydrides, phenol resins, carboxylic acid compounds, and the like. As such a thermosetting catalyst and its commercially available products, for example, those described as a thermosetting catalyst described in JP 2017-111453 A can be mentioned. In the present invention, it is preferable to contain an amine compound as the thermosetting agent, and it is particularly preferable to contain both an imidazole derivative and dicyandiamide. The reason is that the above-mentioned composition becomes an excellent balance between the curability and the heat resistance of the cured product. The content of the thermosetting agent may be one that can obtain the desired curability. For example, it may be 0.1 part by mass or more and 50 parts by mass relative to 100 parts by mass of the total of the cyclic ether compound and cyclic sulfide compound. Servings or less. The reason is that by setting the content of the thermosetting agent in the above range, a composition having an excellent balance between curability and heat resistance of the cured product can be obtained.

5.溶劑 本發明之組合物可含有將化合物A1、硫系抗氧化劑及硬化性成分分散或溶解之溶劑。 上述溶劑可設為於常溫(25℃)且大氣壓下為液狀者。 上述溶劑係可將化合物A1、硫系抗氧化劑及硬化性成分等組合物中之各成分分散或溶解者。因此,即便於常溫(25℃)且大氣壓下為液狀,上述化合物A1及硬化性成分亦不包含於溶劑中。作為上述溶劑,可使用水、有機溶劑及該等混合物之任一種。5. Solvent The composition of the present invention may contain a solvent for dispersing or dissolving compound A1, sulfur-based antioxidant, and curable component. The above-mentioned solvent can be one that is liquid at normal temperature (25°C) and atmospheric pressure. The above-mentioned solvent can disperse or dissolve each component in the composition such as compound A1, sulfur-based antioxidant, and curable component. Therefore, even if it is liquid at normal temperature (25°C) and atmospheric pressure, the above-mentioned compound A1 and the curable component are not included in the solvent. As the above-mentioned solvent, any of water, organic solvents, and mixtures thereof can be used.

作為有機溶劑,可使用公知之溶劑,例如可例舉:碳酸丙二酯等碳酸酯類;甲基乙基酮等酮類;乙醚等醚系溶劑;乙酸甲酯等酯系溶劑;甲醇、乙醇等醇系溶劑;丙二醇-1-單甲醚-2-乙酸酯等醚酯系溶劑;苯等BTX(Benzene-Toluene-Xylene,苯-甲苯-二甲苯)系溶劑;己烷等脂肪族烴系溶劑等。 作為有機溶劑,例如亦可使用國際公開第2018/012383號公報中記載之可將硬化性組合物中之各成分溶解或分散之溶劑、國際公開第2014/021023號公報中記載之有機溶劑等。As the organic solvent, a well-known solvent can be used. For example, carbonates such as propylene carbonate; ketones such as methyl ethyl ketone; ether solvents such as diethyl ether; ester solvents such as methyl acetate; methanol and ethanol Alcohol solvents; propylene glycol-1-monomethyl ether-2-acetate and other ether ester solvents; benzene and other BTX (Benzene-Toluene-Xylene, benzene-toluene-xylene) solvents; hexane and other aliphatic hydrocarbons Department of solvents and so on. As the organic solvent, for example, the solvent described in International Publication No. 2018/012383 that can dissolve or disperse each component in the curable composition, the organic solvent described in International Publication No. 2014/021023, and the like can also be used.

作為本發明之組合物中之上述溶劑之含量,只要為可獲得硬化性及硬化物之耐熱性之平衡優異之組合物者即可,於上述組合物100質量份中,可設為1質量份以上99質量份以下。The content of the above-mentioned solvent in the composition of the present invention may be one that can obtain a composition having an excellent balance of curability and heat resistance of the cured product, and can be set to 1 part by mass in 100 parts by mass of the above-mentioned composition Above 99 parts by mass or less.

6.其他成分 上述組合物可除化合物A1、硫系抗氧化劑、硬化性成分、硬化觸媒、溶劑以外,視需要含有其他成分。 作為此種其他成分,可根據組合物之用途等而選擇,例如可例舉:苯并三唑系、三𠯤系、苯甲酸酯系之紫外線吸收劑;酚系、磷系抗氧化劑;包含陽離子系界面活性劑、陰離子系界面活性劑、非離子系界面活性劑、兩性界面活性劑等之抗靜電劑;鹵素系化合物、磷酸酯系化合物、磷醯胺系化合物、三聚氰胺系化合物、氟樹脂或金屬氧化物、(聚)磷酸三聚氰胺、(聚)磷酸哌𠯤等阻燃劑;烴系、脂肪酸系、脂肪族醇系、脂肪族酯系、脂肪族醯胺系或金屬皂系之潤滑劑;染料、顏料、碳黑等著色劑;薰製二氧化矽、微粒子二氧化矽、矽石、矽藻土類、黏土、高嶺土、矽藻土、二氧化矽凝膠、矽酸鈣、絹雲母、高嶺石、燧石、長石粉、蛭石、厄帖浦石、滑石、雲母、鐵滑石、葉蠟石、二氧化矽等矽酸系無機添加劑;玻璃纖維、碳酸鈣等填充劑;成核劑、結晶促進劑等結晶劑,矽烷偶合劑,可撓性聚合物等橡膠彈性賦予劑,增感劑等。 作為上述其他成分,可使用有機聚合物作為上述硬化性成分以外之樹脂成分。作為此種有機聚合物,可使用國際公開第2014/021023號公報中作為有機聚合物所例舉者。6. Other ingredients In addition to the compound A1, the sulfur-based antioxidant, the curable component, the curing catalyst, and the solvent, the above-mentioned composition may contain other components as necessary. Such other components can be selected according to the application of the composition, and examples include: benzotriazole-based, tri-triazole-based, and benzoate-based ultraviolet absorbers; phenol-based and phosphorus-based antioxidants; including Cationic surfactants, anionic surfactants, nonionic surfactants, amphoteric surfactants and other antistatic agents; halogen compounds, phosphate ester compounds, phosphamide compounds, melamine compounds, fluororesins Or metal oxides, (poly)melamine phosphate, piperazine (poly)phosphate and other flame retardants; lubricants of hydrocarbon series, fatty acid series, aliphatic alcohol series, aliphatic ester series, aliphatic amine series or metal soap series ;Dyes, pigments, carbon black and other colorants; smoked silica, particulate silica, silica, diatomaceous earth, clay, kaolin, diatomaceous earth, silica gel, calcium silicate, sericite , Kaolinite, flint, feldspar powder, vermiculite, Otepite, talc, mica, iron talc, pyrophyllite, silica and other silica-based inorganic additives; glass fiber, calcium carbonate and other fillers; nucleating agent , Crystallization accelerators and other crystallization agents, silane coupling agents, flexible polymers and other rubber elasticity imparting agents, sensitizers, etc. As the above-mentioned other components, an organic polymer can be used as a resin component other than the above-mentioned curable component. As such an organic polymer, what is exemplified as an organic polymer in International Publication No. 2014/021023 can be used.

作為用作上述其他成分之填充劑,更具體而言,可使用阻焊劑等中所使用者,可使用無機填充劑、有機填充劑。 作為上述無機填充劑,可使用矽酮樹脂組合物、環氧樹脂組合物等密封材料中所調配者。例如,可例舉:熔融二氧化矽、熔融球狀二氧化矽、結晶性二氧化矽、膠體二氧化矽、發煙二氧化矽、二氧化矽凝膠等二氧化矽類;氧化鋁、氧化鐵、氧化鈦、三氧化銻等金屬氧化物;氮化矽、氮化鋁、氮化硼、碳化矽等陶瓷;雲母或蒙脫石等礦物;氫氧化鋁、氫氧化鎂等金屬氫氧化物或利用有機改性處理等將該等改質而成者;碳酸鈣、矽酸鈣、碳酸鎂、碳酸鋇等金屬碳酸鹽;硫酸鋇等金屬酸鹽或利用有機改性處理等將該等改質而成者;金屬硼酸鹽、碳黑等顏料;碳纖維、石墨、晶鬚、高嶺土、滑石、玻璃纖維、玻璃珠、玻璃微球、二氧化矽玻璃、層狀黏土礦物、黏土、碳化矽、石英、鋁、鋅等。 作為上述有機填充劑,可例舉:丙烯酸系珠、聚合物微粒子、透明樹脂珠、木粉、紙漿、棉紗碎片等。 本發明中,其中,無機填充劑較佳為二氧化矽類、金屬氧化物、金屬酸鹽、滑石,尤佳為結晶二氧化矽、滑石、硫酸鋇、氧化鈦。As the filler used as the above-mentioned other components, more specifically, those used in solder resists and the like can be used, and inorganic fillers and organic fillers can be used. As the above-mentioned inorganic filler, those formulated in sealing materials such as silicone resin compositions and epoxy resin compositions can be used. For example, examples include: fused silica, fused spherical silica, crystalline silica, colloidal silica, fuming silica, silica gel and other silicas; alumina, oxide Metal oxides such as iron, titanium oxide, and antimony trioxide; ceramics such as silicon nitride, aluminum nitride, boron nitride, and silicon carbide; minerals such as mica or montmorillonite; metal hydroxides such as aluminum hydroxide and magnesium hydroxide Or modified by organic modification treatment, etc.; metal carbonates such as calcium carbonate, calcium silicate, magnesium carbonate, barium carbonate, etc.; metal salts such as barium sulfate, or modified by organic modification treatment, etc. Quality; metal borate, carbon black and other pigments; carbon fiber, graphite, whiskers, kaolin, talc, glass fiber, glass beads, glass microspheres, silica glass, layered clay minerals, clay, silicon carbide, Quartz, aluminum, zinc, etc. Examples of the above-mentioned organic fillers include acrylic beads, polymer particles, transparent resin beads, wood flour, pulp, and cotton yarn fragments. In the present invention, among them, the inorganic filler is preferably silica, metal oxide, metal acid salt, and talc, and particularly preferably crystalline silica, talc, barium sulfate, and titanium oxide.

上述填充劑之平均粒徑只要為可獲得所期望之耐久性者即可,亦根據上述組合物之用途而不同,例如於阻焊劑用途之情形時,較佳為設為10 nm以上100 μm以下。 再者,作為上述平均粒徑之測定方法,可使用雷射繞射-散射法。具體而言,可使用雷射繞射式粒度分佈測定裝置(島津製作所公司製造之SALD-2000J)等。平均粒徑可設為自累積粒度分佈之微粒側成為累積50%之粒徑(中值徑)。The average particle size of the filler may be as long as the desired durability is obtained, and it also varies according to the use of the composition. For example, in the case of solder resist use, it is preferably 10 nm or more and 100 μm or less . Furthermore, as a method for measuring the above-mentioned average particle diameter, a laser diffraction-scattering method can be used. Specifically, a laser diffraction particle size distribution measuring device (SALD-2000J manufactured by Shimadzu Corporation) or the like can be used. The average particle size can be set as the particle size (median diameter) that becomes 50% of the cumulative particle size distribution from the particle side.

作為上述填充劑之含量,例如相對於上述硬化性成分100質量份,較佳為5質量份以上500質量份以下,其中較佳為5質量份以上200質量份以下。其原因在於,藉由使上述填充劑之含量為上述範圍,可獲得硬化性及硬化物之耐熱性之平衡優異之組合物。又,可容易形成耐久性優異之硬化物,例如可容易用於阻焊劑等。 作為上述填充劑之含量,例如於上述組合物之固形物成分100質量份中,較佳為1質量份以上90質量份以下,其中較佳為5質量份以上70質量份以下,且較佳為10質量份以上60質量份以下。其原因在於,藉由使上述含量為上述範圍,可獲得硬化性及硬化物之耐熱性之平衡優異之組合物。又,容易形成耐久性優異之硬化物,例如容易用於阻焊劑等。The content of the filler is, for example, preferably 5 parts by mass or more and 500 parts by mass or less, and more preferably 5 parts by mass or more and 200 parts by mass or less with respect to 100 parts by mass of the curable component. The reason is that by setting the content of the filler in the above range, a composition having an excellent balance between curability and heat resistance of the cured product can be obtained. In addition, a cured product with excellent durability can be easily formed, and for example, it can be easily used as a solder resist. As the content of the filler, for example, in 100 parts by mass of the solid content of the composition, it is preferably 1 part by mass or more and 90 parts by mass or less, of which 5 parts by mass or more and 70 parts by mass or less, and more preferably 10 parts by mass or more and 60 parts by mass or less. The reason is that, by setting the above content within the above range, a composition having an excellent balance between curability and heat resistance of the cured product can be obtained. In addition, it is easy to form a cured product with excellent durability, for example, it is easy to use as a solder resist.

作為上述著色劑之含量,只要為可獲得所期望之外觀等者即可,相對於上述硬化性成分100質量份,較佳為0.01質量份以上10質量份以下,更佳為0.1質量份以上5質量份以下。其原因在於,藉由使上述著色劑之含量為上述範圍,可獲得硬化性及硬化物之耐熱性之平衡優異之組合物。The content of the above-mentioned coloring agent is sufficient as long as the desired appearance and the like can be obtained, and it is preferably not less than 0.01 parts by mass and not more than 10 parts by mass, and more preferably not less than 0.1 parts by mass relative to 100 parts by mass of the curable component. Parts by mass or less. The reason is that, by setting the content of the colorant in the above range, a composition having an excellent balance between curability and heat resistance of the cured product can be obtained.

作為本發明之組合物中之其他成分之合計之含量,於作為上述其他成分而不含有填充劑之情形時,於上述組合物100質量份中可設為50質量份以下。 於上述其他成分含有填充劑之情形時,作為上述其他成分之合計之含量,較佳為90質量份以下,其中較佳為70質量份以下。其原因在於,藉由使上述含量為上述範圍,可獲得硬化性及硬化物之耐熱性之平衡優異之組合物。The total content of the other components in the composition of the present invention may be 50 parts by mass or less in 100 parts by mass of the composition when the other components are not included as the above-mentioned other components. When the above-mentioned other components contain a filler, the total content of the above-mentioned other components is preferably 90 parts by mass or less, and more preferably 70 parts by mass or less. The reason is that, by setting the above content within the above range, a composition having an excellent balance between curability and heat resistance of the cured product can be obtained.

7.其他 上述組合物之製造方法只要為可將上述各成分以所期望之含量進行調配之方法即可,可為將上述各成分同時添加並混合之方法,亦可為一面將各成分依序添加一面混合之方法。7. Other The method for producing the above composition may be a method in which the above-mentioned components can be blended in the desired content, and the above-mentioned components may be added and mixed at the same time, or the components may be added and mixed in sequence.的方法。 The method.

作為上述組合物之用途,較佳為要求硬化性及硬化物之耐熱性之用途,可用於熱硬化性塗料、光硬化性塗料或清漆、熱硬化性接著劑、光硬化性接著劑、印刷基板、或者彩色電視、PC(pesonal computer、個人電腦)顯示器、攜帶型資訊終端、數位相機等彩色顯示之液晶顯示面板中之彩色濾光片、CCD(Charge Coupled Device、電荷耦合元件)影像感測器之彩色濾光片、感光性間隔件、黑管柱狀間隔件、電漿顯示面板用之電極材料、觸控面板、觸控感測器、粉末塗層、印刷墨水、印刷版、接著劑、牙科用組合物、光造形用樹脂、凝膠塗層、電子工學用光阻劑、抗電鍍劑、抗蝕劑、液狀及乾燥膜之兩者、抗焊劑、用於製造各種顯示用途用之彩色濾光片或用於在電漿顯示面板、電發光顯示裝置、及LCD(liquid crystal display、液晶顯示裝置)之製造步驟中形成結構之抗蝕劑、用於將電性及電子零件封入之組合物、阻焊劑、磁記錄材料、微小機械零件、波導、光開關、鍍覆用遮罩、蝕刻遮罩、呈色試驗系統、玻璃纖維纜線塗層、網版印刷用模板、用於利用立體光刻製造三維物體之材料、全像記錄用材料、圖像記錄材料、微細電子電路、脫色材料、用於圖像記錄材料之脫色材料、使用微膠囊之圖像記錄材料用之脫色材料、印刷配線板用光阻劑材料、UV(ultraviolet,紫外線)及可見光雷射直接圖像系統用之光阻劑材料、印刷電路基板之逐次積層中之介電層形成所使用之光阻劑材料、3D安裝用光阻劑材料或保護膜等各種用途中,其用途並無特別限制。 本發明中,其中,可較佳地用於彩色濾光片、感光性間隔件、黑管柱狀間隔件、電極材料、光阻劑、阻焊劑、外覆層、絕緣膜、黑矩陣、間隔壁材料等。其原因在於,可更有效地發揮硬化性及硬化物之耐熱性之平衡優異之效果。 又,該等各構件可較佳地用於要求長時間之耐熱性之汽車、飛行器等運輸機器中所使用之電子機器中之零件形成用途。其原因在於,可更有效地發揮硬化性及硬化物之耐熱性之平衡優異之效果。The use of the above composition is preferably a use requiring curability and heat resistance of the cured product. It can be used for thermosetting paints, photocuring paints or varnishes, thermosetting adhesives, photocuring adhesives, and printed circuit boards. , Or color filters, CCD (Charge Coupled Device, Charge Coupled Device) image sensors in LCD panels with color displays such as color TVs, PC (pesonal computer) monitors, portable information terminals, digital cameras, etc. Color filters, photosensitive spacers, black tube cylindrical spacers, electrode materials for plasma display panels, touch panels, touch sensors, powder coatings, printing inks, printing plates, adhesives, Dental composition, photo-forming resin, gel coat, photoresist for electronic engineering, anti-plating agent, resist, both liquid and dry film, solder resist, for manufacturing various display applications Color filters or resists used to form structures in plasma display panels, electroluminescent display devices, and LCD (liquid crystal display, liquid crystal display devices) manufacturing steps, used to seal electrical and electronic parts The composition, solder resists, magnetic recording materials, micro mechanical parts, waveguides, optical switches, coating masks, etching masks, color test systems, glass fiber cable coatings, templates for screen printing, Materials for producing three-dimensional objects using stereolithography, holographic recording materials, image recording materials, microelectronic circuits, decolorizing materials, decolorizing materials for image recording materials, and decolorizing materials for image recording materials using microcapsules , Photoresist materials for printed wiring boards, photoresist materials for UV (ultraviolet) and visible light laser direct imaging systems, and photoresist materials for the formation of dielectric layers in the sequential build-up of printed circuit boards There are no particular restrictions on its use in various applications such as photoresist materials for 3D mounting or protective films. In the present invention, among them, it can be preferably used for color filters, photosensitive spacers, black tube columnar spacers, electrode materials, photoresists, solder resists, overcoats, insulating films, black matrices, and spacers. Next wall materials, etc. The reason is that it can more effectively exhibit an excellent balance of curability and heat resistance of the cured product. In addition, these components can be preferably used for forming parts in electronic equipment used in transportation equipment such as automobiles and aircrafts that require long-term heat resistance. The reason is that it can more effectively exhibit an excellent balance of curability and heat resistance of the cured product.

B.硬化物 其次,對本發明之硬化物進行說明。 本發明之硬化物係將上述組合物硬化而形成者。B. Hardening Next, the cured product of the present invention will be described. The cured product of the present invention is formed by curing the above-mentioned composition.

根據本發明,由於使用上述組合物,故而會成為耐熱性優異者。According to the present invention, since the above-mentioned composition is used, it becomes one having excellent heat resistance.

本發明之硬化物係使用上述組合物者。 上述硬化物係含有藉由上述組合物中所含之硬化性成分而形成之高分子量物者。 關於此種組合物之內容,可設為與上述「A.組合物」之項中記載之內容相同,故而此處之說明予以省略。The cured product of the present invention is one using the above-mentioned composition. The said hardened|cured material contains the thing of a high molecular weight formed by the hardening component contained in the said composition. The content of such a composition can be the same as the content described in the item of "A. Composition" above, so the description here is omitted.

上述硬化物中所含之化合物A1可為酚性羥基被保護基R101 保護者,亦可為保護基R101 脫離而產生酚性羥基者。 本發明中,就使硬化物成為耐熱性優異者之觀點而言,上述化合物A1較佳為保護基R101 脫離而產生酚性羥基者。The compound A1 contained in the cured product may be a phenolic hydroxyl group protected by a protective group R 101 , or a protective group R 101 may be removed to generate a phenolic hydroxyl group. In the present invention, from the viewpoint of making the cured product excellent in heat resistance, the compound A1 is preferably one where the protective group R 101 is removed and a phenolic hydroxyl group is generated.

關於上述硬化物之俯視形狀,可根據上述硬化物之用途等而適當設定,例如可設為點狀、線狀等圖案狀。Regarding the plan view shape of the cured product, it can be appropriately set in accordance with the use of the cured product, etc., and it can be, for example, a pattern shape such as a dot shape or a line shape.

關於上述硬化物之用途等,可設為與上述「A.組合物」之項中記載之內容相同。Regarding the use of the above-mentioned cured product, etc., it may be the same as the content described in the section of "A. Composition" above.

作為上述硬化物之製造方法,只要為可藉由上述組合物中之硬化性成分而形成高分子量物之方法,則並無特別限定。 作為此種製造方法,例如可使用後述「C.硬化物之製造方法」之項中記載之製造方法。The method for producing the above-mentioned cured product is not particularly limited as long as it is a method capable of forming a high-molecular weight product from the curable component in the above-mentioned composition. As such a manufacturing method, for example, the manufacturing method described in the section of "C. Manufacturing method of hardened product" mentioned later can be used.

C.硬化物之製造方法 其次,對本發明之硬化物之製造方法進行說明。 本發明之硬化物之製造方法之特徵之一在於具有使上述組合物硬化之硬化步驟。C. Manufacturing method of hardened material Next, the manufacturing method of the cured product of the present invention will be described. One of the characteristics of the manufacturing method of the hardened object of the present invention is that it has a hardening step for hardening the above-mentioned composition.

根據本發明,由於使用上述組合物,故而可容易地獲得耐熱性優異之硬化物。According to the present invention, since the above-mentioned composition is used, a cured product excellent in heat resistance can be easily obtained.

1.硬化步驟 本發明中之硬化步驟係使上述組合物硬化之步驟。 作為使上述組合物硬化之方法,可使用藉由硬化性成分而形成高分子量物之方法。1. Hardening step The hardening step in the present invention is a step of hardening the above-mentioned composition. As a method of hardening the above-mentioned composition, a method of forming a high-molecular-weight substance from a curable component can be used.

作為本步驟中之硬化方法,例如可例舉與硬化性成分一併使用硬化觸媒作為上述組合物之方法。 關於上述硬化方法,於含有光自由基聚合起始劑、光陽離子聚合起始劑等光聚合起始劑作為硬化觸媒之情形時,較佳為使用對組合物進行光照射,使硬化性成分彼此硬化之方法。其原因在於,藉由為上述硬化方法,組合物之硬化變得容易。 作為對組合物照射之光,較佳為設為包含波長300 nm~450 nm之光者。其原因在於,藉由使用上述波長之光,組合物之硬化變得容易。 作為上述光照射之光源,例如可較佳地使用發光二極體(LED)、超高壓水銀、水銀蒸汽電弧、碳弧、氙弧等。其原因在於,藉由使用上述光源,組合物之硬化變得容易。 作為上述要照射之光,亦可使用雷射光。作為雷射光,可使用包含波長340~430 nm之光者。 作為雷射光之光源,亦可使用氬離子雷射、氦氖雷射、YAG(Yttrium Aluminium Garnet,釔鋁石榴石)雷射、及半導體雷射等發出可見光至紅外光區域之光者。 再者,於使用該等雷射之情形時,上述組合物可含有吸收可見光至紅外光之區域之增感色素。As the hardening method in this step, for example, a method of using a hardening catalyst as the above-mentioned composition together with a hardening component can be exemplified. Regarding the above-mentioned curing method, when a photopolymerization initiator such as a photoradical polymerization initiator and a photocationic polymerization initiator is contained as a curing catalyst, it is preferable to irradiate the composition with light to make the curable component The way to harden each other. The reason is that by the above-mentioned hardening method, hardening of the composition becomes easy. As the light irradiated to the composition, it is preferable to include light having a wavelength of 300 nm to 450 nm. The reason is that by using light of the above-mentioned wavelength, the curing of the composition becomes easy. As the light source for the above-mentioned light irradiation, for example, a light emitting diode (LED), ultra-high pressure mercury, mercury vapor arc, carbon arc, xenon arc, etc. can be preferably used. The reason is that by using the above-mentioned light source, the curing of the composition becomes easy. As the above-mentioned light to be irradiated, laser light can also be used. As the laser light, one containing light with a wavelength of 340 to 430 nm can be used. As the laser light source, argon ion lasers, helium-neon lasers, YAG (Yttrium Aluminium Garnet, Yttrium Aluminum Garnet) lasers, and semiconductor lasers that emit light in the visible to infrared range can also be used. Furthermore, when these lasers are used, the above-mentioned composition may contain a sensitizing pigment that absorbs visible light to infrared light.

關於上述硬化方法,於含有熱自由基聚合起始劑、熱陽離子聚合起始劑等熱聚合起始劑作為硬化觸媒之情形時,可較佳地使用對組合物進行加熱處理,使硬化性成分彼此硬化之方法。其原因在於,藉由進行加熱處理,組合物之硬化變得容易。 作為加熱溫度,只要為可使上述組合物穩定地硬化者即可,較佳為60℃以上,且較佳為100℃以上300℃以下。其原因在於,藉由為上述加熱溫度,組合物之硬化變得容易。 作為加熱時間,可進行10秒~3小時左右。其原因在於,藉由為上述加熱時間,組合物之硬化變得容易。Regarding the above-mentioned curing method, when a thermal polymerization initiator such as a thermal radical polymerization initiator and a thermal cationic polymerization initiator is contained as a curing catalyst, the composition can be preferably heated to make the composition hardenable. The way the ingredients harden each other. The reason is that heat treatment facilitates hardening of the composition. The heating temperature may be one that can stably harden the above composition, and is preferably 60°C or higher, and more preferably 100°C or higher and 300°C or lower. The reason is that by setting the heating temperature as described above, the curing of the composition becomes easy. The heating time can be about 10 seconds to 3 hours. The reason is that the curing of the composition becomes easy by setting the heating time as described above.

上述硬化方法可僅使用藉由光照射而使硬化性成分硬化之方法,亦可僅使用藉由加熱而使硬化性成分硬化之方法,亦可併用藉由光照射進行硬化之方法與藉由加熱進行硬化之方法。於併用藉由光照射進行硬化之方法與藉由加熱進行硬化之方法之情形時,例如可同時進行光照射及加熱處理,亦可依序進行光照射及加熱處理。The above-mentioned curing method may use only the method of curing the curable component by light irradiation, or only the method of curing the curable component by heating, or the combination of the method of curing by light irradiation and the method of curing by heating. The method of hardening. When the method of curing by light irradiation and the method of curing by heating are used together, for example, light irradiation and heating treatment may be performed at the same time, or light irradiation and heating treatment may be performed sequentially.

2.脫離步驟 本發明之製造方法係具有上述硬化步驟者,就獲得耐熱性優異之硬化物之觀點而言,較佳為具有將保護基R101 自化合物A1脫離之脫離步驟。2. Detachment step The production method of the present invention has the above-mentioned hardening step. From the viewpoint of obtaining a cured product with excellent heat resistance, it is preferable to have a detachment step for detaching the protective group R 101 from the compound A1.

作為本步驟中之將保護基R101 脫離之方法,例如可例舉:對上述化合物A1進行加熱處理之方法、對上述化合物A1進行光照射處理之方法等。 本步驟中,於上述保護基R101 為碳原子數1~40之未經取代或具有取代基之脂肪族烴基、碳原子數6~40之未經取代或具有取代基之含芳香族烴之基、碳原子數2~40之未經取代或具有取代基之含雜環之基或者碳原子數0~40之未經取代或具有取代基之矽烷基中之氧原子側末端的亞甲基被取代為選自上述群I中之二價基而成之基之情形時,上述脫離之方法較佳為對化合物A1進行加熱處理之方法。其原因在於容易進行上述保護基R101 之脫離。 本步驟中,於上述保護基R101 為如鄰硝基苄基之光脫離性保護基之情形時,上述脫離之方法較佳為進行光照射處理之方法。其原因在於容易進行上述保護基R101 之脫離。As a method of removing the protecting group R 101 in this step, for example, a method of heat-treating the above-mentioned compound A1, a method of light-irradiating the above-mentioned compound A1, and the like can be exemplified. In this step, the protective group R 101 is an unsubstituted or substituted aliphatic hydrocarbon group with 1 to 40 carbon atoms, and an unsubstituted or substituted aromatic hydrocarbon-containing group with 6 to 40 carbon atoms. Group, an unsubstituted or substituted heterocyclic group containing 2 to 40 carbon atoms or an unsubstituted or substituted silyl group with 0 to 40 carbon atoms at the oxygen atom side terminal methylene group In the case where it is substituted with a divalent group selected from the above group I, the method of the above-mentioned detachment is preferably a method of heat-treating the compound A1. The reason is that the above-mentioned protective group R 101 can be easily removed. In this step, when the protective group R 101 is a photo-releasable protective group such as o-nitrobenzyl, the method of the above-mentioned detachment is preferably a method of light irradiation treatment. The reason is that the above-mentioned protective group R 101 can be easily removed.

作為對上述化合物A1進行加熱處理之方法,例如只要為可將保護基R101 自組合物或其硬化物中所含之化合物A脫離之方法即可。例如可例舉利用加熱板、烘箱等對組合物或其硬化物進行加熱之方法。 對於上述化合物A1之加熱溫度可設為保護基R101 會脫離之溫度以上之溫度。具體而言,上述加熱溫度較佳為80℃以上300℃以下,較佳為100℃以上290℃以下,其中較佳為120℃以上280℃以下,尤佳為150℃以上250℃以下,其中尤佳為180℃以上240℃以下。其原因在於,藉由為上述加熱溫度,易於將保護基R101 自化合物A脫離。 又,上述加熱溫度於上述組合物含有酸觸媒、鹼觸媒等之情形時,可設為以保護基R101 單獨觀察到之脫離溫度以下。 上述加熱溫度可設為與上述「A.組合物」之「1.化合物A1」之項中記載之內容相同。 作為加熱時間,可設為5分鐘以上3小時以下。As a method of heat-treating the above-mentioned compound A1, for example, what is necessary is just a method which can remove the protective group R 101 from the compound A contained in a composition or its hardened|cured material. For example, a method of heating the composition or its hardened substance using a hot plate, an oven, etc., can be mentioned. The heating temperature for the above compound A1 can be set to a temperature higher than the temperature at which the protective group R 101 will be released. Specifically, the heating temperature is preferably 80°C or more and 300°C or less, preferably 100°C or more and 290°C or less, among which 120°C or more and 280°C or less, and particularly preferably 150°C or more and 250°C or less, especially Preferably, it is 180°C or more and 240°C or less. The reason for this is that the protective group R 101 is easily removed from the compound A by setting the heating temperature as described above. In addition, when the above-mentioned heating temperature is the case where the above-mentioned composition contains an acid catalyst, an alkali catalyst, etc., it can be set to be equal to or lower than the desorption temperature observed with the protecting group R 101 alone. The heating temperature can be set to be the same as the content described in the item of "1. Compound A1" of the above "A. Composition". The heating time may be 5 minutes or more and 3 hours or less.

作為對上述化合物A1進行光照射處理之方法,例如可使用對組合物或其硬化物進行光照射之方法等。 作為對組合物或硬化物照射之光之波長,可設為與上述「A.組合物」之「1.化合物A1」之項中記載之內容相同。 作為上述光照射之光源,可使用上述「1.硬化步驟」中記載之光源。 作為對於上述化合物A1之累計光量,可設為保護基R101 會脫離之累計光量以上。作為上述累計光量,較佳為1000 mJ/cm2 以上10000 mJ/cm2 以下,其中較佳為超過1000 mJ/cm2 且為5000 mJ/cm2 以下,尤其更佳為2000 mJ/cm2 以上4000 mJ/cm2 以下。其原因在於,藉由為上述累計光量,易於將保護基R101 自化合物A脫離。 上述累計光量例如可設為與上述「A.組合物」之「1.化合物A1」之項中記載之內容相同。As a method of light-irradiating the above-mentioned compound A1, for example, a method of light-irradiating the composition or its cured product, etc. can be used. The wavelength of the light irradiated to the composition or the cured product can be the same as the content described in the item "1. Compound A1" of the above-mentioned "A. Composition". As the light source for the above-mentioned light irradiation, the light source described in the above-mentioned "1. Curing Step" can be used. As the cumulative light intensity with respect to the above compound A1, it can be set to be equal to or higher than the cumulative light intensity at which the protecting group R 101 is released. As the above-mentioned cumulative light quantity, it is preferably 1000 mJ/cm 2 or more and 10000 mJ/cm 2 or less, among which it is more than 1000 mJ/cm 2 and 5000 mJ/cm 2 or less, and more preferably 2000 mJ/cm 2 or more 4000 mJ/cm 2 or less. The reason for this is that the protective group R 101 is easily removed from the compound A by being the above-mentioned accumulated light quantity. The above-mentioned accumulated light quantity can be made the same as the content described in the item of "1. Compound A1" of the above-mentioned "A. Composition", for example.

作為本步驟之實施時序,只要為可獲得具有所期望之耐熱性之硬化物者即可。 例如,關於上述實施時序,於本步驟為進行光照射處理之步驟,上述硬化步驟中之硬化方法為對組合物進行光照射,使硬化性成分彼此硬化之方法之情形時,可與上述硬化步驟同時實施。 又,關於上述實施時序,於本步驟為進行加熱處理之步驟,上述硬化步驟中之硬化方法為對組合物進行光照射,使硬化性成分彼此硬化之方法之情形時,較佳為於上述硬化步驟中,在使硬化性成分彼此硬化之光照射處理之後進行。其原因在於,會成為步驟通過性優異者。 於本步驟為進行加熱處理之步驟,上述硬化步驟中之硬化方法為對組合物進行加熱處理,使硬化性成分彼此硬化之方法之情形時,本步驟之實施時序可為與上述硬化步驟中之使硬化性成分彼此硬化之加熱處理或後述之後烘烤步驟同時實施者。As the execution timing of this step, it is only necessary to obtain a cured product having the desired heat resistance. For example, regarding the above implementation sequence, when this step is a step of performing light irradiation treatment, and the curing method in the above curing step is a method of irradiating the composition with light to harden the curable components, it can be combined with the above curing step. Simultaneous implementation. In addition, regarding the above-mentioned implementation sequence, when this step is a step of heat treatment, and the curing method in the above-mentioned curing step is a method of irradiating the composition with light to harden the curable components, it is preferable to use the above-mentioned curing method. In the step, it is carried out after the light irradiation treatment for hardening the curable components to each other. The reason is that it becomes a person with excellent step passability. When this step is a step of heat treatment, and the hardening method in the above-mentioned hardening step is a method of heat-treating the composition to harden the curable components with each other, the execution timing of this step may be the same as that of the above-mentioned hardening step. The heat treatment to harden the curable components or the baking step described later are performed at the same time.

3.其他步驟 上述硬化物之製造方法亦可為除上述硬化步驟、脫離步驟以外,視需要包含其他步驟者。 作為上述其他步驟,可例舉:於上述硬化步驟後,去除組合物之塗膜中之未硬化部分而獲得圖案狀硬化物之顯影步驟;於上述硬化步驟後,對硬化物進行加熱處理之後烘烤步驟;於上述硬化步驟前,對組合物進行加熱處理而去除上述組合物中之溶劑之預烘烤步驟;於上述硬化步驟前,形成上述組合物之塗膜之步驟等。3. Other steps The method of manufacturing the above-mentioned hardened product may include other steps as necessary in addition to the above-mentioned hardening step and detachment step. As the above-mentioned other steps, for example: after the above-mentioned hardening step, the unhardened part of the coating film of the composition is removed to obtain a pattern-like hardened product; after the above-mentioned hardening step, the hardened product is heated and then baked Baking step; before the hardening step, the composition is heated to remove the solvent in the pre-baking step; before the hardening step, the step of forming a coating film of the composition, etc.

作為上述顯影步驟中之去除未硬化部分之方法,例如可例舉將鹼性顯影液塗佈於未硬化部分之方法。 作為上述鹼性顯影液,可使用通常作為氫氧化四甲基銨(TMAH)水溶液或氫氧化鉀水溶液等鹼性顯影液所使用者。 上述顯影步驟之實施時序只要在上述硬化步驟後即可。 作為上述後烘烤步驟中之加熱條件,只要為可提高藉由硬化步驟所得之硬化物之強度等者即可,例如可設為於200℃以上250℃以下進行20分鐘~90分鐘。 上述預烘烤步驟中之加熱條件只要為可去除組合物中之溶劑者即可,例如可設為於70℃以上150℃以下進行30秒~300秒。 作為於形成上述塗膜之步驟中塗佈組合物之方法,可使用旋轉塗佈法、輥塗法、棒式塗佈法、模嘴塗佈法、淋幕式塗佈法、各種印刷、浸漬等公知之方法。 上述塗膜可形成於基材上。 作為上述基材,可根據硬化物之用途等而適當設定,可例舉包含鈉玻璃、石英玻璃、半導體基板、金屬、紙、塑膠等者。 又,上述硬化物可於基材上形成之後自基材剝離而使用,亦可自基材轉印至其他被黏著體而使用。As a method of removing the unhardened portion in the above-mentioned development step, for example, a method of applying an alkaline developer to the unhardened portion can be exemplified. As the alkaline developer, those generally used as alkaline developer such as tetramethylammonium hydroxide (TMAH) aqueous solution or potassium hydroxide aqueous solution can be used. The execution timing of the above-mentioned developing step only needs to be after the above-mentioned hardening step. The heating conditions in the post-baking step may be those that can increase the strength of the cured product obtained in the hardening step. For example, it can be performed at 200°C or higher and 250°C or lower for 20 minutes to 90 minutes. The heating conditions in the above-mentioned pre-baking step may be those that can remove the solvent in the composition, and for example, it can be set at 70°C or higher and 150°C or lower for 30 seconds to 300 seconds. As a method of coating the composition in the step of forming the above-mentioned coating film, spin coating, roll coating, bar coating, die nozzle coating, curtain coating, various printing, and dipping methods can be used. And other well-known methods. The above-mentioned coating film may be formed on a substrate. As the above-mentioned base material, it can be appropriately set according to the use of the cured product, etc., and examples thereof include soda glass, quartz glass, semiconductor substrate, metal, paper, plastic, and the like. In addition, the above-mentioned cured product may be used after being peeled off from the base material after being formed on the base material, or may be used by transferring from the base material to other adherends.

3.其他 關於藉由上述製造方法而製造之硬化物及其用途等,可設為與上述「A.組合物」之項中記載之內容相同。3. Other Regarding the cured product manufactured by the above-mentioned manufacturing method and its use, etc., it can be made the same as the content described in the section of the above-mentioned "A. Composition".

D.添加劑 其次,對本發明之添加劑進行說明。 本發明之添加劑係含有上述通式(A1)所示之化合物與硫系抗氧化劑者。D. Additives Next, the additive of the present invention will be explained. The additive of the present invention contains a compound represented by the above general formula (A1) and a sulfur-based antioxidant.

根據本發明,由於含有上述通式(A1)所示之化合物與硫系抗氧化劑,故而藉由添加至含有硬化性成分之組合物中,可容易地形成硬化性及硬化物之耐熱性之平衡優異之組合物。According to the present invention, since it contains the compound represented by the above general formula (A1) and the sulfur-based antioxidant, by adding it to a composition containing a curable component, a balance of curability and heat resistance of the cured product can be easily formed Excellent composition.

本發明之添加劑係含有化合物A1與硫系抗氧化劑者。The additive of the present invention contains compound A1 and sulfur-based antioxidant.

1.化合物A1及硫系抗氧化劑 作為本發明之添加劑中之化合物A1及硫系抗氧化劑之合計之含量,於上述添加劑之固形物成分100質量份中可設為100質量份,即上述添加劑之固形物成分僅為上述化合物A1及硫系抗氧化劑。 又,上述化合物A1及硫系抗氧化劑之合計之含量於添加劑之固形物成分100質量份中可未達100質量份,即添加劑可為含有上述化合物A1及硫系抗氧化劑以外之其他成分之組合物,例如可設為超過20質量份且為99.99質量份以下。其原因在於,藉由使上述含量為上述範圍,容易形成硬化性及硬化物之耐熱性更優異之組合物等。 本發明中,就容易形成硬化性及硬化物之耐熱性更優異之組合物等之觀點而言,關於上述化合物A1及硫系抗氧化劑之合計之含量之下限,於添加劑之固形物成分100質量份中,較佳為50質量份以上,其中較佳為70質量份以上,尤佳為90質量份以上。其原因在於,藉由使上述含量為上述範圍,易於形成硬化性及硬化物之耐熱性之平衡優異之組合物。又,就添加劑之粒徑控制等變得容易之觀點等而言,關於上述化合物A1及硫系抗氧化劑之合計之含量之上限,於添加劑之固形物成分100質量份中,較佳為99質量份以下,其中較佳為95質量份以下,尤佳為90質量份以下。其原因在於,藉由使上述含量為上述範圍,易於形成硬化性及硬化物之耐熱性之平衡優異之組合物。1. Compound A1 and sulfur-based antioxidants As the total content of the compound A1 and sulfur-based antioxidant in the additive of the present invention, 100 parts by mass of the solid content of the additive can be set to 100 parts by mass, that is, the solid content of the additive is only the compound A1 and Sulfur-based antioxidants. In addition, the total content of the above-mentioned compound A1 and the sulfur-based antioxidant may be less than 100 parts by mass in 100 parts by mass of the solid content of the additive, that is, the additive may be a combination containing the above-mentioned compound A1 and the sulfur-based antioxidant. The substance can be, for example, more than 20 parts by mass and 99.99 parts by mass or less. The reason is that by setting the above content within the above range, it is easy to form a composition having more excellent curability and heat resistance of the cured product. In the present invention, the lower limit of the total content of the above-mentioned compound A1 and sulfur-based antioxidant is less than 100 masses of the solid content of the additive from the viewpoint of easily forming a composition having better curability and better heat resistance of the cured product. Among the parts, it is preferably 50 parts by mass or more, particularly preferably 70 parts by mass or more, and particularly preferably 90 parts by mass or more. The reason is that by setting the above content within the above range, it is easy to form a composition having an excellent balance of curability and heat resistance of the cured product. In addition, from the viewpoint of facilitating the particle size control of the additive, etc., the upper limit of the total content of the compound A1 and the sulfur-based antioxidant is preferably 99 parts by mass based on 100 parts by mass of the solid content of the additive. Parts or less, among them, 95 parts by mass or less is preferable, and 90 parts by mass or less is particularly preferable. The reason is that by setting the above content within the above range, it is easy to form a composition having an excellent balance of curability and heat resistance of the cured product.

再者,關於化合物A1及硫系抗氧化劑,可設為與上述「A.組合物」之「1.化合物A」及「2.硫系抗氧化劑」之項中記載之內容相同。 關於化合物A1及硫系抗氧化劑之合計100質量份中之化合物A1之含量,亦可設為與上述「A.組合物」之項中記載之內容相同。In addition, the compound A1 and the sulfur-based antioxidant can be the same as those described in the items of "1. Compound A" and "2. Sulfur-based antioxidant" of the above-mentioned "A. Composition". The content of the compound A1 in a total of 100 parts by mass of the compound A1 and the sulfur-based antioxidant may be the same as the content described in the item of the above-mentioned "A. composition".

2.溶劑 上述添加劑可除上述化合物A1及硫系抗氧化劑以外,含有溶劑。 作為上述溶劑,只要為可將添加劑中之各成分分散或溶解者即可,可設為與上述「A.組合物」之項中記載之內容相同。 又,作為其含量,於上述添加劑100質量份中,可設為1質量份以上99質量份以下。2. Solvent The above-mentioned additive may contain a solvent in addition to the above-mentioned compound A1 and sulfur-based antioxidant. As said solvent, what is necessary is just to disperse or dissolve each component in an additive, and can be made into the content described in the item of the said "A. Composition". In addition, the content can be 1 part by mass or more and 99 parts by mass or less in 100 parts by mass of the above-mentioned additives.

3.其他成分 上述添加劑亦可為含有化合物A1、硫系抗氧化劑及溶劑以外之其他成分者。 作為上述其他成分,可例舉上述「A.組合物」之「5.其他成分」之項中記載之內容。 上述其他成分之含量可根據上述添加劑之用途等而適當設定,例如於添加劑100質量份中,可設為50質量份以下,較佳為10質量份以下。其原因在於,易於使上述添加劑之化合物A1及硫系抗氧化劑之含有比率較大,而易於形成硬化性及硬化物之耐熱性更優異之組合物。3. Other ingredients The above-mentioned additives may contain other components other than compound A1, sulfur-based antioxidant, and solvent. As the above-mentioned other components, the content described in the item of "5. Other components" of the above-mentioned "A. Composition" can be exemplified. The content of the above-mentioned other components can be appropriately set according to the use of the above-mentioned additive, etc., for example, in 100 parts by mass of the additive, it can be set to 50 parts by mass or less, preferably 10 parts by mass or less. The reason is that it is easy to make the content ratio of the compound A1 of the above additives and the sulfur-based antioxidant relatively large, and it is easy to form a composition having more excellent curability and heat resistance of the cured product.

4.其他 上述添加劑之性狀可根據向組合物之添加方法等而適當設定,例如可設為於溶劑中分散或溶解有化合物A1及硫系抗氧化劑等之液狀、粉體狀、顆粒狀等。 作為上述添加劑之製造方法,只要為可以所期望之調配量含有化合物A1、硫系抗氧化劑之方法即可。4. Other The properties of the above-mentioned additives can be appropriately set according to the method of addition to the composition, etc., for example, it can be in the form of liquid, powder, granule, etc. in which compound A1 and sulfur-based antioxidants are dispersed or dissolved in a solvent. As a manufacturing method of the said additive, what is necessary is just a method which can contain compound A1 and a sulfur-type antioxidant in a desired compounding quantity.

作為上述添加劑之用途,可例舉要求耐熱性等之組合物,較佳為添加至含有硬化性成分之組合物中之用途,其中較佳為硬化性成分含有自由基聚合性化合物之用途。 作為上述組合物之用途,具體而言,可設為與上述「A.組合物」之項中記載之內容相同。The use of the above-mentioned additive includes a composition requiring heat resistance and the like. The use of adding to a composition containing a curable component is preferred, and the use of a curable component containing a radically polymerizable compound is particularly preferred. As the use of the above-mentioned composition, specifically, it can be made the same as the content described in the item of the above-mentioned "A. Composition".

本發明並不限定於上述實施形態。上述實施形態為例示,具有與本發明之申請專利範圍中記載之技術思想實質上相同之構成且發揮相同作用效果者均包含於本發明之技術範圍內。 實施例The present invention is not limited to the above-mentioned embodiment. The above-mentioned embodiments are examples, and those having substantially the same constitution as the technical idea described in the scope of patent application of the present invention and exhibiting the same effects are included in the technical scope of the present invention. Example

以下,例舉實施例等對本發明進一步詳細地進行說明,但本發明並不限定於該等實施例。Hereinafter, the present invention will be described in further detail with examples and the like, but the present invention is not limited to these examples.

[製造例A1-1] 將酚化合物(下述式(C1-1)所示之化合物)0.01 mol、二碳酸二-第三丁酯0.05 mol及吡啶30 g加以混合,於氮氣氛圍下,在室溫添加4-二甲基胺基吡啶0.025 mol,於60℃攪拌3小時,而獲得反應液。冷卻至室溫後,將反應液注入至離子交換水150 g,添加氯仿200 g而進行油水分離。利用無水硫酸鈉將有機層乾燥後,蒸餾去除溶劑,向殘渣中添加甲醇100 g進行晶析。於60℃下對所得之白色粉狀結晶減壓乾燥3小時,而獲得目標物(下述通式(A1-1)所示之化合物)。藉由1 H-NMR確認到所得之白色粉狀結晶為目標物。[Production Example A1-1] A phenol compound (compound represented by the following formula (C1-1)) 0.01 mol, 0.05 mol di-tert-butyl dicarbonate, and 30 g of pyridine were mixed, and under a nitrogen atmosphere, 0.025 mol of 4-dimethylaminopyridine was added at room temperature, and the mixture was stirred at 60°C for 3 hours to obtain a reaction liquid. After cooling to room temperature, the reaction liquid was poured into 150 g of ion-exchange water, and 200 g of chloroform was added to perform oil-water separation. After the organic layer was dried with anhydrous sodium sulfate, the solvent was distilled off, and 100 g of methanol was added to the residue for crystallization. The obtained white powdery crystals were dried under reduced pressure at 60°C for 3 hours to obtain the target product (the compound represented by the following general formula (A1-1)). It was confirmed by 1 H-NMR that the obtained white powdery crystal was the target product.

[製造例A1-2及A1-3] 使用下述式(C1-2)~(C1-3)作為酚化合物,除此以外,以與製造例A1-1相同之方式合成下述式(A1-2)~(A1-3)所示之化合物。藉由1 H-NMR確認到所得之白色粉狀結晶為目標物。[Production Examples A1-2 and A1-3] The following formulae (C1-2) to (C1-3) were used as the phenol compound, and the following formula (A1) was synthesized in the same manner as in Production Example A1-1, except that -2) Compounds shown in (A1-3). It was confirmed by 1 H-NMR that the obtained white powdery crystal was the target product.

[化22]

Figure 02_image047
[化22]
Figure 02_image047

[化23]

Figure 02_image049
[化23]
Figure 02_image049

[實施例1~5及比較例1~6] 依照下述表1中記載之調配,將化合物A、硫系抗氧化劑、非硫系抗氧化劑、硬化性成分、硬化觸媒及添加劑於消泡攪拌機中在初始溫度25℃下攪拌3分鐘而獲得組合物。 又,各成分使用以下之材料。 再者,表中之調配量表示各成分之質量份。[Examples 1 to 5 and Comparative Examples 1 to 6] According to the formulation described in Table 1 below, compound A, sulfur-based antioxidants, non-sulfur-based antioxidants, hardening components, hardening catalysts, and additives were stirred in a defoaming mixer at an initial temperature of 25°C for 3 minutes. combination. In addition, the following materials are used for each component. Furthermore, the blending amount in the table represents the mass parts of each component.

(化合物A) A1-1:上述式(A1-1)所示之化合物 A1-2:上述式(A1-2)所示之化合物 A1-3:上述式(A1-3)所示之化合物(Compound A) A1-1: The compound represented by the above formula (A1-1) A1-2: The compound represented by the above formula (A1-2) A1-3: The compound represented by the above formula (A1-3)

(硫系抗氧化劑) B1-1:下述式(B1-1)所示之化合物 B1-2:下述式(B1-2)所示之化合物(Sulfur-based antioxidant) B1-1: The compound represented by the following formula (B1-1) B1-2: The compound represented by the following formula (B1-2)

(非硫系抗氧化劑) C2-1:下述式(C2-1)所示之化合物(Non-sulfur antioxidant) C2-1: The compound represented by the following formula (C2-1)

(硬化性成分) D-1:下述式(D-1)所示之化合物 D-2:下述式(D-2)所示之化合物(Hardening ingredient) D-1: The compound represented by the following formula (D-1) D-2: The compound represented by the following formula (D-2)

(硬化觸媒) E-1:Irgacure 907(自由基聚合起始劑,醯基膦系化合物)(Hardening catalyst) E-1: Irgacure 907 (radical polymerization initiator, phosphine-based compound)

(添加劑) F-1:東麗道康寧公司製造之SH-29PA(矽酮系界面活性劑)(additive) F-1: SH-29PA (silicone-based surfactant) manufactured by Toray Dow Corning

[化24]

Figure 02_image051
[化24]
Figure 02_image051

[評價] 針對所得之實施例及比較例之組合物,藉由以下之方法進行耐熱性及硬化性之評價。[Evaluation] With respect to the obtained compositions of Examples and Comparative Examples, the heat resistance and curability were evaluated by the following methods.

1.耐熱性評價 於10 cm見方之玻璃之四角端部貼上厚度0.13 mm之間隔件膠帶。 繼而,將實施例及比較例之組合物塗佈於玻璃之由間隔件膠帶所包圍之區域內,利用10 cm見方玻璃夾持,而獲得玻璃積層體。 其次,利用超高壓水銀燈(UL-750:HOYA製造,20 mW/cm2 )對玻璃積層體照射200 mJ/cm2 ,而形成由2片玻璃所夾持之組合物之硬化膜。 然後,自玻璃積層體取出硬化膜。 繼而,將硬化膜於200℃烘箱中靜置30分鐘來進行加熱處理,而獲得試驗片。 針對所得之試驗片,於150℃烘箱中進行250小時加熱處理(加熱試驗)。 依照ASTM(American Society for Testing Materials,美國材料試驗協會)D1925算出試驗片之加熱試驗前後之YI。利用以下之基準評價加熱試驗前後之YI變化(ΔYI)。將結果示於表1。 +:ΔYI未達10 -:ΔYI為10以上 再者,ΔYI越小,可判斷為耐熱性越優異。1. Evaluation of heat resistance A spacer tape with a thickness of 0.13 mm is pasted on the four corners of a 10 cm square glass. Then, the compositions of the examples and comparative examples were coated on the glass in the area surrounded by the spacer tape, and clamped with 10 cm square glass to obtain a glass laminate. Next, an ultra-high pressure mercury lamp (UL-750: manufactured by HOYA, 20 mW/cm 2 ) was used to irradiate the glass laminate with 200 mJ/cm 2 to form a cured film of the composition sandwiched between two sheets of glass. Then, the cured film was taken out from the glass laminate. Then, the cured film was allowed to stand in an oven at 200° C. for 30 minutes to perform heat treatment to obtain a test piece. The obtained test piece was subjected to a heat treatment (heating test) in an oven at 150°C for 250 hours. According to ASTM (American Society for Testing Materials, American Society for Testing Materials) D1925, the YI of the test piece before and after the heating test was calculated. Use the following criteria to evaluate the YI change (ΔYI) before and after the heating test. The results are shown in Table 1. +: ΔYI is less than 10 -: ΔYI is 10 or more. The smaller the ΔYI, the better the heat resistance.

[表1]    實施例1 實施例2 實施例3 實施例4 實施例5 比較例1 比較例2 比較例3 比較例4 比較例5 比較例6 化合物A A1-1 1 1 - - 1 - 1 3 - - 1 A1-2 - - 1 - - - - - - - - A1-3 - - - 1 - - - - - - - 硫系抗氧化劑 B1-1 1 3 3 3 - - - - 1 3 - B1-2 - - - - 3 - - - - - - 非硫系抗氧化劑 C2-1 - - - - - - - - - - 1 聚合性化合物 D-1 80 80 80 80 80 80 80 80 80 80 80 D-2 20 20 20 20 20 20 20 20 20 20 20 聚合起始劑 E-1 1 1 1 1 1 1 1 1 1 1 1 界面活性劑 F-1 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 評價 耐熱性評價 + + + + + - - - - - - [Table 1] Example 1 Example 2 Example 3 Example 4 Example 5 Comparative example 1 Comparative example 2 Comparative example 3 Comparative example 4 Comparative example 5 Comparative example 6 Compound A A1-1 1 1 - - 1 - 1 3 - - 1 A1-2 - - 1 - - - - - - - - A1-3 - - - 1 - - - - - - - Sulfur-based antioxidants B1-1 1 3 3 3 - - - - 1 3 - B1-2 - - - - 3 - - - - - - Non-sulfur antioxidant C2-1 - - - - - - - - - - 1 Polymeric compound D-1 80 80 80 80 80 80 80 80 80 80 80 D-2 20 20 20 20 20 20 20 20 20 20 20 Polymerization initiator E-1 1 1 1 1 1 1 1 1 1 1 1 Surfactant F-1 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 Evaluation Heat resistance evaluation + + + + + - - - - - -

[總結] 表1中雖未記載,但任一實施例之組合物均可硬化。又,根據表1所示之結果,確認到所得之硬化物為耐熱性優異者。例如,確認到獲得於80℃以上250℃以下之溫度條件下等發揮優異之耐熱性之硬化物。相對於此,比較例1之硬化物雖可硬化,但所得之硬化物之耐熱性並不充分。 如上所述,確認到實施例之組合物之硬化性及硬化物之耐熱性兩者之平衡性優異。[to sum up] Although not listed in Table 1, the composition of any of the examples can be hardened. In addition, from the results shown in Table 1, it was confirmed that the obtained cured product was excellent in heat resistance. For example, it was confirmed that a cured product exhibiting excellent heat resistance under temperature conditions of 80°C or higher and 250°C or lower was obtained. In contrast, although the cured product of Comparative Example 1 can be cured, the heat resistance of the cured product obtained is not sufficient. As described above, it is confirmed that the composition of the examples has an excellent balance between the curability of the composition and the heat resistance of the cured product.

[實施例6~10及比較例7~25] 依照下述表2~4中記載之調配,將化合物A、硫系抗氧化劑、非硫系抗氧化劑、硬化性成分、硬化觸媒、添加劑及溶劑於消泡攪拌機中且在初始溫度25℃攪拌3分鐘而獲得組合物。 又,各成分使用以下之材料。 再者,表中之調配量表示各成分之質量份。[Examples 6-10 and Comparative Examples 7-25] According to the formulation described in Tables 2 to 4 below, compound A, sulfur-based antioxidants, non-sulfur-based antioxidants, hardenable ingredients, hardening catalysts, additives, and solvents are stirred in a defoaming mixer at an initial temperature of 25°C The composition was obtained in 3 minutes. In addition, the following materials are used for each component. Furthermore, the blending amount in the table represents the mass parts of each component.

(化合物A) A1-1:上述式(A1-1)所示之化合物 A1-2:上述式(A1-2)所示之化合物 A1-3:上述式(A1-3)所示之化合物(Compound A) A1-1: The compound represented by the above formula (A1-1) A1-2: The compound represented by the above formula (A1-2) A1-3: The compound represented by the above formula (A1-3)

(硫系抗氧化劑) B1-1:上述式(B1-1)所示之化合物 B1-2:上述式(B1-2)所示之化合物(Sulfur-based antioxidant) B1-1: The compound represented by the above formula (B1-1) B1-2: The compound represented by the above formula (B1-2)

(非硫系抗氧化劑) C1-1:上述式(C1-1)所示之化合物 C1-2:上述式(C1-2)所示之化合物 C1-3:上述式(C1-3)所示之化合物 C2-1:上述式(C2-1)所示之化合物(Non-sulfur antioxidant) C1-1: The compound represented by the above formula (C1-1) C1-2: The compound represented by the above formula (C1-2) C1-3: The compound represented by the above formula (C1-3) C2-1: The compound represented by the above formula (C2-1)

(硬化性成分) D-3:昭和電工股份有限公司製造之SPC-1000(自由基聚合性化合物,不飽和改性(甲基)丙烯酸系樹脂,固形物成分濃度29質量%之PEGMEA(Poly(ethylene glycol) methacrylate,聚乙二醇甲基丙烯酸酯)溶液) D-4:昭和電工股份有限公司製造之SPC-3000(自由基聚合性化合物,不飽和改性(甲基)丙烯酸系樹脂,固形物成分濃度43質量%之PEGMEA溶液) D-5:二季戊四醇六丙烯酸酯(自由基聚合性化合物,6官能)(Hardening ingredient) D-3: SPC-1000 (radical polymerizable compound, unsaturated modified (meth)acrylic resin, PEGMEA (Poly(ethylene glycol) methacrylate) with a solid content of 29% by mass, manufactured by Showa Denko Co., Ltd. Polyethylene glycol methacrylate) solution) D-4: SPC-3000 manufactured by Showa Denko Co., Ltd. (free radical polymerizable compound, unsaturated modified (meth)acrylic resin, PEGMEA solution with a solid content of 43% by mass) D-5: Dipentaerythritol hexaacrylate (radical polymerizable compound, 6 functions)

(硬化觸媒) E-1:ADEKA公司製造之NCI-930(自由基聚合起始劑)(Hardening catalyst) E-1: NCI-930 (radical polymerization initiator) manufactured by ADEKA

(添加劑) F-1:東麗道康寧公司製造之FZ-2122(具有聚環氧烷單元之二甲基聚矽氧烷)(additive) F-1: FZ-2122 (Dimethylpolysiloxane with polyalkylene oxide unit) manufactured by Toray Dow Corning Corporation

(溶劑) G-1:丙二醇單甲醚乙酸酯(PGMEA)(Solvent) G-1: Propylene glycol monomethyl ether acetate (PGMEA)

[評價] 針對所得之實施例及比較例之組合物,利用以下之方法進行耐熱性及硬化性之評價。[Evaluation] With respect to the obtained compositions of Examples and Comparative Examples, the heat resistance and curability were evaluated by the following methods.

1.耐熱性評價2 準備10 cm見方之玻璃。 然後,利用旋轉塗佈法將各實施例及各比較例中所得之組合物以加熱處理後之膜厚成為4 μm之方式塗佈於玻璃之一面上,繼而,於90℃烘箱中靜置2分鐘進行預烘烤,而獲得玻璃積層體。對於所得之玻璃積層體,使用鏡面投影對準曝光器(製品名:TME-150RTO,TOPCON股份有限公司製造之高壓水銀燈),不經由遮罩而對塗膜以照射量20 mJ/cm2 照射紫外線,於玻璃上形成硬化膜。然後,將形成有硬化膜之玻璃積層體於200℃烘箱中靜置30分鐘進行加熱處理,而獲得試驗片。 針對所得之試驗片,於150℃烘箱中進行336小時加熱處理(加熱試驗)。 利用紫外可見分光光度計V-760(日本分光製造)測定試驗片之加熱試驗前後之硬化膜之400 nm透過率(%),算出透過率之差(加熱試驗後之硬化膜之400 nm透過率-加熱試驗前之硬化膜之400 nm透過率)。利用以下之基準評價算出之透過率之差。將結果示於表2~4。 +:未達0.4% -:0.4%以上且未達2% --:2%以上 再者,透過率之差越小,可判斷為耐熱性越優異。1. Heat resistance evaluation 2 Prepare 10 cm square glass. Then, the composition obtained in each example and each comparative example was coated on one surface of the glass by the spin coating method in such a way that the film thickness after heat treatment became 4 μm, and then it was allowed to stand in an oven at 90°C for 2 Pre-baking was performed in minutes to obtain a glass laminate. For the obtained glass laminate, a mirror projection aligner (product name: TME-150RTO, a high-pressure mercury lamp manufactured by TOPCON Co., Ltd.) was used to irradiate ultraviolet rays to the coating film at an irradiance of 20 mJ/cm 2 without a mask. , Form a hardened film on the glass. Then, the glass laminate on which the cured film was formed was allowed to stand in an oven at 200° C. for 30 minutes for heat treatment to obtain a test piece. The obtained test piece was subjected to heat treatment (heating test) in an oven at 150°C for 336 hours. Measure the 400 nm transmittance (%) of the cured film before and after the heating test of the test piece with the UV-Vis spectrophotometer V-760 (manufactured by JASCO), and calculate the difference in transmittance (400 nm transmittance of the cured film after the heating test -400 nm transmittance of the cured film before the heating test). Use the following criteria to evaluate the difference in transmittance calculated. The results are shown in Tables 2 to 4. +: less than 0.4% -: more than 0.4% and less than 2% --: more than 2%, the smaller the difference in transmittance, the better the heat resistance.

2.硬化性評價2 將曝光間隙設為100 μm,經由形成有30 μm之線圖案之負型遮罩而照射紫外線,然後,於23℃噴出包含0.04質量%氫氧化鉀水溶液之顯影液,藉此進行40秒噴淋顯影,除此以外,利用以與上述「1.耐熱性評價2」相同之方法獲得試驗片。 測定所得之試驗片之硬化膜之圖案之寬度(線寬),利用以下之基準進行評價。將結果示於表2~4。 +:30 μm以上 -:未達30 μm 再者,線寬越寬,可判斷為硬化性越優異。2. Evaluation of Hardness 2 The exposure gap was set to 100 μm, and ultraviolet rays were irradiated through a negative mask formed with a line pattern of 30 μm. Then, a developer containing a 0.04% by mass potassium hydroxide aqueous solution was sprayed at 23°C to perform spraying for 40 seconds Except for the development, a test piece was obtained by the same method as the above-mentioned "1. Heat resistance evaluation 2". The width (line width) of the pattern of the cured film of the obtained test piece was measured and evaluated using the following criteria. The results are shown in Tables 2 to 4. +: 30 μm or more -: less than 30 μm Furthermore, the wider the line width, the better the curability.

[表2]    實施例6 實施例7 實施例8 實施例9 實施例10 化合物A A1-1 1 1 1 - - A1-2 - - - 1 - A1-3 - - - - 1 硫系抗氧化劑 B1-1 1 3 - 3 - B1-2 - - 1 - 3 非硫系抗氧化劑 C1-1 - - - - - C1-2 - - - - - C1-3 - - - - - C2-1 - - - - - 聚合性化合物 D-3 137 137 137 137 137 D-4 40 40 40 40 40 D-5 43 43 43 43 43 聚合起始劑 E-1 1 1 1 1 1 界面活性劑 F-1 0.2 0.2 0.2 0.2 0.2 溶劑 G-1 386 386 386 386 386 評價 耐熱性評價 + + + + + 硬化性評價 + + + + + [Table 2] Example 6 Example 7 Example 8 Example 9 Example 10 Compound A A1-1 1 1 1 - - A1-2 - - - 1 - A1-3 - - - - 1 Sulfur-based antioxidants B1-1 1 3 - 3 - B1-2 - - 1 - 3 Non-sulfur antioxidant C1-1 - - - - - C1-2 - - - - - C1-3 - - - - - C2-1 - - - - - Polymeric compound D-3 137 137 137 137 137 D-4 40 40 40 40 40 D-5 43 43 43 43 43 Polymerization initiator E-1 1 1 1 1 1 Surfactant F-1 0.2 0.2 0.2 0.2 0.2 Solvent G-1 386 386 386 386 386 Evaluation Heat resistance evaluation + + + + + Hardening evaluation + + + + +

[表3]    比較例7 比較例8 比較例9 比較例10 比較例11 比較例12 比較例13 比較例14 比較例15 比較例16 化合物A A1-1 - 1 3 - - 1 1 - - - A1-2 - - - - - - - - - - A1-3 - - - - - - - - - - 硫系抗氧化劑 B1-1 - - - 1 3 - - - - - B1-2 - - - - - - - - - - 非硫系抗氧化劑 C1-1 - - - - - - - - - 1 C1-2 - - - - - - - - - - C1-3 - - - - - - - - - - C2-1 - - - - - 1 3 1 3 - 聚合性化合物 D-3 137 137 137 137 137 137 137 137 137 137 D-4 40 40 40 40 40 40 40 40 40 40 D-5 43 43 43 43 43 43 43 43 43 43 聚合起始劑 E-1 1 1 1 1 1 1 1 1 1 1 界面活性劑 F-1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 溶劑 G-1 386 386 386 386 386 386 386 386 386 386 評價 耐熱性評價 -- - - -- -- - - -- -- - 硬化性評價 + + + + + + + + + - [table 3] Comparative example 7 Comparative example 8 Comparative example 9 Comparative example 10 Comparative example 11 Comparative example 12 Comparative example 13 Comparative example 14 Comparative example 15 Comparative example 16 Compound A A1-1 - 1 3 - - 1 1 - - - A1-2 - - - - - - - - - - A1-3 - - - - - - - - - - Sulfur-based antioxidants B1-1 - - - 1 3 - - - - - B1-2 - - - - - - - - - - Non-sulfur antioxidant C1-1 - - - - - - - - - 1 C1-2 - - - - - - - - - - C1-3 - - - - - - - - - - C2-1 - - - - - 1 3 1 3 - Polymeric compound D-3 137 137 137 137 137 137 137 137 137 137 D-4 40 40 40 40 40 40 40 40 40 40 D-5 43 43 43 43 43 43 43 43 43 43 Polymerization initiator E-1 1 1 1 1 1 1 1 1 1 1 Surfactant F-1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 Solvent G-1 386 386 386 386 386 386 386 386 386 386 Evaluation Heat resistance evaluation - - - - - - - - - - Hardening evaluation + + + + + + + + + -

[表4]    比較例17 比較例18 比較例19 比較例20 比較例21 比較例22 比較例23 比較例24 比較例25 化合物A A1-1 - 1 1 - - - - - - A1-2 - - - - - - - - - A1-3 - - - - - - - - - 硫系抗氧化劑 B1-1 - - - 1 1       1 - B1-2 - - - - - - - - - 非硫系抗氧化劑 C1-1 3 1 3 1 3 - - - 1 C1-2 - - - - - 1 - - - C1-3 - - - - - - 1 - - C2-1 - - - - - - - 1 1 聚合性化合物 D-3 137 137 137 137 137 137 137 137 137 D-4 40 40 40 40 40 40 40 40 40 D-5 43 43 43 43 43 43 43 43 43 聚合起始劑 E-1 1 1 1 1 1 1 1 1 1 界面活性劑 F-1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 溶劑 G-1 386 386 386 386 386 386 386 386 386 評價 耐熱性評價 - - + - - - - -- - 硬化性評價 - - - - - - - + - [Table 4] Comparative example 17 Comparative Example 18 Comparative Example 19 Comparative example 20 Comparative Example 21 Comparative example 22 Comparative example 23 Comparative example 24 Comparative example 25 Compound A A1-1 - 1 1 - - - - - - A1-2 - - - - - - - - - A1-3 - - - - - - - - - Sulfur-based antioxidants B1-1 - - - 1 1 1 - B1-2 - - - - - - - - - Non-sulfur antioxidant C1-1 3 1 3 1 3 - - - 1 C1-2 - - - - - 1 - - - C1-3 - - - - - - 1 - - C2-1 - - - - - - - 1 1 Polymeric compound D-3 137 137 137 137 137 137 137 137 137 D-4 40 40 40 40 40 40 40 40 40 D-5 43 43 43 43 43 43 43 43 43 Polymerization initiator E-1 1 1 1 1 1 1 1 1 1 Surfactant F-1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 Solvent G-1 386 386 386 386 386 386 386 386 386 Evaluation Heat resistance evaluation - - + - - - - - - Hardening evaluation - - - - - - - + -

根據表2~4所示之結果,確認到實施例6~10之組合物均為具有充分之硬化性者。又,確認到所得之硬化物為耐熱性優異者。相對於此,比較例7~25之組合物之硬化性不充分,或所得之硬化物之耐熱性較差,無法獲得硬化性優異且可獲得耐熱性優異之硬化物之組合物。 如上所述,可確認到實施例6~10之組合物之硬化性及硬化物之耐熱性之兩者之平衡優異。From the results shown in Tables 2 to 4, it was confirmed that the compositions of Examples 6 to 10 all had sufficient curability. In addition, it was confirmed that the obtained cured product was excellent in heat resistance. On the other hand, the curability of the compositions of Comparative Examples 7 to 25 was insufficient, or the heat resistance of the cured product obtained was poor, and it was impossible to obtain a composition having excellent curability and excellent heat resistance. As described above, it can be confirmed that the composition of Examples 6 to 10 has an excellent balance between the curability of the composition and the heat resistance of the cured product.

[製造例4-1] 利用與日本專利特開2017-111453號公報之合成例1相同之方法,獲得溶劑以外之固形物成分之酸值88 mgKOH/g、固形物成分濃度71質量%之含羧基之樹脂(使甲酚酚醛清漆型環氧樹脂與丙烯酸反應所得之環氧丙烯酸酯樹脂)之樹脂溶液。[Manufacturing Example 4-1] Using the same method as in Synthesis Example 1 of JP 2017-111453 A, a carboxyl group-containing resin with an acid value of 88 mgKOH/g of solid components other than the solvent and a solid component concentration of 71% by mass (cresol A resin solution of epoxy acrylate resin obtained by reacting novolac type epoxy resin with acrylic acid.

[實施例11~17及比較例26~46] 依照下述表5~7中記載之調配,將化合物A、硫系抗氧化劑、非硫系抗氧化劑、硬化性成分、硬化觸媒、添加劑及溶劑於消泡攪拌機中且在初始溫度25℃攪拌3分鐘而獲得組合物。 又,表中之各成分表示以下之材料。 再者,表中之調配量表示各成分之質量份。[Examples 11 to 17 and Comparative Examples 26 to 46] According to the formulations described in Tables 5-7 below, compound A, sulfur antioxidants, non-sulfur antioxidants, hardening ingredients, hardening catalysts, additives, and solvents are mixed in a defoaming mixer and stirred at an initial temperature of 25°C The composition was obtained in 3 minutes. In addition, each component in the table indicates the following materials. Furthermore, the blending amount in the table represents the mass parts of each component.

(化合物A) A1-1:上述式(A1-1)所示之化合物 A1-2:上述式(A1-2)所示之化合物 A1-3:上述式(A1-3)所示之化合物(Compound A) A1-1: The compound represented by the above formula (A1-1) A1-2: The compound represented by the above formula (A1-2) A1-3: The compound represented by the above formula (A1-3)

(硫系抗氧化劑) B1-1:上述式(B1-1)所示之化合物 B1-2:上述式(B1-2)所示之化合物(Sulfur-based antioxidant) B1-1: The compound represented by the above formula (B1-1) B1-2: The compound represented by the above formula (B1-2)

(非硫系抗氧化劑) C1-1:上述式(C1-1)所示之化合物 C1-2:上述式(C1-2)所示之化合物 C1-3:上述式(C1-3)所示之化合物 C2-1:上述式(C2-1)所示之化合物(Non-sulfur antioxidant) C1-1: The compound represented by the above formula (C1-1) C1-2: The compound represented by the above formula (C1-2) C1-3: The compound represented by the above formula (C1-3) C2-1: The compound represented by the above formula (C2-1)

(硬化性成分:自由基聚合性化合物) D-5:二季戊四醇六丙烯酸酯(自由基聚合性化合物,6官能) D-6:製造例4-1中製造之含羧基之樹脂之樹脂溶液(固形物成分之酸值88 mgKOH/g,固形物成分濃度71質量%)(Curable component: radical polymerizable compound) D-5: Dipentaerythritol hexaacrylate (radical polymerizable compound, 6 functions) D-6: Resin solution of the carboxyl group-containing resin produced in Production Example 4-1 (acid value of solid content 88 mgKOH/g, concentration of solid content 71% by mass)

(硬化性成分:熱硬化性化合物) D2-1:聯苯型環氧樹脂(日本化藥股份有限公司製造之NC3000,多官能環氧化合物) D2-2:聯苯型環氧樹脂(三菱化學公司製造之YX-4000,多官能環氧化合物)(Curable ingredient: thermosetting compound) D2-1: Biphenyl type epoxy resin (NC3000 manufactured by Nippon Kayaku Co., Ltd., multifunctional epoxy compound) D2-2: Biphenyl type epoxy resin (YX-4000 manufactured by Mitsubishi Chemical Corporation, multifunctional epoxy compound)

(硬化觸媒:自由基聚合起始劑) E-2:IRGACURE TPO(BASF Japan公司製造) E-3:IRGACURE OXE02(BASF Japan公司製造)(Hardening catalyst: radical polymerization initiator) E-2: IRGACURE TPO (manufactured by BASF Japan) E-3: IRGACURE OXE02 (manufactured by BASF Japan)

(硬化觸媒:熱硬化劑) E2-1:雙氰胺 E2-2:咪唑系硬化觸媒(四國化成工業公司製造之2PHZ)(Hardening catalyst: thermal hardening agent) E2-1: Dicyandiamide E2-2: Imidazole-based hardening catalyst (2PHZ manufactured by Shikoku Chemical Industry Co., Ltd.)

(添加劑:填充劑) F2-1:二氧化矽(Admatechs公司製造之SO-E5) F2-2:氧化鈦(石原產業公司製造之TIPAQUE R-820)(Additive: filler) F2-1: Silicon dioxide (SO-E5 manufactured by Admatechs) F2-2: Titanium oxide (TIPAQUE R-820 manufactured by Ishihara Sangyo Co., Ltd.)

(添加劑:著色劑) F3-1:pigment blue 15(顏料) F3-2:pigment yellow 14(顏料)(Additive: colorant) F3-1: pigment blue 15 (pigment) F3-2: pigment yellow 14 (pigment)

(溶劑) G-1:丙二醇單甲醚乙酸酯(PGMEA,醚酯系溶劑)(Solvent) G-1: Propylene glycol monomethyl ether acetate (PGMEA, ether ester solvent)

[評價] 針對所得之實施例11~17及比較例26~46之組合物,利用以下之方法進行耐熱性及硬化性之評價。[Evaluation] With respect to the obtained compositions of Examples 11 to 17 and Comparative Examples 26 to 46, the heat resistance and curability were evaluated by the following methods.

1.耐熱性評價3 將實施例11~17及比較例26~46中所得之各組合物以硬化後之硬化物之膜厚成為20 μm之方式塗佈於厚度1.6 mm之FR-4覆銅積層板後,於80℃使塗膜乾燥30分鐘。然後,對乾燥之塗膜以1000 mJ/cm2 之累計光量進行紫外線曝光。之後,於150℃將紫外線曝光後之塗膜加熱處理60分鐘,而獲得評價用樣品。 繼而,對於評價用樣品,於150℃烘箱中進行250小時加熱處理(加熱試驗)。使用色差計,求出加熱前後之評價樣品之b* 值。利用以下之基準評價加熱試驗前後之b* 值變化(Δb* )。將結果示於下述表5~表7。 +:Δb* 未達5 -:Δb* 為5以上 Δb* 越小,可判斷為耐熱性越優異。1. Heat resistance evaluation 3 The compositions obtained in Examples 11-17 and Comparative Examples 26-46 were applied to FR-4 copper clad with a thickness of 1.6 mm so that the film thickness of the cured product after curing became 20 μm After the laminate is laminated, the coating film is dried at 80°C for 30 minutes. Then, the dried coating film is exposed to ultraviolet rays with a cumulative light quantity of 1000 mJ/cm 2. Then, the coating film after ultraviolet exposure was heat-processed at 150 degreeC for 60 minutes, and the sample for evaluation was obtained. Then, the sample for evaluation was heat-processed (heating test) in 150 degreeC oven for 250 hours. Using a color difference meter, calculate the b * value of the evaluation sample before and after heating. Use the following criteria to evaluate the b * value change (Δb * ) before and after the heating test. The results are shown in Tables 5 to 7 below. +: Δb * less than 5 -: Δb * is 5 or more The smaller the Δb * , the more excellent heat resistance can be judged.

2.硬化性評價3 將實施例11~17及比較例26~46之組合物以硬化後之硬化物之膜厚成為20 μm之方式塗佈於玻璃基板上後,於80℃使塗膜乾燥30分鐘。之後,使用高壓水銀燈,經由光罩(遮罩開口30 μm)對乾燥之塗膜進行曝光(曝光間隙300 μm,曝光量500 mJ/cm2 )。使用1.0質量%碳酸鈉水溶液作為顯影液,將曝光後之塗膜顯影60秒後,充分地水洗,使用潔淨烘箱於150℃進行60分鐘後烘烤,使圖案固定,而獲得評價用樣品。 利用光學顯微鏡觀察所得之評價用樣品上之圖案,並測定與遮罩開口相對應之部分之線寬。 利用光學顯微鏡觀察所得之評價用樣品上之圖案,測定圖案之寬度(線寬),並利用以下之基準進行評價。將結果示於下述表5~表7。 +:30 μm以上 -:27.5 μm以上且未達30 μm。 --:未達27.5 μm。 線寬越寬,可判斷為硬化性越優異。 又,相對於設定線寬之差越小,可判斷為光微影性亦越優異。2. Curability evaluation 3 The compositions of Examples 11-17 and Comparative Examples 26-46 were coated on a glass substrate so that the film thickness of the cured product after curing became 20 μm, and the coating film was dried at 80°C 30 minutes. After that, use a high-pressure mercury lamp to expose the dried coating film through a mask (mask opening 30 μm) (exposure gap 300 μm, exposure amount 500 mJ/cm 2 ). A 1.0% by mass sodium carbonate aqueous solution was used as a developer, and the exposed coating film was developed for 60 seconds, then thoroughly washed with water, and post-baked at 150°C for 60 minutes in a clean oven to fix the pattern to obtain a sample for evaluation. Observe the pattern on the obtained evaluation sample with an optical microscope, and measure the line width of the part corresponding to the opening of the mask. The pattern on the obtained evaluation sample was observed with an optical microscope, the width (line width) of the pattern was measured, and the evaluation was performed using the following criteria. The results are shown in Tables 5 to 7 below. +: 30 μm or more -: 27.5 μm or more and less than 30 μm. --: Less than 27.5 μm. The wider the line width, the better the curability. In addition, the smaller the difference with respect to the set line width, the better it can be judged that the photolithography property is also excellent.

[表5]    實施例11 實施例12 實施例13 實施例14 實施例15 實施例16 實施例17 化合物A A1-1 1 1 - - 1 1 1 A1-2 - - 1 - - - - A1-3 - - - 1 - - - 硫系抗氧化劑 B1-1 1 3 3 3 - 1 1 B1-2 - - - - 3 - - 非硫系抗氧化劑 C1-1 - - - - - - - C1-2 - - - - - - - C1-3 - - - - - - - C2-1 - - - - - - - 硬化性成分 D-5 15 15 15 15 15 15 15 D-6 141 141 141 141 141 141 141 D2-1 25 25 25 25 25 25 25 D2-2 20 20 20 20 20 20 20 硬化觸媒 E-2 7.5 7.5 7.5 7.5 7.5 7.5 7.5 E-3 1 1 1 1 1 1 1 E2-1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 E2-2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 添加劑 F2-1 155 155 155 155 155 155 - F2-2 - - - - - - 155 F3-1 - - - - - 1.5 - F3-2 - - - - - 2 - 溶劑 G-1 5 5 5 5 5 5 5 評價 耐熱性評價3 + + + + + + + 硬化性評價3 + + + + + + + [table 5] Example 11 Example 12 Example 13 Example 14 Example 15 Example 16 Example 17 Compound A A1-1 1 1 - - 1 1 1 A1-2 - - 1 - - - - A1-3 - - - 1 - - - Sulfur-based antioxidants B1-1 1 3 3 3 - 1 1 B1-2 - - - - 3 - - Non-sulfur antioxidant C1-1 - - - - - - - C1-2 - - - - - - - C1-3 - - - - - - - C2-1 - - - - - - - Hardening ingredients D-5 15 15 15 15 15 15 15 D-6 141 141 141 141 141 141 141 D2-1 25 25 25 25 25 25 25 D2-2 20 20 20 20 20 20 20 Hardening catalyst E-2 7.5 7.5 7.5 7.5 7.5 7.5 7.5 E-3 1 1 1 1 1 1 1 E2-1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 E2-2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 additive F2-1 155 155 155 155 155 155 - F2-2 - - - - - - 155 F3-1 - - - - - 1.5 - F3-2 - - - - - 2 - Solvent G-1 5 5 5 5 5 5 5 Evaluation Heat resistance evaluation 3 + + + + + + + Hardening evaluation 3 + + + + + + +

[表6]    比較例26 比較例27 比較例28 比較例29 比較例30 比較例31 比較例32 比較例33 比較例34 比較例35 化合物A A1-1 - 1 3 - - 1 1 - - - A1-2 - - - - - - - - - - A1-3 - - - - - - - - - - 硫系抗氧化劑 B1-1 - - - 1 3 - - - - - B1-2 - - - - - - - - - - 非硫系抗氧化劑 C1-1 - - - - - - - - - 1 C1-2 - - - - - - - - - - C1-3 - - - - - - - - - - C2-1 - - - - - 1 3 1 3 - 硬化性成分 D-5 15 15 15 15 15 15 15 15 15 15 D-6 141 141 141 141 141 141 141 141 141 141 D2-1 25 25 25 25 25 25 25 25 25 25 D2-2 20 20 20 20 20 20 20 20 20 20 硬化觸媒 E-2 7.5 7.5 7.5 7.5 7.5 7.5 7.5 7.5 7.5 7.5 E-3 1 1 1 1 1 1 1 1 1 1 E2-1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 E2-2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 添加劑 F2-1 155 155 155 155 155 155 155 155 155 155 F2-2 - - - - - - - - - - F3-1 - - - - - - - - - - F3-2 - - - - - - - - - - 溶劑 G-1 5 5 5 5 5 5 5 5 5 5 評價 耐熱性評價3 - - - - - - - - - - 硬化性評價3 + + + + + + + + + - [Table 6] Comparative Example 26 Comparative Example 27 Comparative Example 28 Comparative Example 29 Comparative example 30 Comparative example 31 Comparative example 32 Comparative Example 33 Comparative Example 34 Comparative Example 35 Compound A A1-1 - 1 3 - - 1 1 - - - A1-2 - - - - - - - - - - A1-3 - - - - - - - - - - Sulfur-based antioxidants B1-1 - - - 1 3 - - - - - B1-2 - - - - - - - - - - Non-sulfur antioxidant C1-1 - - - - - - - - - 1 C1-2 - - - - - - - - - - C1-3 - - - - - - - - - - C2-1 - - - - - 1 3 1 3 - Hardening ingredients D-5 15 15 15 15 15 15 15 15 15 15 D-6 141 141 141 141 141 141 141 141 141 141 D2-1 25 25 25 25 25 25 25 25 25 25 D2-2 20 20 20 20 20 20 20 20 20 20 Hardening catalyst E-2 7.5 7.5 7.5 7.5 7.5 7.5 7.5 7.5 7.5 7.5 E-3 1 1 1 1 1 1 1 1 1 1 E2-1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 E2-2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 additive F2-1 155 155 155 155 155 155 155 155 155 155 F2-2 - - - - - - - - - - F3-1 - - - - - - - - - - F3-2 - - - - - - - - - - Solvent G-1 5 5 5 5 5 5 5 5 5 5 Evaluation Heat resistance evaluation 3 - - - - - - - - - - Hardening evaluation 3 + + + + + + + + + -

[表7]    比較例36 比較例37 比較例38 比較例39 比較例40 比較例41 比較例42 比較例43 比較例44 比較例45 比較例46 化合物A A1-1    1 1 - - - - - - 1 1 A1-2 - - - - - - - - - - - A1-3 - - - - - - - - - - - 硫系抗氧化劑 B1-1 - - - 1 1 - - 1 3 - - B1-2 - - - - - - - - - - - 非硫系抗氧化劑 C1-1 3 1 3 1 3 1 3 - - - - C1-2 - - - - - - - - - - - C1-3 - - - - - - - - - - - C2-1 - - - - - 1 1 1 1 - - 硬化性成分 D-5 15 15 15 15 15 15 15 15 15 15 15 D-6 141 141 141 141 141 141 141 141 141 141 141 D2-1 25 25 25 25 25 25 25 25 25 25 25 D2-2 20 20 20 20 20 20 20 20 20 20 20 硬化觸媒 E-2 7.5 7.5 7.5 7.5 7.5 7.5 7.5 7.5 7.5 7.5 7.5 E-3 1 1 1 1 1 1 1 1 1 1 1 E2-1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 E2-2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 添加劑 F2-1 155 155 155 155 155 155 155 155 155 155 - F2-2 - - - - - - - - - - 155 F3-1 - - - - - - - - - 1.5 - F3-2 - - - - - - - - - 2 - 溶劑 G-1 5 5 5 5 5 5 5 5 5 5 5 評價 耐熱性評價3 - - + + + - - - - - - 硬化性評價3 -- - -- - -- - -- + + + + [Table 7] Comparative Example 36 Comparative Example 37 Comparative Example 38 Comparative Example 39 Comparative example 40 Comparative Example 41 Comparative example 42 Comparative example 43 Comparative example 44 Comparative Example 45 Comparative Example 46 Compound A A1-1 1 1 - - - - - - 1 1 A1-2 - - - - - - - - - - - A1-3 - - - - - - - - - - - Sulfur-based antioxidants B1-1 - - - 1 1 - - 1 3 - - B1-2 - - - - - - - - - - - Non-sulfur antioxidant C1-1 3 1 3 1 3 1 3 - - - - C1-2 - - - - - - - - - - - C1-3 - - - - - - - - - - - C2-1 - - - - - 1 1 1 1 - - Hardening ingredients D-5 15 15 15 15 15 15 15 15 15 15 15 D-6 141 141 141 141 141 141 141 141 141 141 141 D2-1 25 25 25 25 25 25 25 25 25 25 25 D2-2 20 20 20 20 20 20 20 20 20 20 20 Hardening catalyst E-2 7.5 7.5 7.5 7.5 7.5 7.5 7.5 7.5 7.5 7.5 7.5 E-3 1 1 1 1 1 1 1 1 1 1 1 E2-1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 E2-2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 additive F2-1 155 155 155 155 155 155 155 155 155 155 - F2-2 - - - - - - - - - - 155 F3-1 - - - - - - - - - 1.5 - F3-2 - - - - - - - - - 2 - Solvent G-1 5 5 5 5 5 5 5 5 5 5 5 Evaluation Heat resistance evaluation 3 - - + + + - - - - - - Hardening evaluation 3 - - - - - - - + + + +

根據表5~表7所示之結果,可確認到實施例之組合物之硬化性及硬化物之耐熱性之兩者之平衡優異。 又,如表5~表7所示,可確認到實施例之組合物亦可較佳地用於彩色濾光片、感光性間隔件、黑管柱狀間隔件等含有各種著色劑之著色硬化性組合物、阻焊劑等含有填充劑之組合物等。According to the results shown in Table 5 to Table 7, it can be confirmed that the composition of the examples has an excellent balance between the curability of the composition and the heat resistance of the cured product. In addition, as shown in Tables 5 to 7, it can be confirmed that the compositions of the examples can also be preferably used for coloring hardening containing various coloring agents, such as color filters, photosensitive spacers, and black tube columnar spacers. Compositions, solder resists and other filler-containing compositions.

Figure 109115829-A0101-11-0002-2
Figure 109115829-A0101-11-0002-2

Claims (15)

一種組合物,其含有: 下述通式(A1)所示之化合物; 硫系抗氧化劑;及 硬化性成分;
Figure 03_image053
(式中,R101 表示碳原子數1~40之未經取代或具有取代基之脂肪族烴基、碳原子數6~40之未經取代或具有取代基之含芳香族烴之基、碳原子數2~40之未經取代或具有取代基之含雜環之基、碳原子數0~40之未經取代或具有取代基之矽烷基、或者該脂肪族烴基、該含芳香族烴之基、該含雜環之基或該矽烷基中之亞甲基之1個或2個以上被取代為選自下述群I中之二價基而成之基, R102 及R103 分別獨立地表示氫原子或碳原子數1~40之未經取代或具有取代基之脂肪族烴基, R104 表示鹵素原子、氰基、羥基、硝基、羧基、碳原子數1~40之未經取代或具有取代基之脂肪族烴基、碳原子數6~40之未經取代或具有取代基之含芳香族烴之基、碳原子數2~40之未經取代或具有取代基之含雜環之基、或者該脂肪族烴基、該含芳香族烴之基或該含雜環之基中之亞甲基之1個或2個以上被取代為選自下述群I中之二價基而成之基, 於R104 存在複數個之情形時,有複數個R104 彼此鍵結而形成苯環或萘環之情形, 於R104 存在複數個之情形時,有複數個R104 分別相同之情形,亦有不同之情形, n表示1~10之整數, a1表示0~2之整數, 於n為2~10之情形時,存在複數個之R101 、R102 、R103 、R104 及a1分別可相同亦可不同, X表示n價之基) 群I:-O-、-COO-、-OCO-、-CO-、-CS-、-S-、-SO-、-SO2 -、-NR230 -、-NR230 -CO-、-CO-NR230 -、-NR230 -COO-、-OCO-NR230 -或-SiR230 R231 -;R230 及R231 分別獨立地表示氫原子或未經取代之碳原子數1~40之脂肪族烴基。
A composition comprising: a compound represented by the following general formula (A1); a sulfur-based antioxidant; and a hardening component;
Figure 03_image053
(In the formula, R 101 represents an unsubstituted or substituted aliphatic hydrocarbon group with 1 to 40 carbon atoms, an unsubstituted or substituted aromatic hydrocarbon-containing group with 6 to 40 carbon atoms, and a carbon atom An unsubstituted or substituted heterocyclic group containing 2-40, an unsubstituted or substituted silyl group with 0-40 carbon atoms, or the aliphatic hydrocarbon group or the aromatic hydrocarbon-containing group One or more of the heterocyclic group or the methylene group in the silyl group is substituted with a divalent group selected from the following group I, R 102 and R 103 are each independently Represents a hydrogen atom or an unsubstituted or substituted aliphatic hydrocarbon group with 1-40 carbon atoms, R 104 represents a halogen atom, a cyano group, a hydroxyl group, a nitro group, a carboxyl group, an unsubstituted or a C 1-40 aliphatic hydrocarbon group Substituent aliphatic hydrocarbon group, unsubstituted or substituted aromatic hydrocarbon-containing group with 6 to 40 carbon atoms, unsubstituted or substituted heterocyclic ring-containing group with 2 to 40 carbon atoms , Or one or more of the methylene groups in the aliphatic hydrocarbon group, the aromatic hydrocarbon-containing group or the heterocyclic group-containing group are substituted with a divalent group selected from the following group I when group R 104 in the presence of a plurality of situation, there are plural R 104 bonded to each other to form a benzene or naphthalene ring of the case, in case of presence of a plurality of R 104, there are a plurality of R 104 are the same case, There are also different situations. n represents an integer from 1 to 10, and a1 represents an integer from 0 to 2. When n is 2 to 10, there are plural R 101 , R 102 , R 103 , R 104 and a1 respectively Can be the same or different, X represents the base of n valence) Group I: -O-, -COO-, -OCO-, -CO-, -CS-, -S-, -SO-, -SO 2 -,- NR 230 -, -NR 230 -CO-, -CO-NR 230 -, -NR 230 -COO-, -OCO-NR 230 -or -SiR 230 R 231 -; R 230 and R 231 each independently represent a hydrogen atom Or unsubstituted aliphatic hydrocarbon group with 1-40 carbon atoms.
如請求項1之組合物,其中R101 為碳原子數1~40之未經取代或具有取代基之脂肪族烴基、碳原子數6~40之未經取代或具有取代基之含芳香族烴之基、或者碳原子數2~40之未經取代或具有取代基之含雜環之基中的氧原子側末端之亞甲基被取代為選自上述群I中之二價基而成之基、或者碳原子數0~40之未經取代或具有取代基之矽烷基。The composition of claim 1, wherein R 101 is an unsubstituted or substituted aliphatic hydrocarbon group with 1 to 40 carbon atoms, and an unsubstituted or substituted aromatic hydrocarbon group with 6 to 40 carbon atoms The methylene group at the end of the oxygen atom in an unsubstituted or substituted heterocyclic group containing 2 to 40 carbon atoms is substituted with a divalent group selected from the above group I Group, or unsubstituted or substituted silyl group having 0-40 carbon atoms. 如請求項1之組合物,其中R102 及R103 分別獨立為氫原子、碳原子數1~40之未經取代或具有取代基之烷基。The composition of claim 1, wherein R 102 and R 103 are each independently a hydrogen atom, an unsubstituted or substituted alkyl group having 1 to 40 carbon atoms. 如請求項1之組合物,其中n表示2~4之整數, X為具有與n為同數之價數之碳原子數10~25之未經取代或具有取代基之脂肪族烴基;具有與n為同數之價數之碳原子數4~25之未經取代或具有取代基之含雜環之基;或者該脂肪族烴基或該含雜環之基中之亞甲基之1個或2個以上被取代為選自由-O-、-COO-、-OCO-及-CO-所組成之群中之二價基而成之基。Such as the composition of claim 1, wherein n represents an integer from 2 to 4, X is an unsubstituted or substituted aliphatic hydrocarbon group with 10-25 carbon atoms having the same valence as n; an unsubstituted or substituted aliphatic hydrocarbon group with 4-25 carbon atoms having the same valence as n A substituted or substituted heterocyclic ring-containing group; or one or more of the methylene groups in the aliphatic hydrocarbon group or the heterocyclic ring-containing group are substituted to be selected from -O-, -COO-,- OCO- and -CO- are formed by the divalent group in the group. 如請求項1之組合物,其中上述硫系抗氧化劑為硫醚系抗氧化劑。The composition of claim 1, wherein the sulfur-based antioxidant is a thioether-based antioxidant. 如請求項5之組合物,其中上述硫醚系抗氧化劑為選自由下述通式(B1)、(B2)、(B3)及(B4)所組成之群中之至少一種,
Figure 03_image055
(式中,R1 及R2 分別獨立地表示碳原子數6~20之芳基、碳原子數3~30之烷基、或該烷基中之亞甲基之1個或2個以上被取代為-O-或-S-而成之基, R3 、R4 、R5 、R6 、R7 、R8 、R9 及R10 分別獨立地表示氫原子、碳原子數1~8之烷基、或該烷基中之亞甲基之1個或2個以上被取代為-O-或-S-而成之基, 上述烷基之氫原子之1個或2個以上可被取代為烷氧基、烯基、烯氧基、羥基或氰基, 上述芳基之氫原子之1個或2個以上可被取代為羥基或碳原子數1~8之烷基)
Figure 03_image057
(式中,R11 表示碳原子數6~20之芳基、碳原子數3~30之烷基、或該烷基中之亞甲基之1個或2個以上被取代為-O-或-S-而成之基, R12 、R13 、R14 、R15 、R16 、R17 、R18 及R19 分別獨立地表示氫原子或碳原子數1~8之烷基, 上述烷基之氫原子之1個或2個以上可被取代為烷氧基、烯基、烯氧基、羥基或氰基, 上述芳基之氫原子之1個或2個以上可被取代為羥基或碳原子數1~8之烷基)
Figure 03_image059
(式中,R21 、R22 、R23 及R24 分別獨立地表示碳原子數3~30之烷基、或該烷基中之亞甲基之1個或2個以上被取代為-O-或-S-而成之基, 上述烷基之氫原子之1個或2個以上可被取代為烷氧基、烯基、烯氧基、羥基或氰基)
Figure 03_image061
(式中,R31 及R32 分別獨立地表示氫原子、碳原子數6~20之芳基、碳原子數3~30之烷基、或該烷基中之亞甲基之1個或2個以上被取代為-O-或-S-而成之基, L1 及L2 分別獨立地表示碳原子數1~8之伸烷基, 上述烷基及上述伸烷基之氫原子之1個或2個以上可被取代為烷氧基、烯基、烯氧基、羥基或氰基, 上述芳基之氫原子之1個或2個以上可被取代為羥基或碳原子數1~8之烷基)。
The composition of claim 5, wherein the thioether antioxidant is at least one selected from the group consisting of the following general formulas (B1), (B2), (B3) and (B4),
Figure 03_image055
(In the formula, R 1 and R 2 each independently represent an aryl group with 6 to 20 carbon atoms, an alkyl group with 3 to 30 carbon atoms, or one or more of the methylene groups in the alkyl group. Substituted with -O- or -S-, R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 and R 10 each independently represent a hydrogen atom and the number of carbon atoms is 1-8 The alkyl group, or one or more of the methylene groups in the alkyl group is substituted with -O- or -S-. One or more of the hydrogen atoms of the above-mentioned alkyl group may be (Substituted with alkoxy, alkenyl, alkenyloxy, hydroxyl or cyano, one or more of the hydrogen atoms of the above aryl group may be substituted with a hydroxyl group or an alkyl group with 1 to 8 carbon atoms)
Figure 03_image057
(In the formula, R 11 represents an aryl group with 6 to 20 carbon atoms, an alkyl group with 3 to 30 carbon atoms, or one or more of the methylene groups in the alkyl group are substituted with -O- or -S-, R 12 , R 13 , R 14 , R 15 , R 16 , R 17 , R 18 and R 19 each independently represent a hydrogen atom or an alkyl group having 1 to 8 carbon atoms. One or more of the hydrogen atoms of the group may be substituted with alkoxy, alkenyl, alkenyloxy, hydroxy, or cyano, and one or more of the hydrogen atoms of the above aryl group may be substituted with hydroxy or Alkyl group with 1 to 8 carbon atoms)
Figure 03_image059
(In the formula, R 21 , R 22 , R 23 and R 24 each independently represent an alkyl group having 3 to 30 carbon atoms, or one or more of the methylene groups in the alkyl group are substituted with -O -Or -S-, one or more of the hydrogen atoms of the alkyl group may be substituted with alkoxy, alkenyl, alkenyloxy, hydroxyl or cyano)
Figure 03_image061
(In the formula, R 31 and R 32 each independently represent one or two of a hydrogen atom, an aryl group having 6 to 20 carbon atoms, an alkyl group having 3 to 30 carbon atoms, or the methylene group in the alkyl group. More than one group substituted with -O- or -S-, L 1 and L 2 each independently represent an alkylene group having 1 to 8 carbon atoms, 1 of the above-mentioned alkyl group and the hydrogen atom of the above-mentioned alkylene group One or two or more may be substituted with alkoxy, alkenyl, alkenyl, hydroxy, or cyano, and one or two of the hydrogen atoms of the aryl group may be substituted with hydroxy or with 1-8 carbon atoms的alkyl).
如請求項6之組合物,其中式(B1)中之R1 及R2 分別獨立為碳原子數8~20之烷基, 式(B2)中之R11 為碳原子數8~20之烷基, 式(B3)中之R21 、R22 、R23 及R24 分別獨立為碳原子數8~20之烷基, 式(B4)中之R31 及R32 分別獨立為碳原子數8~20之烷基。Such as the composition of claim 6, wherein R 1 and R 2 in formula (B1) are each independently an alkyl group having 8-20 carbon atoms, and R 11 in formula (B2) is an alkane having 8-20 carbon atoms In formula (B3), R 21 , R 22 , R 23 and R 24 are each independently an alkyl group having 8 to 20 carbon atoms, and R 31 and R 32 in formula (B4) are independently 8 carbon atoms. ~20 alkyl group. 如請求項6之組合物,其中上述硫醚系抗氧化劑為上述通式(B3)或(B4)所示之化合物。The composition of claim 6, wherein the above-mentioned thioether antioxidant is a compound represented by the above-mentioned general formula (B3) or (B4). 如請求項1之組合物,其中上述通式(A1)所示之化合物之含量於上述通式(A1)所示之化合物及上述硫系抗氧化劑之合計100質量份中,為10質量份以上70質量份以下。The composition of claim 1, wherein the content of the compound represented by the general formula (A1) is 10 parts by mass or more in 100 parts by mass of the compound represented by the general formula (A1) and the sulfur-based antioxidant 70 parts by mass or less. 如請求項1之組合物,其中上述硬化性成分含有自由基聚合性化合物。The composition according to claim 1, wherein the curable component contains a radical polymerizable compound. 如請求項10之組合物,其中上述自由基聚合性化合物含有具有酸性基與乙烯性不飽和基之化合物。The composition according to claim 10, wherein the radically polymerizable compound contains a compound having an acidic group and an ethylenically unsaturated group. 如請求項10之組合物,其中上述硬化性成分進而含有熱硬化性化合物。The composition according to claim 10, wherein the curable component further contains a thermosetting compound. 一種硬化物,其係使如請求項1之組合物硬化而成。A hardened product obtained by hardening the composition according to claim 1. 一種硬化物之製造方法,其具有使如請求項1之組合物硬化之硬化步驟。A method for manufacturing a hardened product, which has a hardening step of hardening the composition of claim 1. 一種添加劑,其含有: 下述通式(A1)所示之化合物;及 硫系抗氧化劑;
Figure 03_image063
(式中,R101 表示碳原子數1~40之未經取代或具有取代基之脂肪族烴基、碳原子數6~40之未經取代或具有取代基之含芳香族烴之基、碳原子數2~40之未經取代或具有取代基之含雜環之基、碳原子數0~40之未經取代或具有取代基之矽烷基、或者該脂肪族烴基、該含芳香族烴之基、該含雜環之基或該矽烷基中之亞甲基之1個或2個以上被取代為選自下述群I中之二價基而成之基, R102 及R103 分別獨立地表示氫原子或碳原子數1~40之未經取代或具有取代基之脂肪族烴基, R104 分別獨立地表示鹵素原子、氰基、羥基、硝基、羧基、碳原子數1~40之未經取代或具有取代基之脂肪族烴基、碳原子數6~40之未經取代或具有取代基之含芳香族烴之基、碳原子數2~40之未經取代或具有取代基之含雜環之基、或者該脂肪族烴基、該含芳香族烴之基或該含雜環之基中之亞甲基之1個或2個以上被取代為選自下述群I中之二價基而成之基, 於R104 存在複數個之情形時,有複數個R104 彼此鍵結而形成苯環或萘環之情形, 於R104 存在複數個之情形時,有複數個R104 分別相同之情形,亦有不同之情形, n表示1~10之整數, a1表示0~2之整數, 於n為2~10之情形時,存在複數個之R101 、R102 、R103 、R104 及a1分別可相同亦可不同, X表示n價之基) 群I:-O-、-COO-、-OCO-、-CO-、-CS-、-S-、-SO-、-SO2 -、-NR230 -、-NR230 -CO-、-CO-NR230 -、-NR230 -COO-、-OCO-NR230 -或-SiR230 R231 -;R230 及R231 分別獨立地表示氫原子或未經取代之碳原子數1~40之脂肪族烴基。
An additive comprising: a compound represented by the following general formula (A1); and a sulfur-based antioxidant;
Figure 03_image063
(In the formula, R 101 represents an unsubstituted or substituted aliphatic hydrocarbon group with 1 to 40 carbon atoms, an unsubstituted or substituted aromatic hydrocarbon-containing group with 6 to 40 carbon atoms, and a carbon atom An unsubstituted or substituted heterocyclic group containing 2-40, an unsubstituted or substituted silyl group with 0-40 carbon atoms, or the aliphatic hydrocarbon group or the aromatic hydrocarbon-containing group , One or more of the heterocyclic group or the methylene group in the silyl group is substituted with a divalent group selected from the following group I, R 102 and R 103 are each independently Represents a hydrogen atom or an unsubstituted or substituted aliphatic hydrocarbon group with 1-40 carbon atoms, R 104 each independently represents a halogen atom, a cyano group, a hydroxyl group, a nitro group, a carboxyl group, and a C 1-40 aliphatic hydrocarbon group Substituted or substituted aliphatic hydrocarbon groups, unsubstituted or substituted aromatic hydrocarbon-containing groups with 6 to 40 carbon atoms, unsubstituted or substituted heterogeneous groups with 2 to 40 carbon atoms One or more of the methylene groups in the cyclic group, or the aliphatic hydrocarbon group, the aromatic hydrocarbon-containing group, or the heterocyclic group-containing group is substituted with a divalent group selected from the following group I from the group, there is to the case where a plurality of R 104, R 104 has a plurality bonded to each other to form a benzene or naphthalene ring of the case, there is to the case where a plurality of R 104, R 104 each have a plurality of identical There are also different situations. n represents an integer from 1 to 10, and a1 represents an integer from 0 to 2. When n is 2 to 10, there are multiple R 101 , R 102 , R 103 , R 104 And a1 can be the same or different, respectively, X represents the n-valent base) Group I: -O-, -COO-, -OCO-, -CO-, -CS-, -S-, -SO-, -SO 2 -, -NR 230 -, -NR 230 -CO-, -CO-NR 230 -, -NR 230 -COO-, -OCO-NR 230 -or -SiR 230 R 231 -; R 230 and R 231 are independently Represents a hydrogen atom or an unsubstituted aliphatic hydrocarbon group with 1-40 carbon atoms.
TW109115829A 2019-05-15 2020-05-13 Composition, cured product, cured product production method, and additive TW202108678A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019092480 2019-05-15
JP2019-092480 2019-05-15

Publications (1)

Publication Number Publication Date
TW202108678A true TW202108678A (en) 2021-03-01

Family

ID=73290034

Family Applications (1)

Application Number Title Priority Date Filing Date
TW109115829A TW202108678A (en) 2019-05-15 2020-05-13 Composition, cured product, cured product production method, and additive

Country Status (5)

Country Link
JP (1) JPWO2020230732A1 (en)
KR (1) KR20220008806A (en)
CN (1) CN113785009A (en)
TW (1) TW202108678A (en)
WO (1) WO2020230732A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114096568B (en) * 2019-10-28 2023-08-18 株式会社艾迪科 Composition, cured product, method for producing cured product, and additive

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3985705A (en) * 1973-04-05 1976-10-12 National Starch And Chemical Corporation Stabilized polyester compositions
JP2012230978A (en) * 2011-04-25 2012-11-22 Mitsui Chemicals Inc Solar cell sealing material, method for producing solar cell sealing material, and solar cell module
CN107817650A (en) * 2012-07-31 2018-03-20 株式会社艾迪科 Latency additive and the composition containing the additive
JP2015163672A (en) * 2014-01-30 2015-09-10 株式会社Adeka composition
JP2016038569A (en) * 2014-08-05 2016-03-22 株式会社Adeka Photosensitive composition
JP6654911B2 (en) 2016-01-22 2020-02-26 株式会社Adeka Antistatic thermoplastic resin composition and molded article using the same
TWI729100B (en) * 2016-03-29 2021-06-01 日商艾迪科股份有限公司 Photosensitive composition
TW201823413A (en) 2016-12-20 2018-07-01 日商荒川化學工業股份有限公司 Ultraviolet-curable adhesive, cured object and adhesive sheet wherein the ultraviolet-curable adhesive is substantially a solvent-free transparent adhesive that is not whitened due to high heat and high humidity

Also Published As

Publication number Publication date
JPWO2020230732A1 (en) 2020-11-19
KR20220008806A (en) 2022-01-21
WO2020230732A1 (en) 2020-11-19
CN113785009A (en) 2021-12-10

Similar Documents

Publication Publication Date Title
TWI724015B (en) combination
KR101930048B1 (en) β-HYDROXYALKYL AMIDE AND RESIN COMPOSITION
KR102459496B1 (en) Resin composition, resin sheet, multilayer printed wiring board, and semiconductor device
JP4180844B2 (en) Curable flame retardant composition, cured product thereof and production method thereof
CN106909027B (en) Colored photosensitive resin composition, color filter and method for producing the same, and image display device
KR102430118B1 (en) Resin composition, resin sheet, multilayer printed wiring board, and semiconductor device
TW201807497A (en) Negative photosensitive resin composition, cured film, method for producing cured film, semiconductor device, method for producing laminate, method for producing semiconductor device, and polyimide precursor
TW202014401A (en) Carbamoyl oxime compound, polymerization initiator containing said compound, and polymerizable composition
WO2019216266A1 (en) Compound, latent additive, composition, cured product, method for producing cured product, and method for producing composition
TWI832024B (en) Resin composition, resin sheet, multilayer printed wiring board, and semiconductor device
TW201807486A (en) Composition for forming interlayer insulating film, interlayer insulating film, method for forming interlayer insulating film pattern, and device
TW202108678A (en) Composition, cured product, cured product production method, and additive
TW202104185A (en) Carbamoyl oxime compound, and polymerization initiator and polymerizable composition containing said compound
TWI552981B (en) Novel di-oxime ester compound and photopolymerization initiator and photoresist composition including the same
TW202200633A (en) Radical polymerization initiator, composition, cured product, and cured product manufacturing method
KR20220157365A (en) Compounds, compositions, cured products and methods for preparing cured products
WO2022085475A1 (en) Composition, cured product, method for producing cured product, and additive
TW202104182A (en) Carbamoyloxime compound, and polymerization initiator and polymerizable composition containing said compound
JP2021004295A (en) Resin composition
TW202132356A (en) Composition, cured product, method for manufacturing cured product and additive
TW202130615A (en) Compound and method for producing same, resin composition, resin sheet, mulyilayer printed wiring board, and semiconductor device
TW202132256A (en) Compound and method for producing same, resin composition, resin sheet, mulyilayer printed wiring board, and semiconductor device
TW202112747A (en) Carbamoyl oxime compound, and polymerization initiator and polymerizable composition containing said compound
TW202035360A (en) Compound, acid generator, composition, cured product, cured product manufacturing method, and pattern coating manufacturing method
TW202110794A (en) Carbamoyl oxime compound, and polymerization initiator and polymerizable composition containing said compound